Home
  >  
Section 65

EurekaMag Full Text Articles Chapter 64,731



References:

McDonald, V; Tingzon, M; Quail, J F.; Ayers, J D.; Casey, K 2015: PC170. Chronicling a Decade of Pelvic Vascular Injuries During the Global War on Terror. Journal of Vascular Surgery 61(6): 163s-164s
DuBose, J J.; Perlick, A; Fortuna, G R.; Leake, S S.; Miller, C C.; Winchell, R J.; Safi, H J.; Azizzadeh, A 2015: PC176. Predictors of Aortic-Related Mortality in Blunt Thoracic Aortic Injury. Journal of Vascular Surgery 61(6): 165s-166s
Won, Y Sung 2015: PC180. Incidence and Clinical Characteristics of Deep Vein Thrombosis (DVT) After Total Knee Arthroplasty (TKA) with DVT Chemoprophylaxis. Journal of Vascular Surgery 61(6): 166s-167s
Srivastava, A 2015: PC188. A Comparison of Venous Physiological Outcome in Terms of Venous Refilling Times in Patients With Venous Insufficiency Undergoing Treatment With Endovenous Laser Ablation and Radiofrequency Ablation for SFJ/GSV Reflux. Journal of Vascular Surgery 61(6): 168s-169s
Krol, E; Ormond, D. George; Sheikh, M. Salman; Plummer, D; Hsu, R; Dietzek, A 2015: PC192. A Retrospective Analysis of Factors Influencing Outcomes of Tibial DVT Management and the Use of Anticoagulation. Journal of Vascular Surgery 61(6): 169s-170s
Hong-Tao, W; Qiang-Sun, Z 2015: PC196. Low-Level Electrical Stimulation of Aortic Root Ventricular Ganglionated Plexi Attenuates Autonomic Nerve-Mediated Atrial Fibrillation. Journal of Vascular Surgery 61(6): 170s-171s
Lala, S; Knowles, M; Timaran, D E.; Valentine, R J.; Timaran, C H. 2015: PC2. Superior Mesenteric Artery Outcomes After Fenestrated Endovascular Aortic Aneurysm Repair. Journal of Vascular Surgery 61(6): 116s-117s
McGinigle, K L.; Leese, P J.; Trani, J; Mureebe, L 2015: PC20. The SAAAVE Act Has Yet to Realize Its Promise in the Reduction of Ruptured Aneurysms. Journal of Vascular Surgery 61(6): 122s-123s
Fujimura, N; Xu, B; Xuan, H; Xiong, J J.; Deng, H; Michie, S A.; Dalman, R L. 2015: PC200. Immune Modulator FTY720 Suppresses Experimental Abdominal Aortic Aneurysms. Journal of Vascular Surgery 61(6): 171s-172s
Shortell, C K.; Markovic, J N. 2015: PC206. Analyses of Gene Expression and Mechanisms of Post-Transcriptional Gene Expression Modification(s) in Metabolic Pathways of Chronic Venous Insufficiency. Journal of Vascular Surgery 61(6): 173s-174s
Koons, K C.; Sehgal, C; Shang, E K.; Foley, P J.; Etkin, Y; Davis, J T.; Fairman, R M.; Jackson, B M. 2015: PC210. Turbulence in Saphenous Vein Bypass Grafts by Duplex Ultrasound Imaging. Journal of Vascular Surgery 61(6): 174s-175s
McVeigh, P Z.; Moloney, T; Wheatcroft, M; Wilson, B 2015: PC220. Direct High-Resolution Angioscopic Imaging During Endovascular Surgery. Journal of Vascular Surgery 61(6): 175s-176s
Horkan, D B.; Li, Y; Liu, Z-Jun; Velazquez, O C. 2015: PC224. Increasing E-Selectin by Recombinant Adenoassociated Virus Improves Angiogenesis in a Murine Model of Hind Limb Ischemia. Journal of Vascular Surgery 61(6): 176s-177s
Brooks, A J.; Hatfield, S; Lightell, D; Bazan, H A.; Woods, T. Cooper, C. 2015: PC226. Differences in Carotid Plaque Noncoding RNAs Are Also Observed in Serum: Potential Utility as a Biomarker of Plaque Rupture. Journal of Vascular Surgery 61(6): 177s-178s
Freeman, B M.; Mountain, D J.; Brock, T; Kirkpatrick, S; Arnold, J D.; Stevens, S; Goldman, M; Freeman, M B.; Klein, F; Grandas, O 2015: PC228. Testosterone Replacement Attenuates Hyperplasia Development in an Androgen-Deficient Model of Vascular Injury Independent of Matrix Metalloproteinase Regulation. Journal of Vascular Surgery 61(6): 178s-179s
Sobreira, M L.; Yoshida, W B.; Jaldin, R G.; Correa, C R.; Lourencao, P L.; Yoshida, R A.; Kolvenbach, R 2015: PC232. The Impact of Infrarenal Aortic Cross-Clamping on Cardiovascular and Renal Function During Aortic Surgery: An Experimental Study in a Porcine Model. Journal of Vascular Surgery 61(6): 179s-180s
Dua, A; Wang, D; Desai, S S.; Brown, K; Hieb, R A.; Lewis, B; Rossi, P; Tutton, S; Rilling, W; Patel, P; Lee, C J. 2015: PC24. Impact of Device Type and Long-Term Aortic Remodeling Following TEVAR for Blunt Thoracic Aortic Injury. Journal of Vascular Surgery 61(6): 123s-124s
Goltz, C J.; Fajardo, A; Taubman, M L.; Farlow, E C.; Veeraswamy, R K.; Motaganahalli, R L.; Sawchuk, A P.; Duwayri, Y 2015: PC34. Gender Differences in Patients Undergoing Fenestrated Aortic Aneurysm Repair. Journal of Vascular Surgery 61(6): 126s-127s
Miller, D F.; Brandt, C T.; Ahanchi, S S.; Dexter, D J.; Panneton, J M. 2015: PC38. The Role of Endo Anchors During Complex and Thoracic Endovascular Aortic Repairs: A Feasibility and Early Outcome Study. Journal of Vascular Surgery 61(6): 127s-128s
Ullery, B W.; Suh, G-Young; Lee, J T.; Liu, B; Stineman, R; Dalman, R L.; Cheng, C P. 2015: PC4. Comparative Geometric Analysis of Renal Artery Anatomy Before and After Fenestrated or Snorkel/Chimney EVAR. Journal of Vascular Surgery 61(6): 117s-118s
Veeraswamy, R K.; Birjiniuk, J; Ruddy, J M.; Timmins, L H.; Oshinski, J N.; Ku, D N. 2015: PC42. Phase-Contrast Magnetic Resonance Imaging Reveals Novel Fluid Dynamics in a Patient-Derived Silicone Model of Descending Thoracic Aortic Dissection. Journal of Vascular Surgery 61(6): 128s-129s
Doyle, A; Glocker, R J.; Ellis, J; Illig, K; Stoner, M C. 2015: PC44. The Role of Female Gender in Symptomatic and Ruptured Abdominal Aortic Aneurysm. Journal of Vascular Surgery 61(6): 129s-130s
Dietzek, A M.; Blackwood, S L. 2015: PC48. Emergent Aortic Endograft Explantation Due to Rupture: A Case Report and Video. Journal of Vascular Surgery 61(6): 130s-131s
Allen, K; Dryton, G R.; Michael Borkon, A.; Aggarwal, S A.; Davis, J.R.; Pak, A F.; Stewart, J R.; Stuart, R.S. 2015: PC52. Closed Incision Negative Pressure Dressing: Does it Reduce Wound Complications in Morbidly Obese Diabetics Who Require Groin Incisions for Large Endovascular Device Delivery?. Journal of Vascular Surgery 61(6): 131s-132s
Crawford, J D.; Vatankhah, N; Bohannan, C J.; Chivukula, V Keshav; Haller, S J.; Rugonyi, S; Landry, G J.; Moneta, G L.; Azarbal, A F. 2015: PC6. Aortic Outflow Occlusion Predicts Rupture of Abdominal Aortic Aneurysm. Journal of Vascular Surgery 61(6): 118s-119s
Scali, S T.; Beck, A W.; Feezor, R J.; Chang, C K.; Giles, K A.; Fatima, J; Berceli, S A.; Huber, T 2015: PC66. Risk and Prediction of Mortality After EVAR Conversion in the Vascular Quality Initiative. Journal of Vascular Surgery 61(6): 134s-135s
Mushtaq, H H.; Charlton-Ouw, K M.; Sandhu, H K.; Miller, C C.; Saqib, N U.; Azizzadeh, A; Estrera, A L.; Safi, H J. 2015: PC68. Resection and Graft Replacement of Thoracic Aortic Graft Infections. Journal of Vascular Surgery 61(6): 135s-136s
June, A S.; Laser, A; Harris, D G.; Crawford, A M.; Gammie, J S.; Taylor, B; Sarkar, R; Crawford, R S. 2015: PC70. Acute Limb Ischemia After Cardiothoracic Surgery Is Associated With High Rates of Amputation and Mortality. Journal of Vascular Surgery 61(6): 136s-137s
Chisci, E; Alamanni, N; Procacci, T; Michelagnoli, S; Setacci, C 2015: PC74. A Feasibility Study to Predict the Risk of Rupture of an Abdominal Aortic Aneurysm Using Ultrasound-Derived Imaging. Journal of Vascular Surgery 61(6): 137s-138s
Masterson, L L.; Kudlaty, E A.; Veerman, B; Starr, J E.; Go, M R.; Satiani, B N. 2015: PC78. Significant Cost-Savings for Medicare Can Result From Accurate Coding of Carotid Duplex Indications and Elimination of Inappropriate Tests. Journal of Vascular Surgery 61(6): 138s-139s
Chinnadurai, P; Chintalapani, G; Bechara, C F.; Bismuth, J; Lumsden, A B. 2015: PC82. 3D-3D Image Fusion for EVAR Guidance: Comparison of Spine-Based vs Aortic Wall Calcification-Based Alignment. Journal of Vascular Surgery 61(6): 139s-140s
Jayaraj, A; Huang, Y; DeMartino, R R.; Bower, T C.; Oderich, G S.; Gloviczki, P; Kalra, M; Duncan, A A.; Fleming, M D. 2015: PC84. Inferior Mesenteric Artery Reimplantation During Aortic Aneurysm Surgery. Journal of Vascular Surgery 61(6): 140s-141s
Sawchuk, A P.; Mumbaraddi, A; Yu, H W.; Dalsing, M C. 2015: PC88. The Complex Hemodynamics of Renal Artery Atherosclerosis. Journal of Vascular Surgery 61(6): 141s-142s
Batista, P; DiMuzio, P; Salvatore, D; Abai, B 2015: PC92. Have General Surgery Trainees Kept Pace with the Evolution of Vascular Surgery?. Journal of Vascular Surgery 61(6): 142s-143s
Archie, M M.; Nassiri, N; Eckstein, H Henning; Lawrence, P F. 2015: PC96. Open Surgical Simulation as a Means of Education in Vascular Surgery Training. Journal of Vascular Surgery 61(6): 143s-144s
De la Hoz, E; De La Hoz, E; Ortiz, Aés; Ortega, J; Prieto, B 2015: PCA filtering and probabilistic SOM for network intrusion detection. Neurocomputing 164: 71-81
Priest, J A.; Druce, M; Roberts, J; Schultheiss, P; Nakatsuka, Y; Suzuki, K 2015: PCATS Triaxial: A new geotechnical apparatus for characterizing pressure cores from the Nankai Trough, Japan. Marine and Petroleum Geology 66: 460-470
Madenjian, C P.; Ebener, M P.; Sepúlveda, M S. 2015: PCB concentrations of lake whitefish (Coregonus clupeaformis) vary by sex. Journal of Great Lakes Research 41(4): 1185-1190
Macksasitorn, S.; Janssen, J.; Gray, K.A. 2015: PCBs refocused: Correlation of PCB concentrations in Green Bay legacy sediments with adjacent lithophilic, invasive biota. Journal of Great Lakes Research 41(1): 215-221
Wu, D; Zhao, Y; Li, J 2015: PCF taper-based Mach Zehnder interferometer for refractive index sensing in a PDMS detection cell. Sensors and Actuators B, Chemical 213: 1-4
Canady, V A. 2015: PCPs, rather than mental health providers, seeing more children with MI. Mental Health Weekly 25(40): 1-3
Kil, V. I.; Besedina, E. N.; Tsigikalo, I. S. 2015: PCR analysis of different ladybird species (Coleoptera, Coccinellidae) with universal RAPD primers. Russian Agricultural Sciences 41(6): 446-449
Bernal-Silva, Sía; Villanueva-Segura, O Karina; Lugo-Trampe, Ángel; Trujillo-Murillo, K del Carmen; Ponce-García, G; Favela-Lara, S; Delgado-Encizo, I; Martínez-de-Villarreal, L E.; Garza-Guajardo, R; Barboza-Quintana, O; González-Alvarez, R; Flores-Suarez, A E.; Rodríguez-Sánchez, Iám Pablo 2015: PCR- RFLP for Identification of Bluetongue Virus Serotypes. Southwestern Entomologist 40(1): 25-36
Sousa, D Rayan Teixeira de; Santos, C Silvana da Silva; Wanke, B; Silva Júnior, R Moreira da; Santos, M Cordeiro dos; Cruz, Kátia Santana; Monte, Réia Lins; Nocker, A; Souza, Jão Vicente Braga de 2015: PCR-RFLP as a useful tool for diagnosis of invasive mycoses in a healthcare facility in the North of Brazil. Electronic Journal of Biotechnology 18(3): 231-235
Bailey, J.; Karaoglu, H.; Wellings, C. R.; Park, R. F. 2015: PCR-based simple sequence repeat markers for diagnostic identification of major clonal lineages ofPuccinia striiformisf. sp.triticiand related stripe rust pathogens in Australia. Australasian Plant Pathology 44(1): 97-103
Brinkmann, F.; von Bismarck, P.; Puppe, W.; Ankermann, T. 2015: PCR-basierte Erregerdiagnostik. Der Pneumologe 12(6): 464-473
Schmidt, B F.; Amorim, A F.; Hilsdorf, A W.S. 2015: PCRRFLP analysis to identify four ray species of the genus Dasyatis (Elasmobranchii, Dasyatidae) fished along the southeastern and southern coast of Brazil. Fisheries Research 167: 71-74
Kim, J. G.; Kang, B. W.; Yoon, S. 2015: PD-001 * Prognostic value of tumor infiltrating lymphocytes (TILs) in Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC). Annals of Oncology 26(Suppl 4): Iv101-Iv101
Pam, A.; Vernerey, D.; Chauffert, B.; Louvet, C.; Levi, F.; Galjaard, H.; Gourgou, S.; Bellera, C.; Anota, A.; Bonnetain, F. 2015: PD-002 * Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (DATECAN-2): an analysis of 9 pancreatic cancer trials. Annals of Oncology 26(Suppl 4): Iv101-Iv101
Tanizawa, Y.; Bando, E.; Tokunaga, M.; Kawamura, T.; Makuuchi, R.; Nanri, K.; Terashima, M. 2015: PD-003 * Incidence and risk factors of deep venous thrombosis detected by routine surveillance ultrasonography before surgery in patients with gastric cancer. Annals of Oncology 26(Suppl 4): Iv101-Iv101
Veldeman, L.; De Sutter, C.; Schiettecatte, K.; Monten, C.; Mulliez, T.; Van Greveling, A.; Speleers, B.; De Neve, W. 2015: PD-0043: 2-year cosmetic outcome of large breasted women randomized between prone and supine whole-breast irradiation. RadioTherapy and Oncology 115: S20-S21
Le Pechoux, C.; Kantor, G.; Deutsch, E.; Sargos, P.; Levy, A.; De Baere, T.; Buy, X.; Martinetti, F.; Stoeckle, E.; Terrier, P.; Le Cesne, A.; Italiano, A.; Soria, J.C.; Bonvalot, S. 2015: PD-0045: Ph I/II study evaluating the impact of nanoparticules combined to pre-operative radiotherapy in soft tissue sarcoma. RadioTherapy and Oncology 115: S21-S22
Rodda, S.; Tyldesley, S.; Morris, W. 2015: PD-0047: GU and GI toxicity in ASCENDE-RT*: a multicentre randomized trial of dose-escalated radiation for prostate cancer. RadioTherapy and Oncology 115: S22-S23
Janssens, G.O.; Langendijk, J.A.; Terhaard, C.H.; Doornaert, P.A.; Van den Ende, P.; De Jong, M.A.; Takes, R.P.; Span, P.N.; Kaanders, J.H. 2015: PD-0049: Quality of life after radiotherapy for advanced laryngeal cancer: results of the phase III ARCON trial. RadioTherapy and Oncology 115: S23-S24
Palmer, D.; Meyer, T.; Chao, Y.; Deptala, A.; Fartoux, L.; Feng, Y.- H.; Graham, J.; Lin, D.- Y.; Ma, Y. T.; Peck-Radosavljevic, M.; Ross, P.; Ryoo, B.- Y.; Yen, C.- J.; Hocke, J.; Vlassak, S.; Wenz, A.; Loembe, A.- B.; Cheng, A.- L. 2015: PD-005 * Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma. Annals of Oncology 26(Suppl 4): Iv102-Iv102
Thomsen, M.S.; Grau, C. 2015: PD-0051: Patterns of re-treatment with radiotherapy within a welldefined catchment area. RadioTherapy and Oncology 115: S24-S25
Defourny, N.; Dunscombe, P.; Lievens, Y. 2015: PD-0053: The cost of radiotherapy: a literature review. RadioTherapy and Oncology 115: S25-S26
Marino, D.; Filippi, R.; Cereda, S.; Belli, C.; Spadi, R.; Nasti, G.; Montano, M.; Amatu, A.; Lutrino, S.; Cagnazzo, C.; Ferrari, L.; Siena, S.; Ciuffreda, L.; Reni, M.; Aglietta, M.; Leone, F. 2015: PD-006 * Gemcitabine and Oxaliplatin (GEMOX) with or without Panitumumab as First-Line Treatment in Advanced Biliary Tract Cancer; final results and subgroup analysis of the Vecti-BIL Study. Annals of Oncology 26(Suppl 4): Iv102-Iv102
Cho, Y. K.; Kim, S.; Baek, I. H.; Park, S. J. 2015: PD-007 * Clinical outcome of Endoscopic Resection of Rectal Neuroendocrine Tumor- NET registry multicenter study. Annals of Oncology 26(Suppl 4): Iv102-Iv103
Pedersen, K.; Majithia, N.; Eickoff, R.; Looker, S.; Thanarajasingam, G.; Grothey, A. 2015: PD-008 * Safety and efficacy of desensitization protocols for platinum hypersensitivity reactions. Annals of Oncology 26(Suppl 4): Iv103-Iv103
Bakens, M.; van Gestel, Y.; Laarhoven, H.; Creemers, G.- J.; Besselink, M.; Lemmens, V.; de Hingh, I. 2015: PD-009 * Use of adjuvant chemotherapy after pancreatoduodenectomy for pancreatic cancer: a nationwide population-based study in the Netherlands. Annals of Oncology 26(Suppl 4): Iv103-Iv103
Mesange, P.; Bouygues, A.; Muller, D.; Savina, A.; Chibaudel, B.; Tournigand, C.; Andre, T.; de Gramont, A.; Larsen, A. 2015: PD-010 * Erlotinib attenuates bevacizumab-mediated activation of EGFR-survival signaling in CRC models independent of KRAS status providing a rational basis for the DREAM phase III clinical trial. Annals of Oncology 26(Suppl 4): Iv103-Iv103
Metzger, B.; Mahon, G.; Menzel, A.; Pauly, M.; Dicato, M. 2015: PD-011 * Inexpensive biomarkers for determining individuals at increased risk for colorectal cancer and hence have the repeat screening colonoscopy after the first normal earlier than guidelines recommend. Annals of Oncology 26(Suppl 4): Iv104-Iv104
Ikeda, M.; Yamanaka, T.; Yamazaki, K.; Yamaguchi, K.; Muro, K.; Kusumoto, T.; Uetake, H.; Sato, T.; Kato, T.; Nishina, T.; Kanazawa, A.; Oki, E.; Chao, C.; Maddala, T.; Krishnakumar, J.; Akagi, K.; Ochiai, A.; Ohashi, Y.; Ohtsu, A.; Yoshino, T. 2015: PD-012 * Validation study of the 12-gene Recurrence Score (RS) in patients (pts) with stage II and III colon cancer (CC) without adjuvant chemotherapy; SUNRISE Study. Annals of Oncology 26(Suppl 4): Iv104-Iv104
Heinemann, V.; Rivera, F.; O'Neill, B.; Koukakis, R.; Terwey, J. H.; Douillard, J. Y. 2015: PD-013 * A study level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors (EGFRIs) vs bevacizumab in patients with metastatic colorectal cancer (mCRC). Annals of Oncology 26(Suppl 4): Iv104-Iv105
Greer, P.B.; Woodruff, H.; Simpson, J. 2015: PD-0138: Real-time EPID based delivery verification during lung stereotactic body radiotherapy: initial experience. RadioTherapy and Oncology 115: S65-S66
Rivera, F.; Karthaus, M.; Hecht, J. R.; Fasola, G.; Canon, J.- L.; Koukakis, R.; Demonty, G.; Schwartzberg, L. 2015: PD-014 * First-line treatment with modified FOLFOX6 (mFOLFOX6) + panitumumab or bevacizumab in patients with RAS/BRAF wild-type (WT) metastatic colorectal carcinoma (mCRC). Annals of Oncology 26(Suppl 4): Iv105-Iv105
Bazalova-Carter, M.; Ahmad, M.; Matsuura, T.; Takao, S.; Matsuo, Y.; Fahrig, R.; Shirato, H.; Umegaki, K.; Xing, L. 2015: PD-0140: Proton induced x-ray fluorescence CT (pXFCT) imaging: a step towards proton beam range detection. RadioTherapy and Oncology 115: S66-S67
Mory, C.; Rit, S. 2015: PD-0143: 4D cone-beam computed tomography combining total variation regularization and motion compensation. RadioTherapy and Oncology 115: S68-S69
Boleij, A.; Tembuyser, L.; Taylor, A.; Kafatos, G.; Jenkins-Anderson, S.; Tack, V.; Dequeker, E.; van Krieken, H. 2015: PD-015 * A survey on current RAS-mutation testing practices in Europe. Annals of Oncology 26(Suppl 4): Iv105-Iv105
Grasselli, J.; Elez, E.; Sauri, T.; Macarulla, T.; Alsina, M.; Capdevila, J.; Argiles, G.; Hierro, C.; Salva, F.; Sanz-Garcia, E.; Racca, F.; Azaro, A.; Brana, I.; Ochoa de Olza, M.; Grau, I.; Sala, G.; Rodon, J.; Salazar, R.; Tabernero, J. 2015: PD-016 * Developmental therapeutics activity portrait in metastatic colorectal cancer (mCRC): Vall d'Hebron Institute of Oncology Program. Annals of Oncology 26(Suppl 4): Iv105-Iv106
Nishina, T.; Kuboki, Y.; Shinozaki, E.; Yamazaki, K.; Kajiwara, T.; Shitara, K.; Matsumoto, T.; Tsushima, T.; Okamoto, W.; Mochizuki, N.; Nomura, S.; Sato, A.; Ohtsu, A.; Yoshino, T. 2015: PD-017 * A multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE). Annals of Oncology 26(Suppl 4): Iv106-Iv106
Borot de Battisti, M.; Maenhout, M.; Denis de Senneville, B.; Hautvast, G.; Binnekamp, D.; Lagendijk, J.J.W.; Van Vulpen, M.; Moerland, M.A. 2015: PD-0179: An automated optimization tool for HDR prostate brachytherapy with divergent needles. RadioTherapy and Oncology 115: S88-S89
Hrinczenko, B.; Lehman, T.; Modali, R.; Shaik, M. 2015: PD-018 * Modifiable risk factors for colorectal cancer: A multinational case-control study. Annals of Oncology 26(Suppl 4): Iv106-Iv106
Li, A.; Djupvik, L.H.; Bruheim, K.; Nakken, E.; Skipar, K.; Hellebust, T.P. 2015: PD-0181: Image-guided adaptive brachytherapy for cervix cancer: higher target dose by increasing planning aim. RadioTherapy and Oncology 115: S89-S90
Smolic, M.; Sombroek, C.; Bloemers, M.; Van Triest, B.; Mans, A. 2015: PD-0182: Prediction of needle placement in the first fraction of cervix brachytherapy: pre-MRI plan versus expert opinion. RadioTherapy and Oncology 115: S90-S91
Yoganathan, S.; Hanna, N. 2015: PD-019 * What effect does pre-operative Enhanced Recovery Protocol counselling have on post-operative length of stay after colorectal resections?. Annals of Oncology 26(Suppl 4): Iv106-Iv107
Wyrwicz, L.; Jaroszewicz, S.; Rzepakowski, P.; Bujko, K. 2015: PD-020 * Uplift modeling in selection of patients to either radiotherapy or radiochemotherapy in resectable rectal cancer: reassessment of data from the phase 3 study. Annals of Oncology 26(Suppl 4): Iv107-Iv107
Protik, A.; Sonke, J.J.; Van Herk, M. 2015: PD-0230: Quantifying the impact of respiratory parameters in the spot scanning proton dose delivery. RadioTherapy and Oncology 115: S115-S116
Bertholet, J.; Fledelius, W.; Worm, E.S.; Høyer, M.; Poulsen, P.R. 2015: PD-0231: Time-resolved internal target translation and rotation during liver SBRT treatments. RadioTherapy and Oncology 115: S116-S117
Poulsen, P.; Worm, E.; Høyer, M.; Grau, C.; Petersen, J.B.B. 2015: PD-0233: Calculation of interplay effects caused by liver tumor motion during scanning proton therapy. RadioTherapy and Oncology 115: S117-S118
Steenbeke, F.; Gevaert, T.; Tuleasca, C.; Engels, B.; Van Den Berge, D.; Poels, K.; Verellen, D.; Storme, G.; Levivier, M.; De Ridder, M. 2015: PD-0235: Frameless multimodality image integration using vessel tree segmentation for stereotactic targeting of AVM. RadioTherapy and Oncology 115: S118-S119
Vasquez Osorio, E.M.; Kolkman-Deurloo, I.K.K.; Heijmen, B.J.M.; Hoogeman, M.S. 2015: PD-0237: Assessment of uncertainties in EBRT and BT dose mapping for cervical cancer patients based on ground truth validation. RadioTherapy and Oncology 115: S119-S120
Puxeu Vaqué, J.; Nailon, W.H.; Sankar, A. 2015: PD-0238: PUMA - Predicted Upshot Motion Analysis; a method to evaluate the interplay effect on lung SABR. RadioTherapy and Oncology 115: S120-S121
Rasmussen, J.H.; Vogelius, I.R.; Fischer, B.M.; Aznar, M.C.; Gothelf, A.B.; Friborg, J.; Kristensen, C.A.; Bentzen, S.M.; Specht, L. 2015: PD-028: FDG based dose painting in head and neck cancer: preliminary results of a phase I trial. RadioTherapy and Oncology 114: 17-18
Vogelius, I.; Rasmussen, J.H.; Fischer, B.M.; Aznar, M.C.; Loft, A.; Christensen, C.B.; Friborg, J.; Kristensen, C.A.; Specht, L. 2015: PD-029: Temporal stability and reproducibility of FDG-PET-based dose painting targets in head and neck cancer. RadioTherapy and Oncology 114: 18-19
He, Y.; Zhang, Z.; Zhang, C. 2015: PD-032: Sk(C)ip into the mouth. RadioTherapy and Oncology 114: 19-20
Mehanna, H.; Robinson, M.; Powell, N.; Paleri, V.; Hartley, A.; Fresco, L.; Al-Booz, H.; Junor, E.; Roberts, S.; Harrington, K. 2015: PD-034: Data from Pet Neck and GSK trials: Regional and geographic variability in HPV-associated oropharyngeal cancer. RadioTherapy and Oncology 114: 20-21
Bonner, J.A.; Harari, P.M.; Giralt, J.; Bell, D.; Raben, D.; Liu, J.; Schulten, J.; Ang, K.K.; Rosenthal, D.I. 2015: PD-036: Association of HPV/p16 status with efficacy and safety in pts with OPC in the phase 3 RT/cetuximab registration trial. RadioTherapy and Oncology 114: 21-22
Janssens, G.; Smeets, J.; Vander Stappen, F.; Prieels, D.; Perali, I.; Clementel, E.; Hotoiu, L.; Sterpin, E. 2015: PD-0378: Proton range assessment using prompt gamma monitoring of realistic pencil beam scanning treatments. RadioTherapy and Oncology 115: S180-S181
Høye, E.; Balling, P.; Muren, L.P.; Petersen, J.B.B.; Yates, E.; Skyt, P. 2015: PD-0379: Reducing the dose-rate dependence of a new radiochromic silicone based 3D dosimeter. RadioTherapy and Oncology 115: S181-S182
Duprez, F.; Berwouts, D.; Nevens, D.; Nuyts, S.; De Neve, W. 2015: PD-037: Prospective randomized adaptive dose-de-escalation-trial for the elective neck: acute toxicity and control. RadioTherapy and Oncology 114: 22-23
Reilly, A.J.; Van Esch, A.; Carver, A. 2015: PD-0381: Evaluation of a new Electronic Portal Imaging Device (EPID) for pre-treatment and in vivo dosimetry. RadioTherapy and Oncology 115: S182-S183
Izewska, J.; Wanklyn, M.; Grochowska, P.; Dunscombe, P. 2015: PD-0384: The XX Postal TLD Audit Programme: analysis of 10,660 results. RadioTherapy and Oncology 115: S184-S185
Thwaites, D.I.; Juneja, P.; Blake, S.; Sykes, J.R.; Barber, J.; Bromley, R.; Fisher, S.; Bailey, M.; Deshpande, S.; Cho, G.; Brink, C.; Hansen, C.R. 2015: PD-0386: Multi centre comparative dose accuracy of Flattening Filter Free beams for SBRT lung cancer treatment. RadioTherapy and Oncology 115: S185-S186
Ikawa, H.; Koto, M.; Hasegawa, A.; Takagi, R.; Naganawa, K.; Takenouchi, T.; Tsuji, H.; Kamada, T. 2015: PD-038: Risk factors for recurrence after carbon ion therapy for adenoid cystic carcinoma: impact of the histologic subtypes. RadioTherapy and Oncology 114: 23-24
Jager, E.A.; Schakel, T.; Caldas-Magalhaes, J.; Ligtenberg, H.; Kasperts, N.; Philippens, M.E.P.; Pameijer, F.A.; Terhaard, C.H.J.; Willems, S.M.; Raaijmakers, C.P.J. 2015: PD-0419: Overestimation of tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice. RadioTherapy and Oncology 115: S203-S204
Duprez, F.; Berwouts, D.; Boterberg, T.; De Gersem, W.; Olteanu, L.; Vercauteren, T.; De Neve, W. 2015: PD-0420: Randomised escalation trial with adaptive dose painting by numbers for head and neck cancer: interim analysis. RadioTherapy and Oncology 115: S204-S205
Lustberg, T.; Bailey, M.; Thwaites, D.I.; Miller, A.; Carolan, M.; Holloway, L.; Rios, E.; Dekker, A.; Hoebers, F.; Harris, J.; Dignam, J.; Komaki, R.; Trotti, A.; De los Santos, J.; McGarry, R.; Galloway, T.; Michalski, J. 2015: PD-0422: Validating a 2 year survival prediction model for laryngeal carcinoma patients in a clinical care and trial setting. RadioTherapy and Oncology 115: S205-S206
Reymen, B.; Oberije, C.; Van Loon, J.; Van Baardwijk, A.; Wanders, S.; Troost, E.; Hoebers, F.; Zindler, J.; Dingemans, A.; Bootsma, G.; Lunde, R.; Geraedts, W.; De Ruysscher, D.; Lambin, P. 2015: PD-0426: A clinical model predicting severe esophagitis in individual SCLC patients treated with chemo-radiotherapy. RadioTherapy and Oncology 115: S207-S208
Chundury, A.; Rehman, S.; Roach, M.; Mullen, D.; DeWeese, T.; Bradley, J.; Robinson, C. 2015: PD-0428: Radiation pneumonitis with stereotactic body radiotherapy: effects of angiotensin converting enzyme inhibitors. RadioTherapy and Oncology 115: S208-S209
Zotova, R.; Yarnold, J.; Wheatley, D.; Griffin, C.; Murray, B. 2015: PD-0430: Results from the radiotherapy quality assurance programme for the FAST-Forward breast trial. RadioTherapy and Oncology 115: S209-S210
Young-Afat, D.A.; Verkooijen, H.M.; Gregorowitsch, M.L.; Van Gils, C.H.; Van Vulpen, M.; Van den Bongard, H.J. 2015: PD-0431: Prevalence, risk factors and consequences of breast edema during and following radiotherapy in breast cancer patients. RadioTherapy and Oncology 115: S210-S211
Aguiar, A.; Trigo, L.; Stas, N. 2015: PD-0435: APBI single-centre experience over a decade - risk estimates and indication variations within current guidelines. RadioTherapy and Oncology 115: S212-S213
Ramlov, A.; Kroon, P.S.; Jürgenliemk_Schulz, I.; De Leeuw, A.; Fokdal, L.; Tanderup, K.; Lindegaard, J. 2015: PD-0437: Impact of lymph node dose on nodal control in patients with locally advanced cervical cancer. RadioTherapy and Oncology 115: S213-S214
Fairchild, P.S.; Chitambara, P.; Rajmohan, E.B.; Das, S. 2015: PD-0439: Interstitial brachytherapy in gynaecologic malignancies with IPSA; an analysis of 100 MUPIT applications. RadioTherapy and Oncology 115: S214-S215
Burchardt, E.; Cegla, P.; Roszak, A.; Cholewinski, W. 2015: PD-0441: Comparison of 18F-FLT PET and 18F-FDG PET in the radiotherapy treatment of cervical cancer. RadioTherapy and Oncology 115: S215-S216
Togno, M.; Menichelli, D.; Morin, O.; Oechsner, M.; Wilkens, J.J. 2015: PD-0443: Clinical evaluation of an innovative ionization chamber technology for patient quality assurance. RadioTherapy and Oncology 115: S216-S217
Villaggi, E. 2015: PD-0446: In vivo EPID dosimetry: 3D analysis applied to prostate VMAT treatments. RadioTherapy and Oncology 115: S217-S218
Meylan, S.; Bug, M.U.; Villagrasa, C. 2015: PD-0448: Influence of geometry and DNA target composition on the ionization cluster distributions using MC methods. RadioTherapy and Oncology 115: S218-S219
Carver, A.; Uzan, J.; Baker, C.; Nahum, A. 2015: PD-0450: A more exact approach to uncertainties in radiobiological parameter estimation. RadioTherapy and Oncology 115: S219-S220
Nomoto, A.K.; Sakumi, A.; Takahashi, W.; Igaki, H.; Iwai, Y.; Yoda, K.; Nakagawa, K. 2015: PD-0451: Plan comparison of volumetric modulated arc therapy with gamma knife radiosurgery for multiple brain metastases. RadioTherapy and Oncology 115: S220-S221
Wang, K.; Zhang, B.; Yu, J.; Tran, P.; Iordachita, I.; Patterson, M.; Wong, J. 2015: PD-0453: Bioluminescence tomography guided system for small animal radiation research. RadioTherapy and Oncology 115: S221-S222
Odén, J.; Zimmerman, J.; Poludniowski, G. 2015: PD-0456: Robustness of three stoichiometric CT-calibration parameterizations used in proton therapy. RadioTherapy and Oncology 115: S223-S224
Mönnich, D.; Welz, S.; Pfannenberg, C.; Zips, D.; Thorwarth, D. 2015: PD-0458: Estimation of the robustness of hypoxia PET quantification for multicenter data comparison. RadioTherapy and Oncology 115: S224-S225
Schmidt, M.L.; Knap, M.M.; Rasmussen, T.R.; Folkersen, B.H.; Hoffmann, L.; Møller, D.S.; Poulsen, P.R. 2015: PD-0459: Time-resolved differential motion of tumor and lymph nodes measured during lung cancer radiotherapy. RadioTherapy and Oncology 115: S225-S226
Grønborg, C.; Vestergaard, A.; Høyer, M.; Pedersen, E.M.; Kallehauge, J.; Muren, L.P. 2015: PD-0461: Population-based vs patient-specific margins for intrafractional motion in adaptive bladder radiotherapy. RadioTherapy and Oncology 115: S226-S227
Crijns, W.; Defraene, G.; Van Herck, H.; Depuydt, T.; Haustermans, K.; Maes, F.; Van den Heuvel, F. 2015: PD-0462: Towards dosimetric tracking with adaptive VMAT?. RadioTherapy and Oncology 115: S227-S228
Mercea, P.; Teske, H.; Giske, K.; Bendl, R. 2015: PD-0464: Adaptive search area template matching for image-based lung tumor tracking. RadioTherapy and Oncology 115: S228-S229
Peerlings, J.; Troost, E.; Nelemans, P.; Beets-Tan, R.; Hoffmann, A. 2015: PD-0465: MRI may replace FDG-PET/CT for selective lymph node irradiation in NSCLC radiotherapy: results of a meta-analysis. RadioTherapy and Oncology 115: S229-S230
Slim, N.; Passoni, P.; Gumina, C.; Fiorino, C.; Ronzoni, M.; Ricci, V.; Di Palo, S.; De Nardi, P.; Tamburini, A.; De Cobelli, F.; Orsi, M.; Deli, A.; Galani, D.; Broggi, S.; Rosati, R.; Gianni, L. 2015: PD-0467: Adaptive, preoperative radiotherapy with image guided Tomotherapy concomitant with chemotherapy in rectal cancer. RadioTherapy and Oncology 115: S230-S231
Mancosu, P.; Gaudino, A.; Lobefalo, F.; Maggi, G.; Navarria, P.; Palumbo, V.; Reggiori, G.; Stravato, A.; Scorsetti, M.; Tomatis, S. 2015: PD-0469: Robustness study on pitch and roll rotations for multiple cranial metastases using VMAT. RadioTherapy and Oncology 115: S231-S232
Pinar, B.; Rodriguez-Ibarria, N.; Cabezon-Pons, M.A.; Rey-Baltar, D.; Blanco-Suarez, J.M.; Garcia-Cabrera, L.; Henriquez Hernandez, L.A.; Federico, M.; Lloret, M.; Lara, P.C. 2015: PD-0479: Intraoperative radiation therapy for breast cancer with INTRABEAM: minimizing cost analysis. RadioTherapy and Oncology 115: S236-S237
Costa, P.; Oliveira, F.; Fonseca, G.; Costa, A.; Moutinho, J.; Ribeiro, M.; Vale, J.; Ponte, F. 2015: PD-0482: Early breast cancer treated with an electronic IORT system: report of the first patients treated in Portugal. RadioTherapy and Oncology 115: S237-S238
Boman, E.; Pickup, L.; Kapanen, M.; Kadir, T. 2015: PD-0523: Fractionation-corrected doses with deformable registration as a tool for treatment plan comparison. RadioTherapy and Oncology 115: S252-S253
Grönlund, E.; Johansson, S.; Montelius, A.; Ahnesjö, A. 2015: PD-0525: Analysis of recurrence probability versus pre-treatment FDG-PET SUV for RT patients with HNSCC for dose painting. RadioTherapy and Oncology 115: S253-S254
Warren, S.; Partridge, M.; Hurt, C.; Crosby, T.; Hawkins, M.A. 2015: PD-0526: Robustness of integrated boost plans for oesophageal cancer: arctherapy vs intensity-modulated proton therapy. RadioTherapy and Oncology 115: S254-S255
Van de Schoot, A.J.A.J.; Visser, J.; Van Kesteren, Z.; Janssen, T.M.; Rasch, C.R.N.; Bel, A. 2015: PD-0528: Beam set-up selection using Pareto fronts for robust proton therapy planning in cervical cancer. RadioTherapy and Oncology 115: S255-S256
Wagenaar, D.; Van der Schaaf, A.; Sijtsema, N.M.; Van Dijk, L.V.; Langendijk, J.A.; Steenbakkers, R.J.H.M.; Brouwer, C.L. 2015: PD-0529: CT image features associated with patient-rated xerostomia after radiotherapy for head and neck cancer. RadioTherapy and Oncology 115: S256-S257
Sasaki, M.; Nakamura, M.; Mukumoto, N.; Nakata, M.; Higashimura, K.; Hiraoka, M. 2015: PD-0531: Dosimetric investigation of rotational setup errors for spine stereotactic radiosurgery: a phantom study. RadioTherapy and Oncology 115: S257-S258
Ibáñez, P.; Vidal, M.; García-Marcos, R.; Guerra, P.; Udías, J.M. 2015: PD-0571: New genetic algorithm-based procedure to determine phase space for intraoperative radiation therapy. RadioTherapy and Oncology 115: S278-S279
Costa, F.; Sarmento, S.; Sousa, O. 2015: PD-0572: In vivo dosimetry using Gafchromic films during IOERT of rectal cancer. RadioTherapy and Oncology 115: S279-S280
Costa, F.; Sarmento, S.; Sousa, O. 2015: PD-0574: Dose distributions in pelvic intra-operative radiation therapy (IOERT). RadioTherapy and Oncology 115: S280-S281
Hayes, J.; McGarry, M.; Perkins, G.; Hammoud, R.W.; Paloor, S.; Divakar, S.; Riyas, M.; Benson, B.; Petric, P.; Al Hammadi, N. 2015: PD-0576: Quantification of dosimetric impact of rotational displacements in head and neck VMAT radiotherapy. RadioTherapy and Oncology 115: S281-S282
Hoek, S.Y.; Kraan, B.; Wisse, D.L.; Admiraal, M.A. 2015: PD-0578: Feasibility of expiration breath hold for irradiation of abdominal lesions. RadioTherapy and Oncology 115: S282-S283
Moura, F.; Babo, D.; Azevedo, A.C.; Remédios, C. 2015: PD-0579: Professional profile of the RTT by the level of competence in Portugal and its relationship with ESTRO Core Curriculum. RadioTherapy and Oncology 115: S283-S284
Pastore, G.; Menichelli, C.; Fanelli, A.; Tubin, S.; Arrichiello, C.; Grespi, S.; Ferullo, A.; Casamassima, F. 2015: PD-0581: In vivo dosimetry as verification of delivered dose leading to an adaptive radiotherapy. RadioTherapy and Oncology 115: S284-S285
Carlson, R H. 2015: PD-1 Inhibitor Active in Multiple Hard-to-Treat Tumor Types. Oncology Times 37(12): 30-31
Carlson, R H. 2015: PD-1 Inhibitor Active in Triple-Negative Breast Cancer. Oncology Times 37: 7-8
Carlson, R H. 2015: PD-1, CTLA-4 Checkpoint Inhibitors Face Off in Advanced Melanoma. Oncology Times 37(11): 9-10
Herzog, T.J.; Arguello, D.; Reddy, S.K.; Gatalica, Z. 2015: PD-1, PD-L1 expression in 1599 gynecological cancers: Implications for immunotherapy. Gynecologic Oncology 137: 204-205
Carlson, R H. 2015: PD-L1 Inhibitor MPDL3280A Could Be First Targeted Agent in Triple-Negative Breast Cancer. Oncology Times 37(11): 30-31
Matsuno, Y; Marukaawa, K; Hatanaka, Y 2015: PD1-4Pathology quality assurance in companion diagnosis. Annals of Oncology 26(Suppl 7): Vii 52-Vii 52
Ito, K-ichi; Ono, M; Oba, T; Iesato, A; Hanamura, T; Ito, T; Kanai, T; Maeno, K 2015: PD2-1Will molecular-targeted agents change clinical practice for advanced thyroid cancer?. Annals of Oncology 26(Suppl 7): Vii 53.1-Vii 53
Kiyota, N 2015: PD2-2Current status and future perspectives of molecular targeting treatment for thyroid cancer. Annals of Oncology 26(Suppl 7): Vii 53.2-Vii 53
Mochida, S 2015: PD4-1Reactivation of HBV in patients with resolved infection during and after antitumor and/or immunosuppressive therapies. Annals of Oncology 26(Suppl 7): Vii 54.1-Vii 54
Ikeda, M 2015: PD4-2Reactivation of hepatitis B viral infection in patients with solid tumor receiving chemotherapy. Annals of Oncology 26(Suppl 7): Vii 54.2-Vii 54
Tsushima, T 2015: PD4-3Prophylactic measure against reactivation of hepatitis B virus in chemotherapy for gastrointestinal cancer. Annals of Oncology 26(Suppl 7): Vii 54.3-Vii 54
Izadi, M; Abdollahi, J; Dubljevic, S S. 2015: PDE backstepping control of one-dimensional heat equation with time-varying domain. Automatica 54: 41-48
Dashkevich, A.; Tuuminen, R.; Keränen, M.; Raissadati, A.; Krebs, R.; Jokkinen, J.; Ylä-Herttuala, S.; Nykanen, A.; Lemström, K. 2015: PDGF-B Is Protective During Ischemia-Reperfusion Injury in Rat Cardiac Allografts. Journal of Heart and Lung Transplantation 34(4): S267-S268
Hutton, N; Oliver, D; Oliver, D; Hendricks-Ferguson, V; Ritchie, C 2015: PDIA Awards Presentation (TH334). Journal of Pain and Symptom Management 49(2): 344-345
Nakata, Y; Itoh, J-Ichi 2015: PDM Control Method for a Matrix Converter Converting Several-Hundred-kHz Single-Phase Input to Commercial Frequency Three-Phase Output. Electrical Engineering in Japan 191(4): 34-42
Fürjes, P.; Holczer, E. G.; Tóth, E.; Iván, K.; Fekete, Z.; Bernier, D.; Dortu, F.; Giannone, D. 2015: PDMS microfluidics developed for polymer based photonic biosensors. Microsystem Technologies 21(3): 581-590
Curro, F A; Robbins, D A; Naftolin, F; Grill, A; Vena, D; Terracio, L; Thompson, V P 2015: PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes. Clinical Investigation 5(5): 441-445
Descamps, L.; Labadie, C.; Joly, A.; Bazile, E.; Arbogast, P.; Cébron, P. 2015: PEARP, the Mto-France short-range ensemble prediction system. Quarterly Journal of the Royal Meteorological Society 141(690): 1671-1685
Krátký, S; Urbánek, M; Kolařík, V 2015: PEC Reliability in 3D E-beam DOE Nanopatterning. Microscopy and Microanalysis 21(S4): 230-235
Töfflinger, J Amaru; Laades, A; Korte, L; Leendertz, C; Montañez, L Margarita; Stürzebecher, U; Sperlich, H-Peter; Rech, B 2015: PECVD-AlOx/SiNx passivation stacks on wet chemically oxidized silicon: Constant voltage stress investigations of charge dynamics and interface defect states. Solar Energy Materials and Solar Cells 135: 49-56
Furtado, M 2015: PEDIATRICSB-91Racial-Ethnic Identity Development Among Intellectually Disabled Children and Adolescents: Theoretical and Practical Considerations. Archives of Clinical Neuropsychology 30(6): 555.3-556
Wilkening, G 2015: PEDIATRICSB-94Pediatric Amnestic Disorder: Without Hippocampal Involvement. Archives of Clinical Neuropsychology 30(6): 557-558
Belaidi, F. Sekli; Civélas, A.; Castagnola, V.; Tsopela, A.; Mazenq, L.; Gros, P.; Launay, J.; Temple-Boyer, P. 2015: PEDOT-modified integrated microelectrodes for the detection of ascorbic acid, dopamine and uric acid. Sensors and Actuators B, Chemical 214: 1-9
Jiang, Q; Liu, C; Lu, B; Xu, J; Song, H; Shi, H; Mo, D; Wang, Z; Jiang, F; Zhu, Z 2015: PEDOT:PSS film: a novel flexible organic electrode for facile electrodeposition of dendritic tellurium nanostructures. Journal of Materials Science 50(14): 4813-4821
Liu, X; Zhong, J; Li, J; Huang, S; Song, W 2015: PEG-assisted hydrothermal synthesis of BiOCl with enhanced photocatalytic performance. Applied Physics A: Materials Science and Processing 119(4): 1203-1208
Shi, G; Xia, S; Ye, J; Huang, Y; Liu, C; Zhang, Z 2015: PEG-simulated drought stress decreases cadmium accumulation in castor bean by altering root morphology. Environmental and Experimental Botany 111: 127-134
Shi, Y; Fan, S; Li, L; Li, Q; Chai, X; Ren, Q; Zhou, C 2015: PEGylated Aucore Agshell Nanorods as Optical Coherence Tomography Signal Nanoamplifiers. Plasmonics 10(6): 1381-1389
Wang, X-Dong; Teng, H; Hu, J-Jing; Xiu, Z-Long 2015: PEGylation of recombinant hirudin in mixed aqueousorganic solutions. Process Biochemistry 50(3): 367-377
Devrim, Yılser; Devrim, H 2015: PEM fuel cell short stack performances of silica doped nanocomposite membranes. International Journal of Hydrogen Energy 40(24): 7870-7878
Li, L; Rasmuson, A; Ingram, A; Johansson, M; Remmelgas, J; von Corswant, C; Folestad, S 2015: PEPT study of particle cycle and residence time distributions in a Wurster fluid bed. Aiche Journal 61(3): 756-768
Taniyama, Y; Yamauchi, T; Takeuchi, S; Kuroda, Y 2015: PER1polymorphism associated with shift work disorder. Sleep and Biological Rhythms 13(4): 342-347
Lagomarsino, S; Cattari, S 2015: PERPETUATE guidelines for seismic performance-based assessment of cultural heritage masonry structures. Bulletin of Earthquake Engineering 13(1): 13-47
Ashouri, H; Hsu, K-Lin; Sorooshian, S; Braithwaite, D K.; Knapp, K R.; Cecil, L. Dewayne; Nelson, B R.; Prat, O P. 2015: PERSIANN-CDR: Daily Precipitation Climate Data Record from Multisatellite Observations for Hydrological and Climate Studies. Bulletin of the American Meteorological Society 96(1): 69-83
Ahern, V. 2015: PET Scans for locally advanced breast cancer and diagnostic MRI to determine the extent of operation and radiotherapy (PET LABRADOR); TROG 12.02. Breast 24(3): 304-305
Kim, Y. K.; Lee, D. S. 2015: PET and SPECT in Neurology. Journal of Nuclear Medicine 56(11): 1804-1805
Lee, D. S. 2015: PET and SPECT in Neurology * PET and SPECT in Psychiatry * PET and SPECT of Neurobiological Systems. Journal of Nuclear Medicine 56(10): 1635-1635
Choi, H.; Lee, D. S. 2015: PET and SPECT of Neurobiological Systems. Journal of Nuclear Medicine 56(11): 1805-1805
Thomas, M.E.; Scott, C.; Badlani, J. 2015: PET scans in H&N malignancies friend or foe?. International Journal of Oral and Maxillofacial Surgery 44: E151-E152
Guo, D-Ming; Chen, X-Quan; Tang, L; Wu, J-Ning; Fu, T; Wang, X-Lin; Wang, X-Li; Chen, L; Wang, Y-Zhong 2015: PET-based copolyesters with bisphenol A or bisphenol F structural units: Their distinct differences in pyrolysis behaviours and flame-retardant performances. Polymer Degradation and Stability 120: 158-168
Sideras, P A.; Patil, V; Li, Z; Heiba, S; Kostakoglou, L 2015: PETCT of mesenteric panniculitis: A potential confounder of lymphoma. Radiography 21(1): E51-E53
Hintzke, M; Harrington, A 2015: PFA-100 Utilization: One Institution's Experience. American Journal of Clinical Pathology 144(Suppl 2): A131-A131
Belhaj, M.; Dridi, C.; Elhouichet, H. 2015: PFE: ZnO hybrid nanocomposites for OLED applications: Fabrication and photophysical properties. Journal of Luminescence 157: 53-57
Morrow, M. 2015: PG 1.01 Surgical management of early breast cancer 2015. Breast 24: S1-S2
Hudis, C. 2015: PG 1.04 Big data: are large prospective randomized trials obsolete in the future?. Breast 24: S3-S4
Whelan, T. 2015: PG 10.02 Evolving standards in breast cancer radiotherapy: who should receive locoregional RT?. Breast 24: S19-S20
Kunkler, I. 2015: PG 10.03 Technical innovation in adjuvant radiotherapy: evolution and evaluation of new treatments for today and tomorrow. Breast 24: S20-S21
Burstein, H.J. 2015: PG 11.02 Endocrine therapy for post-menopausal patients: type and duration. Breast 24: S21-S22
Hart, C.D.; Di Leo, A. 2015: PG 12.02 Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes. Breast 24: S22-S23
Wolff, A.C. 2015: PG 12.04 Long term side effects of adjuvant chemotherapy in patients with early breast cancer. Breast 24: S23-S24
Smith, I. 2015: PG 13.02 Management of breast cancer in older and frail patients. Breast 24: S24-S25
Reis-Filho, J.S.; Weigelt, B. 2015: PG 2.03 Discrepancies between genetic tools and immunohistochemistry: bad pathology and good signature, and vice-versa. Breast 24: S4-S5
Prat, A. 2015: PG 3.01 Clinical implications of the intrinsic molecular subtypes. Breast 24: S5-S6
Loi, S. 2015: PG 3.03 Molecular segmentation in luminal breast cancer: how to select the driver pathways. Breast 24: S6-S7
Balkwill, F. 2015: PG 4.01 Tumorstroma crosstalk: targeting stroma and inflammation. Breast 24: S7-S8
Gnant, M. 2015: PG 4.03 Targeting bone microenvironment: clinical implications. Breast 24: S8-S9
Tutt, A. 2015: PG 5.02 Targeting DNA repair pathways. Breast 24: S9-S10
Garber, J. 2015: PG 6.01 Using germline genetics in the management of breast cancer patients and their families. Breast 24: S10-S11
Goodwin, P.J. 2015: PG 6.03 Obesity and insulin resistance: clinical relevance and research priorities. Breast 24: S11-S12
Osborne, C.K.; Schiff, R. 2015: PG 7.03 The changing role of ER in endocrine resistance. Breast 24: S12-S13
Loibl, S. 2015: PG 8.01 Primary systemic therapy for clinicians: medical and research perspectives. Breast 24: S13-S14
Von Minckwitz, G. 2015: PG 8.03 Clinical usefulness and relevance of intermediate endpoints for cytotoxic primary systemic therapy. Breast 24: S14-S15
Carey, L.A. 2015: PG 8.04 Clinical trial designs in the neoadjuvant setting: challenges of the genomic era. Breast 24: S15-S16
Galimberti, V. 2015: PG 9.02 Feasibility of sentinel node biopsy in breast cancer after neoadjuvant treatment. Breast 24: S16-S17
Rutgers, E.J.T. 2015: PG 9.04 Conservative surgery for multifocal/multicentric disease. Breast 24: S17-S18
Rezai, M.; Kellersmann, S.; Knispel, S.; Kimmig, R.; Kern, P. 2015: PG 9.05 Breast conservative surgery and local recurrence. Breast 24: S18-S19
Diamond, J.M.; Cantu, E.; Lederer, D.J.; Tobias, J.; Arcasoy, S.; Olthoff, K.M.; Chang, B.; Feng, R.; Meyer, K.; Emond, J.; Shaked, A.; Christie, J.D. 2015: PGD Is Associated With Persistent Differential Gene Expression After Lung Transplantation. Journal of Heart and Lung Transplantation 34(4): S170-S171
Svetlitskaya, T V.; Tolstykh, N D.; Izokh, A E.; Thi, P Ngo 2015: PGE geochemical constraints on the origin of the Ni-Cu-PGE sulfide mineralization in the Suoi Cun intrusion, Cao Bang province, Northeastern Vietnam. Mineralogy and Petrology 109(2): 161-180
Do, T Dinh Thac; Termier, A; Laurent, A; Negrevergne, B; Omidvar-Tehrani, B; Amer-Yahia, S 2015: PGLCM: efficient parallel mining of closed frequent gradual itemsets. Knowledge and Information Systems 43(3): 497-527
Voermans, N.; Preisler, N.; Madsen, K.; Janssen, M.; Kusters, B.; Maas, D.; Groothuis, J.; Vissing, J.; van Engelen, B.; Lefeber, D. 2015: PGM1 deficiency A heterogeneous myopathy with opportunities for treatment. Neuromuscular Disorders 25: S188-S189
Loughan, A; Harrell, M; Perna, R; Allen, A; Suddarth, B 2015: PGR-1Megalencephaly-Capillary Malformation Syndrome: Pediatric Neuropsychological Case Report. Archives of Clinical Neuropsychology 30(6): 471.1-471
Holder, C; Rach, A 2015: PGR-2Neuropsychological Profile of Pediatric Pseudotumor Cerebri Syndrome: A Case Study. Archives of Clinical Neuropsychology 30(6): 471.2-471
Wilkinson-Smith, A; Greenberg, B; Ayers, A 2015: PGR-3The Princess and the P-Value: Functional Neurological Symptoms and Rare Neuroimmunological Disease. Archives of Clinical Neuropsychology 30(6): 472-472
Morling, D 2015: PHNs covering rural and remote areas must hit the ground running. Australian Journal of Rural Health 23(3): 191-191
Drießen, J; Schöttler, M; Enzmann, F; Lakdawala, Z; Steiner, K; Popov, P; Iliev, O; Drews, M; Wieber, G; Kersten, M 2015: PHREASIM – Ein Expertensystem zur Simulation von Fließverhältnissen in Grundwassermessstellen und deren unmittelbarem Nahfeld. Grundwasser 20(3): 181-195
Kim, I.A.; Jang, N.Y.; Kim, D.H.; Cho, B.J.; Choi, E.J. 2015: PI3K Inhibitor Increased Radiosensitizing Effect of PARP Inhibitor in BRCA-Proficient Triple Negative Breast Cancer Cells. International Journal of Radiation Oncology*biology*physics 93(3): E533-E534
Veltkamp, C; Feuerecker, B; Mattes, C; Schönhuber, N; Schuck, K; Seidler, B; Schwaiger, M; Schmid, R M.; Schneider, Günter; Saur, D 2015: PI3K signaling in pancreatic cancer progression and maintenance. Pancreatology 15(3): S16-S17
Zhang, H; Trias, F. Xavier; Oliva, A; Yang, D; Tan, Y; Shu, S; Sheng, Y 2015: PIBM: Particulate immersed boundary method for fluidparticle interaction problems. Powder Technology 272: 1-13
Trunec, D.; Bonaventura, Z.; Zikin, P.; Jánský, J. 2015: PIC/MCC Simulation of Electron and Ion Currents to Spherical Langmuir Probe. Contributions to Plasma Physics 55(6): 481-493
Martin, D.T.; Baributsa, D.; Huesing, J.E.; Williams, S.B.; Murdock, L.L. 2015: PICS bags protect wheat grain, Triticum aestivum (L.), against rice weevil, Sitophilus oryzae (L.) (Coleoptera: Curculionidae). Journal of Stored Products Research 63: 22-30
Santos, D Costa; Barroso, M da Luz; Gomes, N; Ramião, N; Martins, P; Dias, Cáudia Camila; Costa, Hácio 2015: PIP breast implant ruptureA retrospective study from Portugal. European Journal of Plastic Surgery 38(4): 301-308
Zhang, X; Su, G; Yu, J; Yao, Z; He, F 2015: PIV measurement and simulation of turbulent thermal free convection over a small heat source in a large enclosed cavity. Building and Environment 90: 105-113
Edwards, J M.; Danao, L Angelo; Howell, R J. 2015: PIV measurements and CFD simulation of the performance and flow physics and of a small-scale vertical axis wind turbine. Wind Energy 18(2): 201-217
Besbes, S.; El Hajem, M.; Ben Aissia, H.; Champagne, J.Y.; Jay, J. 2015: PIV measurements and Eulerian Lagrangian simulations of the unsteady gasliquid flow in a needle sparger rectangular bubble column. Chemical Engineering Science 126: 560-572
Shestakov, M V.; Dulin, V M.; Tokarev, M P.; Sikovsky, D Ph.; Markovich, D M. 2015: PIV study of large-scale flow organisation in slot jets. International Journal of Heat and Fluid Flow 51: 335-352
Baakman, A.C.; Rissmann, R.; Klaassen, E.S.; van Gerven, J.M.A.; Groeneveld, G.J. 2015: PK and PD of a nicotinic anticholineric challenge with mecamylamine in comparison to scopolamine. Clinical Therapeutics 37(8): E10-E11
Bogiel, M.; Pawlowska, M.; Duda, J.; Sieradzki, E 2015: PK/PD Modelling of Diltiazem in healthy subjects using HRV parameters. Clinical Therapeutics 37(8): E97-E98
Sorenson, J L.; Mercedes, R; Schlessman, J L.; García-Moreno, B 2015: PKA Values of Buried Groups in Proteins are Sensitive to the Global Thermodynamic Stability. Biophysical Journal 108(2): 530a-531a
Heinz, A. 2015: PL.03.01 The role of motivation and reward in mental disorders. European Neuropsychopharmacology 25: S107-S108
Kalin, N.H. 2015: PL.06.01 Anxious temperament: results from a translational neuroscience approach. European Neuropsychopharmacology 25: S108-S109
Rees, H 2015: PL01.1Gollow lecture sti and sustainable development in 2015 and beyond. Sexually Transmitted Infections 91(Suppl 2): A1.2-A1
Barbour, V 2015: PL01.2Sti and the open access revolution in publishing. Sexually Transmitted Infections 91(Suppl 2): A1.3-A1
Allen, K; Pearson-Stuttard, J; Hooton, W; Diggle, P; Capewell, S; O'Flaherty, M 2015: PL01Exploring the potential of trans fats policies to reduce socio-economic inequalities in cardiovascular disease mortality in england: a cost-effectiveness modelling study. Journal of Epidemiology and Community Health 69(Suppl 1): A52.1-A52
Arabena, K 2015: PL02.1Falling between the gaps: an overview of issues for aboriginal and torres strait islander women who want to be sexually healthy. Sexually Transmitted Infections 91(Suppl 2): A2.1-A2
McClelland, S 2015: PL02.2Reproductive tract infections in women. Sexually Transmitted Infections 91(Suppl 2): A2.2-A2
Bin, Y 2015: PL02.3Syphilis elimination in china. Sexually Transmitted Infections 91(Suppl 2): A2.3-A3
Guo, W; Reeves, G; Key, T 2015: PL02Body size and composition, physical activity and breast cancer risk: results from the UK biobank prospective cohort. Journal of Epidemiology and Community Health 69(Suppl 1): A52.2-A53
Valdivia, R 2015: PL03.1Advances in chlamydia genetics from understanding basic biology to vaccine design. Sexually Transmitted Infections 91(Suppl 2): A3.1-A3
Hocking, J 2015: PL03.2Screening for chlamydia: does it work, results from accept. Sexually Transmitted Infections 91(Suppl 2): A3.2-A3
Keane, E; Perry, C; Kearney, P; Harrington, J; Perry, I; Cullinan, J; Layte, R 2015: PL03Childhood obesity, dietary quality and the role of the local food environment: cross-sectional analysis from the growing up in ireland study. Journal of Epidemiology and Community Health 69(Suppl 1): A53.1-A53
Agot, K 2015: PL04.1Male circumcision for sti prevention: how well does it work and how is it done?. Sexually Transmitted Infections 91(Suppl 2): A3.3-A3
de Vries, H JC 2015: PL04.3Sexually transmitted infections in men who have sex with men. Sexually Transmitted Infections 91(Suppl 2): A4.2-A4
Cohen, M S 2015: PL05.1Treatment to prevent hiv: does timing matter?. Sexually Transmitted Infections 91(Suppl 2): A4.3-A5
Passmore, J-Ann 2015: PL05.2Why sti-associated genital tract inflammation still matters in hiv transmission. Sexually Transmitted Infections 91(Suppl 2): A5.1-A5
Ghanem, K 2015: PL05.3Hiv and syphilis: a syndemic with no end in sight. Sexually Transmitted Infections 91(Suppl 2): A5.2-A5
Cáceres, C 2015: PL06.1Legal and human rights dimensions of hiv and sti: historical background and policy implications. Sexually Transmitted Infections 91(Suppl 2): A5.3-A6
Adams, P C. 2015: PLACE ATTACHMENT: Advances in Theory, Methods and Applications. Geographical Review 105(1): 129-132
Zelenyi, L. M.; Zastenker, G. N.; Petrukovich, A. A.; Chesalin, L. S.; Nazarov, V. N.; Prokhorenko, V. I.; Balaz, J.; Kudela, K.; Strgarski, I.; Slivka, M.; Gladyshev, V. A.; Kirpichev, I. P.; Sarris, E.; Sarris, T.; Lakutina, E. V.; Minskaya, L. K.; Krukovskaya, E. V.; Beznos, A. V.; Markov, Y. I.; Tretyakov, A. E.; Batanov, O. V.; Korotkov, F. V.; Melnik, A. P.; Konoplev, V. V.; Ryabova, A. D.; Gevorkova, E. V.; Klimenchenko, M. V.; Bazhenov, A. G.; Belova, I. E.; Gavrilova, E. A.; Ananenkova, A. N.; Rudnevskaya, L. V.; Dyachkov, A. V.; Starostina, O. A.; Ryazanova, E. E.; Eismont, N. A.; Safrankova, J.; Nemecek, Z.; Prech, L.; Cermak, I.; Vaverka, J.; Komarek, A.; Vojta, J.; Karimov, B. T.; Agafonov, Y. N.; Borodkova, N. L.; Gagua, T. I. 2015: PLASMA-F experiment: Three years of on-orbit operation. Solar System Research 49(7): 580-603
Zabihi, F; Yang, M; Leng, Y; Zhao, Y 2015: PLGAHPMC nanoparticles prepared by a modified supercritical anti-solvent technique for the controlled release of insulin. Journal of Supercritical Fluids 99: 15-22
Moschas, F; Stiros, S 2015: PLL bandwidth and noise in 100 Hz GPS measurements. Gps Solutions 19(2): 173-185
Harrou, F; Nounou, M N.; Nounou, H N.; Madakyaru, M 2015: PLS-based EWMA fault detection strategy for process monitoring. Journal of Loss Prevention in the Process Industries 36: 108-119
Lobo, P; Hagen, D E.; Whitefield, P D.; Raper, D 2015: PM emissions measurements of in-service commercial aircraft engines during the Delta-Atlanta Hartsfield Study. Atmospheric Environment 104: 237-245
Nicolás, J.F.; Galindo, N.; Yubero, E.; Crespo, J.; Soler, R. 2015: PM1 variability and transport conditions between an urban coastal area and a high mountain site during the cold season. Atmospheric Environment 118: 127-134
Djalalova, I; Delle Monache, L; Wilczak, J 2015: PM2.5 analog forecast and Kalman filter post-processing for the Community Multiscale Air Quality (CMAQ) model. Atmospheric Environment 108: 76-87
Salameh, D; Detournay, A; Pey, J; Pérez, N; Liguori, F; Saraga, D; Bove, M Chiara; Brotto, P; Cassola, F; Massabò, D; Latella, A; Pillon, S; Formenton, G; Patti, S; Armengaud, A; Piga, D; Jaffrezo, J Luc; Bartzis, J; Tolis, E; Prati, P; Querol, X; Wortham, H; Marchand, N 2015: PM2.5 chemical composition in five European Mediterranean cities: A 1-year study. Atmospheric Research 155: 102-117
Pokhrel, A K.; Bates, M N.; Acharya, J; Valentiner-Branth, P; Chandyo, R K.; Shrestha, P S.; Raut, A K.; Smith, K R. 2015: PM2.5 in household kitchens of Bhaktapur, Nepal, using four different cooking fuels. Atmospheric Environment 113: 159-168
Pirovano, G.; Colombi, C.; Balzarini, A.; Riva, G.M.; Gianelle, V.; Lonati, G. 2015: PM2.5 source apportionment in Lombardy (Italy): Comparison of receptor and chemistry-transport modelling results. Atmospheric Environment 106: 56-70
Xiao, Z-Yi; Huang, S-Xian; Zhai, S-Ru; Zhai, B; Zhang, F; An, Q-Da 2015: PMHS-reduced fabrication of hollow AgSiO2composite spheres with developed porosity. Journal of Sol-Gel Science and Technology 75(1): 82-89
Zhang, Z; Liu, L; Yu, C; Li, H; He, Y; Lü, X; Wong, W-Kwok; Jones, R A. 2015: PMMA-supported hybrid materials doped with highly near-infrared (NIR) luminescent neutral trikis-β-diketonate Yb3+ complex. Inorganic Chemistry Communications 52: 53-55
Wu, L; Kravchinsky, V A.; Potter, D K. 2015: PMTec: A new MATLAB toolbox for absolute plate motion reconstructions from paleomagnetism. Computers and Geosciences 82: 139-151
Hu, Q; Hu, W; Kong, J; Zhang, X 2015: PNA-based DNA assay with attomolar detection limit based on polygalacturonic acid mediated in-situ deposition of metallic silver on a gold electrode. Microchimica Acta 182(1-2): 427-434
Chesney, M L. 2015: PNPs Needed to Influence and Leverage Resources to Confront Threats to Children's Health and Well-Being. Journal of Pediatric Health Care 29(2): 123-125
Nasseripour, M.; Meningaud, J. 2015: PO-059: Head and neck cancer: challenges raised by the free movement of oral surgeons in the European Union. RadioTherapy and Oncology 114: 32-33
Netto, E.; Ferreira, M.; Sargento, I.; Esteves, S.; Almeida, T.; Pocinho, R.; Carita, L.; Montalvão, P.; Magalhães, M.; Roldão, M. 2015: PO-062: Dose-painting IMRT with chemotherapy for nasopharyngeal carcinoma: single institution retrospective study. RadioTherapy and Oncology 114: 33-34
Pedraza Fernández, S.; Hernández Martínez, A.C.; Ruiz Solis, S.; Fernandez Bedoya, V.; Cabezas Mendoza, A.M.; Sanchez, D.; Perez-Regadera, J.F.; Ruiz Alonso, A. 2015: PO-0640: The advantages of using 18FDG PET-CT in staging and delineation of radiotherapy target volume for head and neck cancer. RadioTherapy and Oncology 115: S310-S311
Castelli, J.; Simon, A.; Rigaud, B.; Henry, O.; Chajon, E.; Haigron, P.; Ospina Arango, J.D.; Vauleon, E.; Benezery, K.; De Crevoisier, R. 2015: PO-0642: Nomograms to assess the parotid gland dose in head and neck IMRT based on anatomical markers. RadioTherapy and Oncology 115: S311-S312
Tribius, S.; Donner, J.; Haladyn, S.; Münscher, A.; Gröbe, A.; Krüll, A.; Petersen, C.; Tennstedt, P. 2015: PO-0645: Does overall treatment time matter in patients with locally advanced head and neck cancer? An old chestnut revisited. RadioTherapy and Oncology 115: S313-S314
Differding, S.; Sterpin, E.; Lee, J.A.; Grégoire, V. 2015: PO-0646: Adaptive and robust FDG-PET-based dose painting by numbers (DPBN) in head and neck tumors: a methodological approach. RadioTherapy and Oncology 115: S314-S315
Christianen, M.E.M.C.; Verdonck-de Leeuw, I.M.; Doornaert, P.; Chouvalova, O.; Steenbakkers, R.J.H.M.; Leemans, R.; Oosting, S.F.; Slotman, B.J.; Bijl, H.P.; Langendijk, J.A. 2015: PO-0648: Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. RadioTherapy and Oncology 115: S315-S316
Ghorbal, L.; Jmour, O.; Elloumi, F.; Siala, W.; Toumi, N.; Ghorbel, A.; Frikha, M.; Daoud, J. 2015: PO-064: Nodal failures of nasopharyngeal cancer: a Tunisian experience. RadioTherapy and Oncology 114: 34-35
Wiedenmann, N.; Kerti, H.; Bunea, A.; Mix, M.; Grosu, A.L. 2015: PO-0650: Dynamics of tumor hypoxia in serial 18F-Misonidazole PET for SCCHN during chemoradiation and correlation to outcome. RadioTherapy and Oncology 115: S316-S317
Yamamoto, T.; Niibe, Y.; Yamashita, H.; Katsui, K.; Nakagawa, K.; Kanazawa, S.; Kawamori, J.; Koto, M.; Terahara, A.; Jingu, K. 2015: PO-0652: Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state. RadioTherapy and Oncology 115: S317-S318
Li, B.; Han, D.; Huang, W.; Zhou, T.; Zhang, Z.; Wang, Z.; Wei, Y.; Lin, H.; Li, H. 2015: PO-0654: Efficacy of simultaneous integrated boost intensitymodulated radiation therapy in patients with LD-SCLC. RadioTherapy and Oncology 115: S318-S319
Groom, N.; Wilson, E.; Falk, S.; Faivre-Finn, C. 2015: PO-0656: Effect of accurate heart outlining on radiation dose to the heart - the CONVERT Trial experience. RadioTherapy and Oncology 115: S319-S320
Dankers, F.; Wijsman, R.; Troost, E.; Bussink, J.; Hoffmann, A. 2015: PO-0659: 2D dose-surface data does not improve predictive performance of NTCP model for esophageal toxicity. RadioTherapy and Oncology 115: S320-S321
Wilson, E.; Groom, N.; Falk, S.; Faivre-Finn, C. 2015: PO-0660: A survey of current lung radiotherapy treatment techniques used during the CONVERT Trial. RadioTherapy and Oncology 115: S321-S322
Farr, K.P.; Khalil, A.A.; Kramer, S.; Morsing, A.; Grau, C. 2015: PO-0662: Role of SPECT in predicting the risk of lung toxicity after radiotherapy in lung cancer patients. a prospective study. RadioTherapy and Oncology 115: S322-S323
Chan, C.; McCloskey, P.; Ashcroft, L.; Whitehurst, P.; Kennedy, J.; Shears, A.; Bewley, M.; Goldstraw, R.; Bayman, N.; Faivre-Finn, C. 2015: PO-0663: Lung V5 does not predict for lung toxicity after fixed-beam intensity modulated radiotherapy (IMRT) for lung cancer. RadioTherapy and Oncology 115: S323-S324
Lindberg, K.; Grozman, V.; Lindberg, S.; Lax, I.; Lewensohn, R.; Wersäll, P. 2015: PO-0665: Radiation induced brachial plexus toxicity after SBRT of apically located lung lesions. RadioTherapy and Oncology 115: S324-S325
Nowicki, S.; Mangion, K.; Berry, C.; Sattar, N.; Sankaralingham, M.; Glegg, M.; Lawless, C.; Paul, J.; Stobo, J.; Foster, J.; O'Rourke, N.; Mohammed, N. 2015: PO-0667: Cardiac toxicity in lung cancer patients after chemo-radiotherapy (CART): a pilot study. RadioTherapy and Oncology 115: S325-S326
Oberije, C.; Deasy, J.; Lievens, Y.; Belderbos, J.; Vandecasteele, K.; Uyterlinde, W.; Rimner, A.; Troost, E.G.C.; Lambin, P. 2015: PO-0669: External validation of a survival model for stage III NSCLC: focus on similarities or differences?. RadioTherapy and Oncology 115: S326-S327
Bonomo, P.; Paiar, F.; Desideri, I.; Turkaj, A.; Ciabatti, C.; Santi, R.; Deganello, A.; Gallo, O.; Squadrelli, M.; Livi, L. 2015: PO-066: Impact of intensity-modulated radiotherapy in the treatment of nasopharyngeal cancer: single center experience. RadioTherapy and Oncology 114: 35-36
Stuschke, M.; Pöttgen, C.; Abu Jawad, J.; Gauler, T.; Guberina, M.; Bockisch, A.; Stamatis, G.; Eberhardt, W. 2015: PO-0670: Decrease in tumor SUVmax during definitive or neoadjuvant RT/CT is a prognostic factor in LAD lung cancer. RadioTherapy and Oncology 115: S327-S328
Fontanella, A.; Jeong, J.; Zuniga, A.; Thorstad, W.L.; Bradley, J.B.; Robinson, C.R.; Sonke, J.J.S.; Chen, C.C.; Deasy, J.D. 2015: PO-0672: Predicting tumor control from dose and fractionation schedule: fitting and validation with clinical data. RadioTherapy and Oncology 115: S328-S329
Pöttgen, C.; Stuschke, M.; Gauler, T.; Friedel, G.; Veit, S.; Heinzelmann, F.; Welter, S.; Spengler, W.; Schmidberger, H.; Lütke-Brintrup, H.; Jöckel, K.H.; Schuler, M.; Stamatis, G.; Eberhardt, W. 2015: PO-0674: Brain relapses in stage III NSCLC after multimodality treatment: prognostic factors from a randomised trial. RadioTherapy and Oncology 115: S329-S330
Arcidiacono, F.; Bellavita, R.; Falcinelli, L.; Saldi, S.; Matrone, F.; Mendichi, M.; Salari, B.; Bini, V.; Aristei, C. 2015: PO-0676: Dosimetric predictive factors for radiation pneumonitis in sterotactic body radiotherapy. RadioTherapy and Oncology 115: S330-S331
Fiorentino, A.; Mazzola, R.; Ricchetti, F.; Giajlevra, N.; Fersino, S.; Naccarato, S.; Sicignano, G.; Ruggeri, R.; Di Paola, G.; Alongi, F. 2015: PO-0678: IMRT with simultaneous integrated boost in post-operative breast irradiation. RadioTherapy and Oncology 115: S331-S332
Mast, M.; Heijenbrok, M.; Van Kempen - Harteveld, L.; Petoukhova, A.; Scholten, A.; Wolterbeek, R.; Schreur, J.; Struikmans, H. 2015: PO-0680: Calcium scores of the coronary arteries are reduced using breath-hold for breast radiotherapy. RadioTherapy and Oncology 115: S332-S333
Krenn-Pilko, S.; Langsenlehner, U.; Thurner, E.M.; Stojakovic, T.; Pichler, M.; Gerger, A.; Kapp, K.S.; Langsenlehner, T. 2015: PO-0682: External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients. RadioTherapy and Oncology 115: S333-S334
Cazzaniga, L.; Gritti, G.; Gambirasio, A.; Källi, M.; Filippone, F.R.; Maffioletti, L.; Feltre, L.; Muni, R.; Piccoli, F.; Andreoli, S.; Fortunato, M.; Colleoni, P.; Bianchi, C.; Fenaroli, P.; Ferro, M.; Paludetti, A.; Mauri, E.; Burgoa, L.; Giovanelli, M.; Valerii, C. 2015: PO-0683: Electron Intra Operative Radio Therapy (ELIOT) in early breast cancer: Outcome analysis of a non-randomized study. RadioTherapy and Oncology 115: S334-S335
Maduro, J.H.; Stiekema, G.J.; Huizenga, M.K.; Van der Schaaf, A.; Eltahir, Y.; Langendijk, J.A.; Vos, J.R.; Jansen, L.; Crijns, A.P.G. 2015: PO-0686: Larger tumor bed delineation volumes in irradiated breast cancer patients after oncoplastic surgery. RadioTherapy and Oncology 115: S335-S336
Sweeney, R.; Wilbert, J.; Menge, M.; Gibson, A.; Klement, R. 2015: PO-0688: Implementation of a breath-hold lung gating system for left-sided breast cancer; hurdles and benefits. RadioTherapy and Oncology 115: S336-S337
Lee, Y.H.; Kim, Y.S.; Jang, H.S.; Choi, B.O.; Chang, J.H.; Kim, M.S.; Sun, D.I.; Kang, J.H.; Hong, S.H.; Jung, S.L. 2015: PO-068: Soft tissue necrosis in head and neck cancer patients treated with radiation therapy after transoral robotic surgery. RadioTherapy and Oncology 114: 36-37
Chatterjee, S.; Reddy, V.K.; Sarkar, K.; Ahmed, R.; Mahata, A.; Mallick, I.; Shrimali, R.K.; Achari, R.B. 2015: PO-0690: Answering questions for hypofractionated RT in Indian breast cancers: analysis of toxicities and outcomes. RadioTherapy and Oncology 115: S337-S338
Duane, F.K.; McGale, P.; Darby, S.C.; Cutter, D.; Correa, C.; Gigante, B.; Jensen, M.; Lorenzen, E.L.; Brønnum, D.; Warren, S.; Hackett, S.; Rahimi, K.; Hall, P.; Ewertz, M.; Taylor, C.W. 2015: PO-0691: Radiation doses to cardiac structures in women treated for breast cancer in Sweden and Denmark between 1958 and 2001. RadioTherapy and Oncology 115: S338-S339
Trip, A.K.; Sikorska, K.; Boot, H.; Cats, A.; Van Sandick, J.W.; Jansen, E.P.M.; Verheij, M. 2015: PO-0694: Radiation dose-dependent changes of the spleen following chemoradiotherapy for gastric cancer. RadioTherapy and Oncology 115: S340-S341
Chiang, C.L.; Lee, A.S.; Leung, R.W.K.; Lee, V.W.Y.; Choi, K.K.; Wong, C.S.; Sze, W.K.; Tung, Y.; Chan, M.K.H. 2015: PO-0698: Clinical outcomes of 4D CBCT-guided stereotactic body radiotherapy for inoperable hepatocellular carcinomas. RadioTherapy and Oncology 115: S342-S343
Wilson, J.M.; Mukherjee, S.; Grimes, D.R.; Durrant, L.; Brunner, T.B.; Partridge, M.; Hawkins, M.A. 2015: PO-0700: Fluoromisonidazole-PET/CT in pancreatic cancer: moving towards hypoxic biological target volume definition. RadioTherapy and Oncology 115: S343-S344
Van Soest, J.; Marshall, M.S.; Van Stiphout, R.; Gatta, R.; Damiani, A.; Valentini, V.; Dekker, A. 2015: PO-0701: Automated application of radiation oncology prediction models for clinical decision support. RadioTherapy and Oncology 115: S344-S345
De Bari, B.; Lestrade, L.; Jumeau, R.; Kontouri, M.; Matzinger, O.; Bourhis, J.; Zilli, T.; Ozsahin, M. 2015: PO-0703: Safety and efficacy of image guided intensity-modulated radiation therapy in the treatment of anal canal cancer. RadioTherapy and Oncology 115: S345-S346
Ozsahin, E.; De Bari, B.; Saidi, A.; Hanhloser, D.; Wagner, D.; Yan, P.; Matzinger, O.; Bourhis, J. 2015: PO-0705: Could acute toxicity predict tumor regression rate in rectal cancer patients undergoing neoadjuvant treatment?. RadioTherapy and Oncology 115: S346-S347
Elnahal, S.; Luber, B.; Wild, A.T.; Dholakia, A.; Wang, H.; Pawlik, T.; Herman, J.M.; Alcorn, S. 2015: PO-0707: Multidisciplinary clinic models deliver higher value care for patients with pancreatic cancer. RadioTherapy and Oncology 115: S347-S348
Chu, W.; Picahrdo, S.; Tillander, M.; Staruch, R.M.; Köhler, M.O.; Huang, Y.; Ylihautala, M.; McGuffin, M.; Czarnota, G.; Hynynen, K. 2015: PO-0709: MRg-HIFU hyperthermia for recurrent rectal cancer: MR thermometry evaluation and preclinical validation. RadioTherapy and Oncology 115: S348-S349
Franzese, C.; Comito, T.; Clerici, E.; De Rose, F.; Tozzi, A.; D'Agostino, G.; Navarria, P.; Iftode, C.; Villa, E.; Ascolese, A.M.; Piergallini, L.; Gaudino, A.; Reggiori, G.; Scorsetti, M. 2015: PO-0710: Clinical outcomes for inoperable HCC treated with SBRT: mono- institutional experience. RadioTherapy and Oncology 115: S349-S350
Felipe, C.; Del Cerro, E.; Recio, M.; Diaz-Gavela, A.A.; Marcos, F.J.; Rodriguez-Luna, J.M.; Bueno, C. 2015: PO-0712: Role of 3T multiparametric MRI in the detection of local recurrent prostate cancer after radical prostatectomy. RadioTherapy and Oncology 115: S350-S351
Heemsbergen, W.D.; Incrocci, L.; Lebesque, J.V.; Pos, F.J. 2015: PO-0714: Prognostic factors for prostate cancer death: baseline symptoms predictive for fatal disease. RadioTherapy and Oncology 115: S351-S352
Fiorino, C.; Bedenchini, F.; Palorini, F.; Avuzzi, B.; Degli Esposti, C.; Girelli, G.; Vavassori, V.; Valdagni, R.; Rancati, T.; Cozzarini, C. 2015: PO-0715: Predictors of impotence 1 year after RT in potent, hormone-nave patients: a multi-centric prospective trial. RadioTherapy and Oncology 115: S352-S353
Siva, S.; Jackson, P.; Kron, T.; Shaw, M.; Chander, S.; Gill, S.; Hardcastle, N.; Pham, D.; Hofman, M.; Foroudi, F. 2015: PO-0716: Kidney function loss is directly dose dependent after SBRT for primary RCC as assessed by Cr-51 EDTA + DMSA SPECT/CT. RadioTherapy and Oncology 115: S353-S354
Ciabatti, S.; Siepe, G.; Zompatori, M.; Torre, G.; Mattiucci, G.C.; Macchia, G.; Cammelli, S.; Deodato, F.; Valentini, V.; Frezza, G. 2015: PO-0718: Impact on quality of life of radio-hormone therapy for prostate cancer: a "pooled analisys". RadioTherapy and Oncology 115: S354-S355
Wilkins, A.; Mossop, H.; Griffin, C.; Dearnaley, D.; Hall, E. 2015: PO-0720: Patient reported outcomes of overall bowel and urinary bother in the CHHiP trial (CRUK: 8262/A7257). RadioTherapy and Oncology 115: S355-S356
Farina, E.; Tolento, G.; Zompatori, M.; Nuzzo, G.; Mantini, G.; Macchia, G.; Cammelli, S.; Deodato, F.; Valentini, V.; Morganti, A.G. 2015: PO-0722: Impact on radio-induced toxicity of adjuvant hormone therapy in prostate cancer: a "pooled analysis". RadioTherapy and Oncology 115: S356-S357
Deodato, F.; Milani, A.; Ippolito, E.; Ferro, M.; Mantini, G.; Macchia, G.; Cammelli, S.; Cilla, S.; Valentini, V.; Morganti, A.G. 2015: PO-0724: Hypofractionated RT, radiosurgical boost, hormone therapy for prostate cancer: a dose escalation study (ISIDEP3). RadioTherapy and Oncology 115: S357-S358
Pos, F.; Van der Heide, U.A.; Heemsbergen, W.D. 2015: PO-0726: Is seminal vesicle invasion detected on MRI still the same poor prognostic factor as it used to be?. RadioTherapy and Oncology 115: S358-S359
Schooneveldt, G.; Geijsen, E.D.; Van Ommen, F.; Bakker, A.; Kok, H.P.; Westendarp Zanartu, M.A.; De la Rosette, J.J.M.C.H.; Hulshof, M.C.C.M.; De Reijke, T.M.; Crezee, J. 2015: PO-0727: Thermophysical fluid modelling for loco-regional hyperthermia treatment of Non-Muscle Invasive Bladder Cancer. RadioTherapy and Oncology 115: S359-S360
Langsenlehner, T.; Krenn-Pilko, S.; Thurner, E.M.; Kapp, K.S.; Stojakovic, T.; Langsenlehner, U.; Pichler, M. 2015: PO-0729: The neutrophil-to-lymphocyte ratio is prognostic factor in prostate cancer patients treated with radiotherapy. RadioTherapy and Oncology 115: S360-S361
Kirste, S.; Bell, E.H.; Fleming, J.; Stegmaier, P.; Drendel, V.; Mo, X.; Ling, S.; Fabian, D.; Jilg, C.; Schultze-Seemann, W.; Zynger, D.; Martin, D.; White, J.; Werner, M.; Chakravarti, A.; Grosu, A.L. 2015: PO-0731: A miRNA-based predictive model in prostate cancer patients. RadioTherapy and Oncology 115: S361-S362
Borghetti, P.; Buglione, M.; Cavagnini, R.; Alghisi, A.; Baushi, L.; Spiazzi, L.; Cozzaglio, C.; Polonini, A.; Moretti, R.; Caraffini, B.; Barbera, F.; Magrini, S.M. 2015: PO-0733: Postoperative radiotherapy prostate cancer: survival, toxicity and use of an in house analysis system (PRODVH). RadioTherapy and Oncology 115: S362-S363
Mason, M.; Rodda, S.L.; Musunuru, H.; Collier, N.; Al-Qaisieh, B.; Smith, J.; Bownes, P.; Franks, K.; Carey, B.; Bottomley, D.; Henry, A. 2015: PO-0734: Long term outcomes stratified by age for men treated with monotherapy I-125 permanent brachytherapy. RadioTherapy and Oncology 115: S363-S364
Murray, J.R.; Alexander, E.J.; Gao, A.; Wilkins, A.C.; Thomas, K.; Dearnaley, D.P.; Gulliford, S.L. 2015: PO-0736: Bladder and trigone surface doses are related to acute urinary toxicity in focally dose-escalated prostate IMRT. RadioTherapy and Oncology 115: S364-S365
Tontini, L.; Galuppi, A.; Massaccesi, M.; Ferro, M.; Tagliaferri, L.; Macchia, G.; Cammelli, S.; Deodato, F.; Valentini, V.; Morganti, A.G. 2015: PO-0738: Adjuvant conventionally fractionated 3D-CRT vs hypofractionated IMRTSIB: comparison of two prospectives studies. RadioTherapy and Oncology 115: S365-S366
Strom, T.; Trotti, A.M.; Naghavi, A.; Russell, J.; Rao, N.G.; Harrison, L.B.; Caudell, J.J. 2015: PO-073: Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients *70 years. RadioTherapy and Oncology 114: 38-39
Foti, C.; Magli, A.; Malisan, M.R.; Ceschia, T.; Crespi, M.; Prisco, A.; Parisi, G.; Titone, F.; Fongione, S. 2015: PO-0740: An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer. RadioTherapy and Oncology 115: S366-S367
Alitto, A.R.; Dinapoli, N.; Gatta, R.; Fionda, B.; Catucci, F.; Balducci, M.; Frascino, V.; Valentini, V.; Mantini, G. 2015: PO-0744: Develope predictive models to foresee toxicity: validation of a software to help clinicians. RadioTherapy and Oncology 115: S368-S369
Shiba, S.; Wakatsuki, M.; Kato, S.; Ohno, T.; Karasawa, K.; Kiyohara, H.; Tsujii, H.; Nakano, T.; Kamada, T.; Shozu, M. 2015: PO-0746: Clinical outcome of carbon ion radiotherapy for FIGO stage IVA uterine cervical cancer. RadioTherapy and Oncology 115: S369-S370
Kreynina, J.M.; Solodky, V.A.; Iksanova, A.R. 2015: PO-0748: Adjuvant chemoradiation with preventive paraaortic irradiation in endometrial cancer II-III FIGO treatment. RadioTherapy and Oncology 115: S370-S371
Bashir, I.; Chufal, K.; Thakwani, A.; Bhatnagar, A.; Jain, S.; Khullar, P.; Ghosh, D. 2015: PO-0750: Dosimetric correlation of rectal dose and rectal distension in cervical cancer patients undergoing brachytherapy. RadioTherapy and Oncology 115: S371-S372
Verges Capdevila, R.; Giraldo, A.; Seoane, A.; Toral, E.; Ruiz, M.C.; Pons, A.; Giralt, J. 2015: PO-0752: Does ITV vaginal procedure ensure dosimetric coverage during IMRT of postoperative Gynaecologic tumors?. RadioTherapy and Oncology 115: S372-S373
Ivankova, V.; Baranovska, L.; Domina, E.; Ryabchenko, N.; Nesterenko, T. 2015: PO-0754: Conformal radiotherapy technique with radiobiological support in patients with locally advanced cervical cancer. RadioTherapy and Oncology 115: S374-S375
Lindel, K.; Vercruysse, M.; Rieken, S.; Daffinger, S.; Weber, K.J.; Debus, J. 2015: PO-0756: Carbon-ion and photon radiation effects on HPVpositive and negative cervical carcinoma cells. RadioTherapy and Oncology 115: S374-S375
Hobbs, C.; Olson, M. 2015: PO-0758: Wilms tumor outcomes at a single institution treated by Children's Oncology Group (COG) protocols. RadioTherapy and Oncology 115: S375-S376
Culié, D.; Benezery, K.; Vandersteen, C.; Chamorey, E.; Ettaiche, M.; Dassonville, O.; Poissonnet, G.; Peyrade, F.; Saada, E.; Bozec, A. 2015: PO-075: Induction chemotherapy in locally advanced hypopharynx cancer: treatment outcomes and role of nutritional status. RadioTherapy and Oncology 114: 39-40
Alcorn, S.; Chen, M.; Dieckmann, K.; Ermoian, R.; Ford, E.; Kobyzeva, D.; Ladra, M.; MacDonald, S.; Nechesnyuk, A.; Nilsson, K.; Villar, R.; Winey, B.; Terezakis, S. 2015: PO-0760: Patterns of stereotactic radiotherapy in pediatrics: results from an international pediatric research consortium. RadioTherapy and Oncology 115: S376-S377
Bonet, M.; Bonfill, T.; Folgar, A.; Nuñez, M.; De Verdonces, L.; Gallardo, E.; Fernandez-Morales, L.; Bastús, R.; Aguilar, A.; Prats, J. 2015: PO-0761: Trimodality for bladder preservation in very elderly patients. RadioTherapy and Oncology 115: S377-S378
Jeppesen, S.; Schytte, T.; Brink, C.; Hansen, O. 2015: PO-0764: Octogenarians with early stage NSCLC undergoing SBRT -same outcomes as younger patients?. RadioTherapy and Oncology 115: S378-S379
Pardo-Masferrer, J.; Murcia, M.; Soto, R.; González, J.; Alastuey, I.; Montemuiño, S.; Ortiz, I.; Mena, A. 2015: PO-0765: A randomized study with a hyaluronic acid and chondroitin sulfate lotion for radiodermitis in breast cancer patients. RadioTherapy and Oncology 115: S379-S380
Guerriero, F.; Cremonesi, M.; Ferrari, M.E.; Bonomo, G.; Orsi, F.; Colandrea, M.; Marotta, G.; De Cicco, C. 2015: PO-0767: PET versus CT to predict survival after the radioembolization of liver metastases with 90Y resin microspheres. RadioTherapy and Oncology 115: S380-S381
Das, R.; Bhandari, R.; Gupta, A. 2015: PO-0769: Adequacy of pain management during radiotherapy in advanced head and neck cancers. RadioTherapy and Oncology 115: S381-S382
Van Beek, K.M.; Kaanders, J.H.A.M.; Janssens, G.O.R.J.; Takes, R.P.; Span, P.; Verhoef, C.G. 2015: PO-0771: Hypofractionated high-dose IMRT: effective and less toxic than 2D-RT in incurable head and neck cancer. RadioTherapy and Oncology 115: S383-S384
Liang, L.; Bekerat, H.; Tomic, N.; DeBlois, F.; Vuong, T.; Devic, S.; Nobah, A.; Mohiuddin, M.; Moftah, B. 2015: PO-0774: Optimal beam quality for Linac-based Spatially Fractionated Grid Radiation Therapy (SFGRT). RadioTherapy and Oncology 115: S385-S386
Flejmer, A.M.; Edvardsson, A.; Dohlmar, F.; Josefsson, D.; Witt Nyström, P.; Dasu, A. 2015: PO-0776: Are scanned protons better than photons for breast cancer radiation therapy with respiratory gating?. RadioTherapy and Oncology 115: S386-S387
Kindts, I.; Verhoeven, K.; Hortobágyi, E.; Weltens, C. 2015: PO-0777: Does the introduction of new delineation guidelines for breast node radiotherapy entail a change in practice?. RadioTherapy and Oncology 115: S387-S388
Brunner, T.B.; Wiehle, R.; Kirste, S.; Röhner, F.; Prokic, V.; Grosu, A.L.; Nestle, U. 2015: PO-0779: SIB-SIP: Combined simultaneous integrated boost and protection for upper abdominal SBRT. RadioTherapy and Oncology 115: S388-S389
Socha, J.; Wolakiewicz, G.; Wasilewska-Tesluk, E.; Janiga, P.; Kondraciuk, T.; Majewska, A.; Olearski, K.; Kepka, L. 2015: PO-0781: Clinical target volume in postoperative radiotherapy for gastric cancer: the interobserver variability. RadioTherapy and Oncology 115: S389-S390
Van den Begin, R.; Intven, M.; Kleijnen, J.J.E.; Burbach, J.P.M.; Philippens, M.E.P.; Reerink, O. 2015: PO-0784: Rectal tumor volume shrinkage evaluated with MRI during preoperative chemoradiotherapy. RadioTherapy and Oncology 115: S391-S392
Di Perri, D.; Lee, J.A.; Bol, A.; Differding, S.; Doumont, T.; Gillart, J.; Janssens, J.; Labar, D.; Robert, A.; Hanin, F.X.; Sterpin, E.; Geets, X. 2015: PO-0787: CT-based geometric dose escalation as an alternative to PET-based dose painting by numbers. RadioTherapy and Oncology 115: S393-S394
Posma, J.J.; Persoon, L.C.; Eekers, D.B.; Troost, E.G.; Granzier, M.; Bosmans, G.; Nijsten, S.M.; Hoebers, F.J. 2015: PO-0789: Trends in DVH metrics of OARs and tumor in 3 consecutive TPS for 270 HNC patients: an automated institutional analysis. RadioTherapy and Oncology 115: S394-S395
Mnejja, W.; Toumi, N.; Bouzguenda, R.; Siala, W.; Khanfir, A.; Ghorbel, M.; Frikha, M.; Daoud, J. 2015: PO-078: Concurrent Cisplatin-radiotherapy with or without induction chemotherapy in nasopharyngeal carcinoma. RadioTherapy and Oncology 114: 40-41
Hamming-Vrieze, O.; Depauw, N.; Craft, D.L.; Chan, A.W.; Verheij, M.; Sonke, J.J.; Kooy, H. 2015: PO-0791: Interpretation of uncertainty scenarios for head and neck IMPT treatment plans using TCP and NTCP models. RadioTherapy and Oncology 115: S396-S397
Goldsworthy, S.; Roe, B.; McGrail, S.; Latour, J.M.; Morgan, K. 2015: PO-0793: Developing and implementing a radiotherapy research activity assessment tool. RadioTherapy and Oncology 115: S397-S398
Tshamala, D.; Pelecanos, A.; Davies, M.W. 2018: Factors associated with infants receiving their mother's own breast milk on discharge from hospital in a unit where pasteurised donor human milk is available. Journal of Paediatrics and Child Health 54(9): 1016-1022
Oehlke, O.; Sturm, D.; Egger, K.; Grosu, A.; Frings, L. 2015: PO-0801: Hippocampal-avoiding WBRT selectively prevents hippocampal atrophy as determined by automated volumetry. RadioTherapy and Oncology 115: S401-S402
Botticella, A.; Defraene, G.; Nackaerts, K.; Deroose, C.; Coolen, J.; Nafteux, P.; Peeters, S.; De Ruysscher, D. 2015: PO-0803: Optimization of GTV definition and treatment planning in lung-sparing VMAT for pleural mesothelioma. RadioTherapy and Oncology 115: S402-S403
Vagge, S.; Lamanna, G.; Vidano, G.; Ibatici, A.; Agostinelli, S.; Carella, A.M.; Corvò, R. 2015: PO-0804: Volumetric Total Lymphoid Irradiation: step-up an effective treatment for stem cell transplantation in lymphoma. RadioTherapy and Oncology 115: S403-S404
Devecka, M.; Kampfer, S.; Hugo, C.; Habl, G.; Kessel, K.A.; Combs, S.E. 2015: PO-0806: Dosimetric evaluation of Tomo Therapy and 3D conventional radiotherapy with respect to bone marrow sparing. RadioTherapy and Oncology 115: S404-S405
Vischioni, B.; Fiore, M.R.; Fossati, P.; Iannalfi, A.; Vitolo, V.; Ciurlia, E.; Bonora, M.; Krengli, M.; Molinelli, S.; Mirandola, A.; Gallio, E.; Russo, S.; Panizza, D.; Ciocca, M.; Valvo, F.; Orecchia, R. 2015: PO-0808: Hadrontherapy in skullbase chordoma: CNAO experience. RadioTherapy and Oncology 115: S405-S406
Thariat, J.; Troussier, I.; Krengli, M.; Miroir, J.; Sun, X.S.; Shakeel, S.; Coutte, A.; Blanchard, N. 2015: PO-080: Trends in irradiating the mucosae in cervical adenopathies from unknown primaries. RadioTherapy and Oncology 114: 41-42
Alitto, A.R.; Longo, S.; Chiesa, S.; Gaudino, S.; Ferro, M.; Diletto, B.; Frascino, V.; Marchesano, D.; Manfrida, S.; Anile, C.; Valentini, V.; Balducci, M. 2015: PO-0810: Impact of low dose radiation therapy with Bevacizumab in recurrent glioblastoma: final report. RadioTherapy and Oncology 115: S406-S407
Socha, J.; Kepka, L.; Ghosh, S.; Roa, W.; Kumar, N.; Sinaika, V.; Matiello, J.; Lomidze, D.; Guedes de Castro, D.; Hentati, D.; Fidarova, E. 2015: PO-0811: Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients. RadioTherapy and Oncology 115: S407-S408
Burbach, J.P.M.; Reerink, O.; Intven, M.; Kleijnen, J.J.E.; Koopman, M.; Van Grevenstein, W.M.U.; Van Vulpen, M.; Verkooijen, H.M. 2015: PO-0813: Feasibility of using the 'cohort multiple Randomized Controlled Trial' design to conduct the RECTAL BOOST* study. RadioTherapy and Oncology 115: S408-S409
Skyt, P.S.; Høye, E.M.; Yates, E.S.; Schmidt, M.L.; Petersen, J.B.B.; Balling, P.; Muren, L.P. 2015: PO-0815: Dosimetric precision of 3D gel dosimetry compared with radiochromic films in volumetric modulated arc therapy. RadioTherapy and Oncology 115: S409-S410
Chung, C.; LI, W.; Bootsma, G.; Cho, Y.B.; Von Schultz, O.; Carlsson, P.; Jaffray, D.A. 2015: PO-0817: Clinical evaluation of intrafraction motion in mask system for Gamma Knife measured with IR tracking and cone-beam CT. RadioTherapy and Oncology 115: S410-S411
Garcia, R.; Bodez, V.; Khamphan, C.; Jaegle, E.; Alayrach, M.E.; Badey, A.; Martinez, P. 2015: PO-0818: Spirometric gated VMAT: QA of potential breath hold interruptions. RadioTherapy and Oncology 115: S411-S412
Watson, P.; Popovic, M.; Seuntjens, J. 2015: PO-0820: An in-air Monte Carlo investigation of a miniature low energy x-ray tube. RadioTherapy and Oncology 115: S412-S413
Lobefalo, F.; Fogliata, A.; Reggiori, G.; Stravato, A.; Cozzi, L.; Pimpinella, M.; Palumbo, V.; Mancosu, P.; Gaudino, A.; Scorsetti, M.; Tomatis, S. 2015: PO-0821: Configuration of a treatment planning system: study and dosimetric evaluation for treatments with small fields. RadioTherapy and Oncology 115: S413-S414
Lorentini, S.; Fracchiolla, F.; Schwarz, M. 2015: PO-0822: Towards 'matched' gantries in scanning beam protontherapy. RadioTherapy and Oncology 115: S414-S415
Bueno, M.; Schulte, R.; Meylan, S.; Villagrasa, C. 2015: PO-0824: Influence of the biological target volume modeling on ionization cluster-size distributions using Geant4-DNA. RadioTherapy and Oncology 115: S415-S416
Talamonti, C.; Zani, M.; Menichelli, D.; Friedl, F.; Bisello, F.; Bonomo, P.; Bruzzi, M.; Paiar, F.; Scaringella, M.; Bucciolini, M. 2015: PO-0826: Novel epitaxial silicon array for small field dosimetry. RadioTherapy and Oncology 115: S416-S417
Stravato, A.; Reggiori, G.; Pimpinella, M.; Lobefalo, F.; Cozzi, L.; Fogliata, A.; Gaudino, A.; Mancosu, P.; Palumbo, V.; Scorsetti, M.; Tomatis, S. 2015: PO-0827: Dosimetric characterization of PTW Micro Diamond for FFF beams and small fields: experimental and Monte Carlo study. RadioTherapy and Oncology 115: S417-S418
De Pooter, J.A.; De Prez, L.A. 2015: PO-0828: Rotation dependency of radiochromic films. RadioTherapy and Oncology 115: S418-S419
Reggiori, G.; Lobefalo, F.; Gaudino, A.; Palumbo, V.; Scorsetti, M.; Stravato, A.; Tomatis, S.; Mancosu, P. 2015: PO-0831: Characterization of an unshielded diode prototype for small field dosimetry under flattening filter free beams. RadioTherapy and Oncology 115: S419-S420
Rossomme, S.; Hopfgartner, J.; Delor, A.; Fukumura, A.; Vynckier, S.; Palmans, H. 2015: PO-0832: Ion recombination correction for a parallel-plate ionization chamber in a carbon ion beam. RadioTherapy and Oncology 115: S420-S421
Tielenburg, R.; Olaciregui-Ruiz, I.; Rozendaal, R.; Mijnheer, B.; Van Herk, M. 2015: PO-0834: Derivation of a universal dataset for commissioning of an EPID-based dosimetry system. RadioTherapy and Oncology 115: S421-S422
Lee, Y.K.; Kim, A.T.; Zhao, P.; Karotki, A. 2015: PO-0836: Dose sensitivity in the craniospinal IMRT junction region to positional and dose error. RadioTherapy and Oncology 115: S422-S423
Van het Loo, M.; Welleweerd, J. 2015: PO-0837: 3D dose verification of VMAT lung SBRT using Mobius3D. RadioTherapy and Oncology 115: S423-S424
Masi, L.; Russo, S.; De Martin, E.; Frassanito, C.; Fumagalli, M.L.; Martinotti, A.S.; Rondi, E.; Vigorito, S.; Vite, C.; Redaelli, I.; Marino, C.; Fiandra, C.; Clemente, S.; Strigari, L.; Esposito, M.; Giglioli, F.R.; Stasi, M.; Begnozzi, L.; Verona Rinati, G.; Marinelli, M.; Pimpinella, M.; Mancosu, P. 2015: PO-0839: Synthetic diamond detector for Cyber Knife beam output measurements: a multi-site study. RadioTherapy and Oncology 115: S424-S425
Raben, A.; Dan, T.U.; Schneider, C.; Hockstein, N.; Witt, R. 2015: PO-083: Freedom from regional failure of contralateral neck with ipsilateral neck radiotherapy for node and tonsil cancer. RadioTherapy and Oncology 114: 42-43
Mateus, D.; Beyer, G.; Vieira, S.; Greco, C. 2015: PO-0840: Small field dosimetry for flattening filter free photon beams. RadioTherapy and Oncology 115: S425-S426
Duch, M.; Carrasco, P.; Jornet, N.; Hernández, F.; Camats, R.; Jordi, O.; Ribas, M. 2015: PO-0842: Detector comparison for dose measurements in the buildup zone. RadioTherapy and Oncology 115: S426-S427
Rozendaal, R.; Spreeuw, H.; Mijnheer, B.J.; Mans, A.; Gonzalez, P.; Olaciregui-Ruiz, I.; Van Herk, M. 2015: PO-0843: Hot-spot analysis for incident detection in real-time 3D EPID-based in vivo dosimetry. RadioTherapy and Oncology 115: S427-S428
Georg, D.; Azangwe, G.; Followill, D.; Grochowska, P.; Kry, S.; Lechner, W.; Povall, J.; Tenhunen, M.; Thwaites, D.I.; Tomsej, M.; Izewska, J. 2015: PO-0845: Development of methodology for remote IMRT audits and related tests. RadioTherapy and Oncology 115: S428-S429
De Wagter, C.; De Maeseneire, N.; Goethals, N.; De Puysseleyr, A.; De Neve, W.; Lievens, Y. 2015: PO-0847: Exploiting the asymmetric layer geometry of EBT2 radiochromic film for assessment of skin dose and steep gradients. RadioTherapy and Oncology 115: S429-S430
Deufel, C.; Furutani, K.M. 2015: PO-0849: Heterogeneous dose calculations for COMS eye plaques using actual seed configurations and TG43 formalism. RadioTherapy and Oncology 115: S430-S431
Pansini, F.; Bazani, A.; Cambria, R.; Cattani, F.; Morra, A.; Leonardi, M.C.; Orecchia, R. 2015: PO-0851: Skin dose study in chest wall tomohelical treatments with gafchromic EBT film. RadioTherapy and Oncology 115: S431-S432
Abolaban, F.; Zaman, S.; Cashmore, J.; Nisbet, A.; Clark, C. 2015: PO-0854: How has IMRT verification practice in the UK changed over the last two years?. RadioTherapy and Oncology 115: S433-S434
Trnkova, P.; Bolsi, A.; Albertini, F.; Weber, D.C.; Lomax, A.J. 2015: PO-0857: Are the dosimetric verification results of spot scanned IMPT fields dependent on field specific parameters?. RadioTherapy and Oncology 115: S435-S436
Canters, R.A.M.; Kusters, J.M.A.M.; Oellig, J.; Carrasco, J.P.; Huizenga, H. 2015: PO-0859: Real-time detection of deviations in VMAT and IMRT beam delivery using a head-mounted detector. RadioTherapy and Oncology 115: S436-S437
Prieto, I.; Gomez-Tejedor, S.; Marin, J.P.; Perez, A.M. 2015: PO-085: Evaluation of the impact of the oral cavity contour on dose and constraint compliance in head-and-neck IMRT. RadioTherapy and Oncology 114: 43-44
Grochowska, P.; Bencsik, B.; Cole, A.; Izewska, J. 2015: PO-0860: Film quality audit of MLC performance for IMRT dosedelivery. RadioTherapy and Oncology 115: S437-S438
Jensen, H.R.; Bertelsen, A.; Brink, C.; Barber, J.; Thwaites, D.; Hansen, C.R. 2015: PO-0862: Flattening filter free beam used for normal fractionated treatments. RadioTherapy and Oncology 115: S438-S439
De Kerf, G.; Van Gestel, D.; Mommaerts, L.; Van den Weyngaert, D.; Verellen, D. 2015: PO-0864: Pareto front investigation of Tomo Therapys plan quality range. RadioTherapy and Oncology 115: S439-S440
Mihaylov, I. 2015: PO-0865: DVH- and energy-minimization based inverse optimization in NSCLC. RadioTherapy and Oncology 115: S440-S441
Miras, H.; Jiménez, R.; Perales, A.; Miras, C. 2015: PO-0867: Using a commercial cloud for Monte Carlo radiotherapy treatment calculations. RadioTherapy and Oncology 115: S441-S442
García Hernández, T.; Ortiz, M.; Irazola, L.; Terrón, J.A.; Romero-Expósito, M.; Sánchez-Nieto, B.; Sánchez-Doblado, F. 2015: PO-0868: Neutron peripheral dose estimation: treatment planning system implementation. RadioTherapy and Oncology 115: S442-S443
Van Abbema, J.K.; Van Goethem, M.; Greuter, M.J.W.; Van der Schaaf, A.; Brandenburg, S.; Van der Graaf, E.R. 2015: PO-0871: Relative electron density determination for radiotherapy and proton therapy treatment planning. RadioTherapy and Oncology 115: S444-S445
Van Soest, T.; Wolthaus, J.W.H. 2015: PO-0872: A general software tool for the analysis of profiles and depth dose curves. RadioTherapy and Oncology 115: S445-S446
Hindmarsh, J.; David, R.; Zwan, B.; Sloan, K.; Lee, C. 2015: PO-0874: Pre-treatment QA for IMRT: comparison of planar and helical diode arrays and 3D patient dose reconstruction. RadioTherapy and Oncology 115: S446-S447
Gevaert, T.; Steenbeke, F.; Pellegri, L.; Engels, B.; Christian, N.; Hoornaert, M.; Mitine, C.; Verellen, D.; De Ridder, M. 2015: PO-0875: Evaluation of a dedicated brain metastases planning algorithm for radiosurgery: a new treatment paradigm. RadioTherapy and Oncology 115: S447-S448
South, C.P.; Barry, M.A.; Hussein, M.; Adams, E.J.; Jordan, T.J.; Nisbet, A. 2015: PO-0877: Knowledge-based treatment planning of IMRT for prostate cancer. RadioTherapy and Oncology 115: S448-S449
Knäus, B.; Nemecek, S.; Fuchs, H.; Georg, D. 2015: PO-0880: MC dose calculation for protons - evaluation of plan quality and translation into clinical practice. RadioTherapy and Oncology 115: S450-S451
Bresciani, S.; Gino, E.; Pesente, S.; Ermacora, D.; Miranti, A.; Poli, M.; Stasi, M. 2015: PO-0882: From Tomotherapy to VMAT : evaluation of the dose mimicking function with a novel DVH metric. RadioTherapy and Oncology 115: S451-S452
Ziegenhein, P.; Pirner, S.; Oelfke, U. 2015: PO-0884: Fast CPU-based Monte Carlo simulation for radiotherapy dose calculation. RadioTherapy and Oncology 115: S452-S453
Olsen, L.; Kavanaugh, J.; Yang, M.; Gay, H.; Thorstad, W.; Mutic, S. 2015: PO-0885: Validation of a head and neck DVH prediction model for use in commercially available knowledge-based planning software. RadioTherapy and Oncology 115: S453-S454
Souris, K.; Lee, J.A.; Sterpin, E. 2015: PO-0887: Fast and realistic Monte Carlo evaluation of the robustness of proton therapy plans. RadioTherapy and Oncology 115: S454-S455
Sorriaux, J.; Testa, M.; Souris, K.; Orban de Xivry, J.; Lee, J.A.; Bertrand, D.; Traneus, E.; Paganetti, H.; Vynckier, S. 2015: PO-0888: Evaluation of 6 proton dose calculation algorithms using a critical experimental phantom. RadioTherapy and Oncology 115: S455-S456
Fiandra, C.; Loi, G.; Fusella, M.; Lanzi, E.; Orlandi, G.; Strigari, L.; Orlandini, L.C.; Stasi, M.; Paiusco, M.; Menghi, E.; Lucio, F.; Carosi, A. 2015: PO-0889: A multi-institutional study for the evaluation of DIR algorithms for structure delineation in virtual phantoms. RadioTherapy and Oncology 115: S456-S457
Harrop, V.; Meade, S.; Wagstaff, L.; Babrah, J.; Gaunt, P.; Robinson, M.; Cashmore, J.; Mehanna, H.; Hartley, A.; Sanghera, P. 2015: PO-088: Chemoradiotherapy for poor/intermediate risk oropharyngeal carcinoma: First results of the ArCHIMEDEs study. RadioTherapy and Oncology 114: 44-45
Gauer, T.; Sothmann, T.; Werner, R. 2015: PO-0891: Experimental verification of 4DCT-based dose accumulation for IMRT and VMAT beam techniques in lung and liver SBRT. RadioTherapy and Oncology 115: S457-S458
Patterson, N.; Spezi, E.; Grassi, E.; Ferri, V.; Fioroni, F.; Iori, M. 2015: PO-0894: Patient specific 3D dose calculation for 177Lu treatment of neuroendocrine tumours using the Raydose MC code. RadioTherapy and Oncology 115: S459-S460
Jones, G.W.; Lewis, D.G.; Mason, M.D.; Moore, A.R.; Donovan, J.L.; Neal, D.E.; Hamdy, F.C.; Staffurth, J.; Lane, J.A. 2015: PO-0896: Radiotherapy quality assurance in the NIHR ProtecT trial. RadioTherapy and Oncology 115: S460-S461
Kruszyna, M.; Adamczyk, S.; Adamczyk, M.; Pawalowski, B. 2015: PO-0897: A critical evaluation of 2D-ARRAYs (1500, SRS1000 and 729) and OCTAVIUS 4D phantom for QA of FFF prostate plans. RadioTherapy and Oncology 115: S461-S462
Jakobi, A.; Bandurska-Luque, A.; Stützer, K.; Haase, R.; Löck, S.; Wack, L.; Mönnich, D.; Thorwarth, D.; Kovacevic, M.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C. 2015: PO-0898: Identification of individual NTCP benefit of dose-escalated IMPT in advanced HNC patients. RadioTherapy and Oncology 115: S462-S463
Kyroudi, A.; Bochud, F.; Petersson, K.; Ozsahin, M.; Bourhis, J.; Moeckli, R. 2015: PO-0900: Where do radiation oncologists and medical physicists look when they evaluate a patient treatment plan?. RadioTherapy and Oncology 115: S463-S464
Coates, J.; Jeyaseelan, A.K.; Ybarra, N.; Tao, J.; David, M.; Faria, S.; Souhami, L.; Cury, F.; Duclos, M.; El Naqa, I. 2015: PO-0901: Evaluation of NTCP radiogenomic modelling frameworks in hypofractionated prostate cancer patients. RadioTherapy and Oncology 115: S464-S465
Jochems, A.; Troost, E.; Dekker, A.; Lambin, P.; Oberije, C. 2015: PO-0903: Improving prediction models in the era of rapid learning health care: weighting data to reflect relative importance. RadioTherapy and Oncology 115: S465-S466
Aznar, M.; Maraldo, M.V.; Schut, D.A.; Lundemann, M.; Brodin, N.P.; Vogelius, I.R.; Berthelsen, A.K.; Specht, L.; Petersen, P.M. 2015: PO-0904: Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold and/or IMRT?. RadioTherapy and Oncology 115: S466-S467
Olsson, C.E.; Thor, M.; Oh, J.H.; Elleberg Petersen, S.; Alsadius, D.; Høyer, M.; Pettersson, N.; Waldenström, A.C.; Bentzen, L.; Deasy, J.O.; Muren, L.P.; Steineck, G. 2015: PO-0906: Is the anal sphincter a key structure for gastrointestinal toxicity in prostate cancer radiotherapy?. RadioTherapy and Oncology 115: S467-S468
Selvaraj, J.; Lebesque, J.; Peulen, H.; Belderbose, J.; Guckenberger, M.; Werner-Wasik, M.; Hope, A.; Grills, I.; Sonke, J. 2015: PO-0907: TCP modeling in a large cohort of NSCLC patients inclusive of geometric uncertainties. RadioTherapy and Oncology 115: S468-S469
Deasy, J.; Thor, M.; Olsson, C.E.; Oh, J.H.; Alsadius, D.; Pettersson, N.; Steineck, G. 2015: PO-0908: Corpora cavernosa dose and patient-reported sexual dysfunction in prostate cancer radiotherapy. RadioTherapy and Oncology 115: S469-S470
Appelt, A.L.; Vogelius, I.R.; Jakobsen, A. 2015: PO-0909: Dose and volume effects of gastrointestinal toxicity during neoadjuvant IMRT for rectal cancer. RadioTherapy and Oncology 115: S470-S471
Wopken, K.; Kierkels, R.G.J.; Bijl, H.P.; Langendijk, J.A.L. 2015: PO-090: Normal tissue complication probability based multicriteria optimized IMRT in head and neck cancer radiotherapy. RadioTherapy and Oncology 114: 45-46
Stokkevåg, C.; Engeseth, G.M.; Muren, L.P.; Ytre-Hauge, K.S.; Ekanger, C.; Hysing, L.B. 2015: PO-0912: The risk of radiation-induced cancer following VMAT vs. IMPT of prostate cancer. RadioTherapy and Oncology 115: S472-S473
Pacelli, R.; Oh, J.H.; Deasy, J.O.; Conson, M.; D'Avino, V.; Picardi, M.; Pressello, M.C.; Boboc, G.; Battistini, R.; Donato, V.; Cella, L. 2015: PO-0913: Machine learning-based prediction of late radiationinduced lung toxicity in Hodgkin's lymphoma survivors. RadioTherapy and Oncology 115: S473-S474
Sharfo, A.W.M.; Dirkx, M.L.P.; Breedveld, S.; Heijmen, B.J.M.; Mendez Romero, A.M. 2015: PO-0914: Knowledge-based automated VMAT Planning for liver metastases. RadioTherapy and Oncology 115: S474-S475
Jensen, K.; Bernchou, U.; Schytte, T.; Hansen, O.; Brink, C. 2015: PO-0916: Are mean lung dose and changes in respiration during RT predictive for pulmonary function changes after RT?. RadioTherapy and Oncology 115: S475-S476
Thor, M.; Olsson, C.; Oh, J.H.; Elleberg Petersen, S.; Alsadius, D.; Hoyer, M.; Pettersson, N.; Bentzen, L.; Muren, L.P.; Deasy, J.O.; Steineck, G. 2015: PO-0917: Predicting radiation-induced patient-reported genitorurinary toxicity in four prostate cancer cohorts. RadioTherapy and Oncology 115: S476-S477
Van der Weide, N.C.; Admiraal, M.A.; Rosario, T.S. 2015: PO-0920: Intra-fraction motion detection with Triggered Imaging for prostate cancer patients with implanted gold seeds. RadioTherapy and Oncology 115: S478-S479
Van Heijst, T.C.F.; Philippens, M.E.P.; Den Hartogh, M.D.; Lagendijk, J.J.W.; Van den Bongard, H.J.G.D.; Van Asselen, B. 2015: PO-0921: Determining intra-fraction motion in breast radiotherapy using supine cine-MRI. RadioTherapy and Oncology 115: S479-S480
Ballhausen, H.; Li, M.; Hegemann, N.S.; Ganswindt, U.; Belka, C. 2015: PO-0923: Intra-fraction motion of the prostate is a random walk. RadioTherapy and Oncology 115: S480-S481
Jöhl, A.; Schmid Daners, M.; Ehrbar, S.; Guckenberger, M.; Klöck, S.; Lang, S. 2015: PO-0925: Respiratory motion prediction filters for real time tumor tracking during radiation treatment. RadioTherapy and Oncology 115: S481-S482
Ehrbar, S.; Jöhl, A.; Stieb, S.; Riesterer, O.; Stark, L.S.; Guckenberger, M.; Klöck, S.; Lang, S. 2015: PO-0926: Dosimetric comparison of different motion management techniques. RadioTherapy and Oncology 115: S482-S483
Poels, K.; Verellen, D.; Dhont, J.; Engels, B.; Collen, C.; Burghelea, M.; Gevaert, T.; Depuydt, T.; De Ridder, M. 2015: PO-0929: Dual-modality simultaneous orthogonal kV and portal MV imaging for verification of tumor tracking on SBRT patients. RadioTherapy and Oncology 115: S484-S485
Arias, F.; Hernández, I.; Asín, G.; Contreras, J.; Villar, E.; Pérez, A.M.; Casado, V.; Bonfill, T.; Vera, R. 2015: PO-092: Phase II study of TPF and cetuximab+RT in locally advanced laryngeal/hypopharyngeal carcinoma. RadioTherapy and Oncology 114: 46-47
Roussakis, Y.; McWilliam, A.; Hartley, A.; Sangera, P.; Benghiat, H.; Hickman, M.; Meade, S.; Zarkar, A.; Dehghani, H.; Green, S.; Webster, G. 2015: PO-0931: Evaluation of multiple auto-segmentation solutions against inter-observer variability. RadioTherapy and Oncology 115: S485-S486
Heerkens, H.D.; Reerink, O.; Van Vulpen, M.; Tijssen, R.H.; Stemkens, B.; Crijns, S.P.M.; Hiensch, R.R.; Van den Berg, C.A.T.; Meijer, G.J. 2015: PO-0932: Use of a custom abdominal corset to reduce pancreatic tumor motion during stereotactic radiotherapy. RadioTherapy and Oncology 115: S486-S487
Hansen, R.; Ravkilde, T.; Worm, E.S.; Toftegaard, J.; Grau, C.; Macek, K.; Poulsen, P.R. 2015: PO-0933: Calypso-guided MLC tracking on a True Beam accelerator. RadioTherapy and Oncology 115: S487-S488
Rigaud, B.; Simon, A.; Castelli, J.; Gobeli, M.; Ospina Arango, J.D.; Cazoulat, G.; Henry, O.; Haigron, P.; De Crevoisier, R. 2015: PO-0935: Evaluation of deformable image registration methods for dose monitoring in head and neck adaptive radiotherapy. RadioTherapy and Oncology 115: S488-S489
Wang, Y.; Petit, S.F.; Vásquez Osorio, E.; Gupta, V.; Mendez Romero, A.; Heijmen, B. 2015: PO-0938: An individualized strategy to deal with uncertainties of non-rigid registration for dose accumulation. RadioTherapy and Oncology 115: S490-S491
Persoon, L.C.G.G.; Sanizadeh, A.; De Ruiter, B.; Nijsten, S.; Verhaegen, F.; Troost, E.G.C. 2015: PO-0941: Adaptive radiotherapy based on integrated transit planar dosimetry for lung cancer patients. RadioTherapy and Oncology 115: S492-S493
Samsøe, E.; Andersen, E.; Hansen, C.R.; Johansen, J.; Sand, H.M.B.; Andersen, L.J.; Petersen, J.B.B.; Jensen, K.; Smulders, B.; Kristensen, C.A.; Grau, C. 2015: PO-0944: Radiotherapy QA of the DAHANCA 19 protocol. RadioTherapy and Oncology 115: S494-S495
Schuring, D.; De Smet, M.; De Jaeger, K. 2015: PO-0945: A method for fast dose re-evaluation on Elekta CBCTs as decision tool for adaptive RT in lung cancer patients. RadioTherapy and Oncology 115: S495-S496
Schneidt, M.; Kovacevic, M.; Thiele, J.; Jakobi, A.; Haase, R.; Makocki, S.; Krause, M.; Hölscher, T.; Richter, C. 2015: PO-0946: Prospective evaluation of patient positioning for interfractional variation in proton therapy of prostate cancer. RadioTherapy and Oncology 115: S496-S497
Winey, B.; Park, Y.K.; Phillips, J.; Sharp, G.C. 2015: PO-0948: Adaptive proton therapy using CBCT to calculate daily dose. RadioTherapy and Oncology 115: S497-S498
Marrazzo, L.; Casati, M.; Pallotta, S.; Reversi, L.; Bonomo, P.; Simontacchi, G.; Livi, L.; Bucciolini, M. 2015: PO-0949: Advantages and shortcomings of planning hypofractionated lung treatments with VMAT on the average CT. RadioTherapy and Oncology 115: S498-S499
Zukauskaite, R.; Brink, C.; Hansen, C.R.; Bertelsen, A.; Grau, C.; Johansen, J.; Eriksen, J.G. 2015: PO-0950: Validation of the deformable image registration system elastix in the head and neck region. RadioTherapy and Oncology 115: S499-S500
Aramburu Nuñez, D.; Del Olmo Claudio, J.; Lopez Medina, A.; Mera Iglesias, M.; Salvador, F.; Ochagavia, V.; Nieto, I.; Del Moral, F.; Calzado, A.; Muñoz, V. 2015: PO-0952: Multimodality functional imaging for biologically guided radiation therapy. RadioTherapy and Oncology 115: S500-S501
Bornstein, M.; Negård, A.; Holmedal, S.H.; Borthne, A.S.; Ree, A.H.; Røe, K. 2015: PO-0953: Quantitative diffusion-weighted MRI of rectal cancer is strongly influenced by the choice of b-values. RadioTherapy and Oncology 115: S501-S502
Ciardo, D.; Gerardi, M.A.; Vigorito, S.; Ricotti, R.; Leonardi, M.C.; Morra, A.; Dell'Acqua, V.; Diaz, F.J.; Cattani, F.; Baroni, G.; Jereczek-Fossa, B.A.; Orecchia, R. 2015: PO-0954: Evaluation of specific and general-purpose atlases for automatic segmentation in breast cancer radiotherapy. RadioTherapy and Oncology 115: S502-S503
Kipritidis, J.; Siva, S.; Hofman, M.S.; Callahan, J.; Hardcastle, N.; Keall, P.J. 2015: PO-0955: Comparing lung function changes between serial CT-ventilation and Galligas Ventilation PET/CT. RadioTherapy and Oncology 115: S503-S504
Lee, S.; Davis, A.; Palmer, A.L.; Muscat, S. 2015: PO-0956: Quantification of helical 4DCT imaging dose for radiotherapy cancer patients. RadioTherapy and Oncology 115: S504-S505
Vilches-Freixas, G.; Létang, J.M.; Presich, K.; Steininger, P.; Rit, S. 2015: PO-0959: Optimal dose balance between energy levels for material decomposition with dual-energy X-ray CT. RadioTherapy and Oncology 115: S506-S507
Nissen, H.D.; Bangsgaard, J.P. 2015: PO-0960: Automated review of patient positioning CBCTs: a novel tool for quantitative evaluation of registration quality. RadioTherapy and Oncology 115: S507-S508
Giri, M.G.; Cavedon, C. 2015: PO-0962: A Dirichlet process mixture model for automatic segmentation of 18F-FDG PET-CT images. RadioTherapy and Oncology 115: S508-S509
Petillion, S.; Verhoeven, K.; Van den Heuvel, F.; Weltens, C. 2015: PO-0965: Deep inspiration breath-hold in left-sided breast radiotherapy or not?: decision based on a single CT-slice. RadioTherapy and Oncology 115: S510-S511
Pollock, S.; Kipritidis, J.; Lee, D.; Bernatowicz, K.; Keall, P. 2015: PO-0966: Audiovisual biofeedback breathing training during thoracic 4DCT imaging: a digital phantom study. RadioTherapy and Oncology 115: S511-S512
Leijenaar, R.T.H.; Nalbantov, G.; Carvalho, S.; Van Elmpt, W.J.C.; Troost, E.G.C.; Boellaard, R.; Aerts, H.J.W.L.; Gillies, R.J.; Lambin, P. 2015: PO-0968: The effect of SUV discretization in PET Radiomics: the need for standardized methodology in tumor texture analysis. RadioTherapy and Oncology 115: S512-S513
Cella, L.; Conson, M.; Palma, G.; Apte, A.; Deasy, J.O.; D'Avino, V.; Liuzzi, R.; Pacelli, R. 2015: PO-0969: Cardiac motion and breathing effects: estimation of dosimetric uncertainties. RadioTherapy and Oncology 115: S513-S514
Friesland, S.; Specht, L.; Haugen, H.; Söderström, K. 2015: PO-096: Cetuximab(CET), 5-FU and cisplatin or carboplatin (CA) vs CET, paclitaxel and CA in metastatic head and neck cancer. RadioTherapy and Oncology 114: 48-49
Ding, A.Y.; Wong, O.L.; Lo, G.G.; Yuan, J.; Law, M.W.K.; Cheng, K.F.; Chan, K.T.; Cheung, K.Y.; Yu, S.K. 2015: PO-0970: Assessment of regional positional repeatability in head and neck using a dedicated MR simulator. RadioTherapy and Oncology 115: S514-S515
Burghelea, M.; Verellen, D.; Poels, K.; Gevaert, T.; Depuydt, T.; Tournel, K.; De Ridder, M.; Hiraoka, M.; Simon, V. 2015: PO-0972: Geometric verification of Dynamic Wave Arc using orthogonal X-ray fluoroscopic imaging. RadioTherapy and Oncology 115: S515-S516
Joshi, K.; Marchant, T. 2015: PO-0973: Monte Carlo study of Cone-Beam CT dose variation with patient size. RadioTherapy and Oncology 115: S516-S517
Redondo, R.; Bueno, G. 2015: PO-0974: Evaluation of quality metrics for CDRAD radiographical images. RadioTherapy and Oncology 115: S517-S518
Law, M.W.K.; Yuan, J.; Lo, G.G.; Ding, A.Y.; Wong, O.L.; Cheng, K.F.; Chan, K.T.; Cheung, K.Y.; Yu, S.K. 2015: PO-0975: Quantitative assessment of 3D geometric accuracy of a 1.5T wide-bore MR-simulator: a phantom study. RadioTherapy and Oncology 115: S518-S519
Spezi, E.; Berthon, B.; Marshall, C. 2015: PO-0977: ATLAAS: A model for optimal auto-segmentation of PET images in RT planning. RadioTherapy and Oncology 115: S519-S520
Pallotta, S.; Russo, S.; Esposito, M.; Marrazzo, L.; Simontacchi, G.; Bastiani, P.; Paiar, F.; Livi, L.; Bucciolini, M. 2015: PO-0978: Testing the C-RAD Catalyst elastic image registration software using a deformable female phantom. RadioTherapy and Oncology 115: S520-S521
Huang, B.; Lu, J.; Lin, P.; Chen, C. 2015: PO-0981: Optimizing the planning parameters to obtain the lowest monitor units in lung stereotactic body radiation therapy. RadioTherapy and Oncology 115: S522-S523
Anducas Santiago, N.; Seoane Ramallo, A. 2015: PO-0983: Accuracy of a 4D-PET system in determining the position of a mobile phantom. RadioTherapy and Oncology 115: S524-S525
Eaton, D.J.; Tsang, Y.; Carver, A.; Groom, N.; Harris, C.; Faivre-Finn, C. 2015: PO-0985: How accurate is lung IMRT and VMAT delivery? A multicentre audit as part of the Isotoxic IMRT trial. RadioTherapy and Oncology 115: S525-S526
Carrington, R.; Spezi, E.; Gwynne, S.; Dutton, P.; Hurt, C.; Crosby, T.; Staffurth, J. 2015: PO-0986: Can radiotherapy dose distribution be related to outcome? An analysis of the SCOPE 1 oesophageal cancer trial data. RadioTherapy and Oncology 115: S526-S527
Koivumäki, T.; Heikkilä, J.; Väänänen, A.; Seppälä, J. 2015: PO-0988: Beam delivery time reduction in breath-hold treatments for left-sided breast cancer using FFF technique. RadioTherapy and Oncology 115: S527-S528
Walsh, K.; Chesham, H.; Ariyaratne, H. 2015: PO-0989: Does DiBH reduce lung within the field? A review of irradiated lung volumes for breast patients treated in DiBH. RadioTherapy and Oncology 115: S528-S529
Wilkinson, D.; Hackworth, W.; Kenny, J.; Clark, C.H.; Haworth, A. 2015: PO-0990: A study into alternative evaluation methods to external audit for clinical trial VMAT credentialing. RadioTherapy and Oncology 115: S529-S530
Montelius, A.; Nyholm, T.; Gustafsson, A.; Karlsson, M.G.; Nyström, L.; Skönevik, J.; Zackrisson, B. 2015: PO-0993: A national database solution for radiotherapy quality registries and clinical studies. RadioTherapy and Oncology 115: S531-S532
Pandya, D.; Podofillini, L.; Emert, F.; Lomax, A.J.; Dang, V.N. 2015: PO-0994: Human error analysis in radiotherapy: first steps towards a prospective and quantitative method. RadioTherapy and Oncology 115: S532-S533
Ciardo, D.; Bazani, A.; Pansini, F.; Russo, S.; Molinelli, S.; Comi, S.; Cambria, R.; Cattani, F.; Petralia, G.; Vischioni, B.; Zerini, D.; Baroni, G.; Valvo, F.; Orecchia, R.; Jereczek-Fossa, B.A. 2015: PO-0995: Evaluation of VMAT-RapidArc, IMRT-VERO and proton-RT for a hypofractionated scheme of prostate cancer treatment. RadioTherapy and Oncology 115: S533-S534
Ford, E.; Bojechko, C.; Kalet, A.; Phillips, M. 2015: PO-0997: Validation of a multi-layered automatic detection system to improve quality and safety in radiotherapy. RadioTherapy and Oncology 115: S534-S535
Dana, F.; Mosleh-Shirazi, M.A.; Faghihi, R.; Piroozmand, A.; Karbasi, S.; Sina, S.; Safigholi, H. 2015: PO-0999: Simulation of a miniature x-ray tube used with nanoparticles for improved tumor dose homogeneity and enhancement. RadioTherapy and Oncology 115: S535-S536
Bozec, A.; Ebran, N.; Sudaka, A.; Etinne-Grimaldi, M.C.; Penaud-Llorca, F.; Milano, G. 2015: PO-099: Combination of mTOR targeting with cetuximab, and chemotherapy: a preclinical study on head and neck cancer. RadioTherapy and Oncology 114: 49-50
Malisan, M.R.; Guernieri, M.; Foti, C.; Crespi, M.; Moretti, E.; Magli, A. 2015: PO-1002: Retrospective assessment of treatment planning quality in prostate SBRT. RadioTherapy and Oncology 115: S537-S538
Ong, C.L.; Zindler, J.D.; Swinnen, A.C.C.; Troost, E.G.C.; Willems, D.; De Rooy, M.; Wanders, R.G.; Lambin, P.; Van Baardwijk, A. 2015: PO-1003: Clinical setup accuracy for fractionated stereotactic ablative body radiotherapy for vertebral metastases. RadioTherapy and Oncology 115: S538-S539
Calandrino, R.; Perna, L.; Belli, M.L.; Botti, A.; Cattaneo, G.M.; Fiorino, C.; Cozzarini, C.; Iori, M. 2015: PO-1004: Estimating second tumor induction in rotational IMRT for prostate cancer: impact of age and pelvic nodes irradiation. RadioTherapy and Oncology 115: S539-S540
Shields, L.; O'Brien, D.; McCavana, P.; McClean, B. 2015: PO-1006: Investigation into out-of-field dosimetry. RadioTherapy and Oncology 115: S540-S541
Sanchez-Nieto, B.; El-far, R.; Castrillon, M.; Irazola, L.; Terron, J.A.; Sanchez-Doblado, F. 2015: PO-1008: Validation of a photon peripheral dose model for IMRT treatments. RadioTherapy and Oncology 115: S541-S542
Jackowiak, W.; Kruszyna, M.; Malicki, J.; Kowalik, A.; Adamczyk, S. 2015: PO-1009: A comparison of the dosimetric methods in out-of-field dose measurement for photons. RadioTherapy and Oncology 115: S542-S543
Ytre-Hauge, K.; Velure, A.; Larsen, E.F.; Stokkevåg, C.H.; Röhrich, D.; Brekke, N.; Odland, O.H. 2015: PO-1010: Characterization of a SRAM-based neutron detector for particle therapy. RadioTherapy and Oncology 115: S543-S544
Cambeiro, M.; Martinez-Regueira, F.; Olartecoechea, B.; Pina, L.; Santisteban, M.; Valtueña, G.; Aristu, J.J.; Martinez-Monge, R.; Rodriguez-Spiteri, N. 2015: PO-1012: Comparative study of surgery with or without intraoperative multicatheter breast implant for PBI. RadioTherapy and Oncology 115: S544-S545
Alonso Sanchez, D.; Federico, M.; Torres Pozas, S.; Tornero López, A.M.; Blanco, J.; Lara, P.C. 2015: PO-1014: OAR Intra/interfraction dose variability in tandem-ovoids MRI/CTguided brachytherapy for cervical cncer. RadioTherapy and Oncology 115: S545-S546
McGivern, U.; Byrne, M.; Vennard, H.; Drake, A.; Clarke, J.; Workman, G. 2015: PO-1015: High Dose Rate image guided adaptive brachytherapy for cervical cancer - a single centre experience. RadioTherapy and Oncology 115: S546-S547
Rovirosa, A.; Ascaso, C.; Camarasa, A.; Herreros, A.; Arenas, M.; Sabater, S.; Ríos, I.; Vargas, A.; Valduvieco, I.; Biete, A. 2015: PO-1017: EQD 23Gy vaginal toxicity study in 2 protracted HDR brachytherapy schedules in postoperative endometrial cancer. RadioTherapy and Oncology 115: S547-S548
Juhler-Nøttrup, T.; Serup-Hansen, E.; Klitgaard, D. 2015: PO-1018: Clinical results after introduction of MR guided brachytherapy single institution experience. RadioTherapy and Oncology 115: S548-S549
Broglie Daeppen, M.A.; Roessle, M.; Kiessling, S.Y.; Soltermann, A.; Haile, S.R.; Huber, G.F.; Stoeckli, S.J. 2015: PO-101: Podoplanin expression in oropharyngeal cancer influences staging and prognosis only in p16 negative tumors. RadioTherapy and Oncology 114: 50-51
Perrucci, E.; Lancellotta, V.; Bini, V.; Mariucci, C.; Di Benedetto, M.; Trinari, S.; Verzini, S.; Aristei, C. 2015: PO-1020: High-dose rate vaginal brachytherapy in early stage endometrial cancer. RadioTherapy and Oncology 115: S549-S550
Babu, G.; Mathews, S.; Azariah, B.; Kumar, R.; Jayaprakash, P.G. 2015: PO-1022: Outcome of cervix cancer patients treated with CT based plans - data from a limited resource setting. RadioTherapy and Oncology 115: S550-S551
Castilla, L.; Rovirosa, A.; Ríos, I.; Arenas, M.; Sabater, S.; Camacho, C.; Vargas, A.; Llorente, R.; Valduvieco, I.; Biete, A. 2015: PO-1024: Long-term results of daily HDR brachytherapy in the postoperative setting of endometrial carcinoma. RadioTherapy and Oncology 115: S551-S552
Aleksandrova Stanojevic, A.; Ruzic, K.; Despot, A.; Kopic, D.; Matkovic, V. 2015: PO-1025: From 2D to 3D brachytherapy, changing clinical brachytherapy practice, a single institution experience. RadioTherapy and Oncology 115: S552-S553
Kim, R.; Taylor, R.B.; Lopez-Araujo, J.; Burnett, O.L.; Shen, S. 2015: PO-1027: Reducing vaginal wall dose for HDR interstitial brachytherapy of gynecological cancer: dosimetric comparison. RadioTherapy and Oncology 115: S553-S554
Siavashpour, Z.; Aghamiri, M.R.; Jaberi, R.; Dehghan Manshadi, H.R. 2015: PO-1029: Intra-fractional organ position variation evaluation during HDR intracavitary brachytherapy of cervical cancer. RadioTherapy and Oncology 115: S554-S555
Kovács, G.; Tagliaferri, L.; Autorino, R.; Dinapoli, N.; Gatta, R.; Lanzotti, V.; Gambacorta, M.A.; Damiani, A.; Valentini, V. 2015: PO-1031: ENT COBRA (COnsortium for BRachytherapy data Analysis) : Standardized data collection (SDC) for H&N patients. RadioTherapy and Oncology 115: S555-S556
Hayman, O.; Palmer, A.L. 2015: PO-1032: Choice of radionuclides for HDR Brachytherapy: clinical and economic differences. RadioTherapy and Oncology 115: S556-S557
Bieleda, G.; Zwierzchowski, G.; Mikolajczak, J. 2015: PO-1034: Can gamma analysis using radiochromich films be a reliable method to verify MBDCA reported by AAPM TG-186?. RadioTherapy and Oncology 115: S557-S558
Stserbakov, V. 2015: PO-1036: Primary standard of source-to-ion.chamber distance device in brachytherapy water phantom for absolute dosimetry. RadioTherapy and Oncology 115: S558-S559
Walker, E.; Jones, E. 2015: PO-1037: Quantifying underdosage in skin brachytherapy resulting from incomplete scatter environments. RadioTherapy and Oncology 115: S559-S560
Merrell, K.; Davis, B.; Goulet, C.; Furutani, K.; Mynderse, L.; Wilson, T.; Deufel, C.; Birckhead, B.; Choo, R. 2015: PO-1039: Comparison of seed migration to the chest after permanent prostate brachytherapy with loose, stranded or mixed seeds. RadioTherapy and Oncology 115: S560-S561
Gupta, M.; Husain, N.; Mehrotra, R. 2015: PO-103: Comparison of VEGF Expression in non malignant, premalignant lesion and squamous cell carcinoma of oral cavity. RadioTherapy and Oncology 114: 51-52
Juan-Senabre, X.J.; Pérez-Mestre, M.; Sánchez-Iglesias, A.L.; López-Tarjuelo, J.; Santos-Serra, A.; Conde-Moreno, A.J.; Beltrán-Persiva, J.; Ferrer-Albiach, C. 2015: PO-1041: Learning curve impact results from 8 years of experience in low-dose brachytherapy for prostate cancer. RadioTherapy and Oncology 115: S561-S562
Jolicoeur, M.; Tetreault-Laflamme, A.; Nguyen-Huynh, T.V.; Benoit, N.; Guay, J.P.; Fortin, B.; Vincent, F.; Lambert, C.; Saad, F. 2015: PO-1042: 5-year results of HDR brachytherapy, plus radiotherapy and ADT for intermediate prostate cancer: a phase II trial. RadioTherapy and Oncology 115: S562-S563
Mascarenhas, F.; Marques, F.; Germano, S.; Faustino, S.; Miguel, C. 2015: PO-1044: Dose escalation in dominant intraprostatic lesion with MRIguided HDR brachytherapy in localized prostate cancer. RadioTherapy and Oncology 115: S563-S564
Colmenares, R.; Polo, A.; Hervás, A.; Morís, R. 2015: PO-1045: Dosimetric impact of uncertainty in the reconstruction of needles in HDR prostate. RadioTherapy and Oncology 115: S564-S565
O'Cathail, S.M.; Day, K.; Doggart, A.; Rogers, P.; O'Donnell, H. 2015: PO-1049: A single centre experience of dosimetric outcomes in LDR prostate brachytherapy with I-125 seeds prescribed to 160Gy. RadioTherapy and Oncology 115: S566-S567
Novikov, S.N.; Kanaev, S.V.; Gafton, G.I.; Ilin, N.D.; Krzhivitskiy, P.I. 2015: PO-1054: 99mTc-MIBI SPECT-CT guided salvage HDR brachytherapy for recurrent malignant soft tissue sarcomas. RadioTherapy and Oncology 115: S568-S569
Flores-Balcazar, C.; Santiago-Concha, G.; Sánchez-Castro, R.; Rosales-Pérez, S.; Bargalló-Rocha, E.; Rivera-Corona, J. 2015: PO-1057: Low-kilovoltage single dose intraoperative radiation therapy for breast cancer. RadioTherapy and Oncology 115: S570-S571
Zerp, S.; Stoter, T.R.; Hoebers, F.J.P.; Van den Brekel, M.W.M.; Dubbelman, R.; Kuipers, G.; Lafleur, V.; Slotman, B.J.; Verheij, M. 2015: PO-1060: Combining radiation with the pan-Bcl-2 inhibitor AT-101: in vitro studies and clinical pharmacokinetics in HNSCC. RadioTherapy and Oncology 115: S571-S572
Orth, M.; Belka, C.; Lauber, K. 2015: PO-1062: Radiosensitization of tumor cells by Paclitaxel relies on chromosome missegregation and depends on TPX2. RadioTherapy and Oncology 115: S572-S573
Cremonesi, M.; Garibaldi, C.; Ferrari, M.; Bodei, L.; Zerini, D.; Botta, F.; Cattani, F.; Jereczek, B.; Grana, C.; Pedroli, G.; Orecchia, R. 2015: PO-1064: 90y/ 177Lu-radiopeptide therapy and external beam radiation therapy applied to neuroendocrine tumor patients. RadioTherapy and Oncology 115: S573-S574
Leroi, N.; Blacher, S.; Van Overmiere, E.; Van Ginderachter, J.; Lallemand, F.; Coucke, P.; Noel, A.; Martinive, P. 2015: PO-1065: Impact of fractionated radiotherapy on tumor microenvironment. RadioTherapy and Oncology 115: S574-S575
Zhang, B.; Wang, K.; Iordachita, I.; Reyes, J.; Tran, P.; Patterson, M.; Wong, J. 2015: PO-1067: Evaluation of on- and offline bioluminescence tomography system for focal irradiation guidance. RadioTherapy and Oncology 115: S575-S576
Van Obberghen-Schilling, E.; Beghelli-de la Forest Divonne, S.; Veracini, L.; Gopal, S.; Grall, D.; Butori, C.; Hofman, P.; Bozec, A.; Orend, G.; Sudaka, A. 2015: PO-106: The Extracellular Matrix in head and neck cancer at the leading edge of invasive growth. RadioTherapy and Oncology 114: 52-53
Ozen, A.; Cakina, S.; Turkkan, G.; Cosar, R.; Sipahi, T.; Kocak, Z.; Uzal, C. 2015: PO-1070: The effect of gender differences on radiation induced acute lung toxicity by using XRCC1, XRCC3 and HHR2L gene panel. RadioTherapy and Oncology 115: S577-S578
Alastuey, I.; Ariño, A.; Vara, J.; Castejón, M.A.; Pardo, J.; Font, J.; Montemuiño, S.; Ortiz, I. 2015: PO-1071 Radiation-induced cancer risk in breast cancer patients. Boost by photons or electrons? Definitive results. RadioTherapy and Oncology 115: S578-S579
Kuriakose, V.G.; Jayakumar, K.L.; Aravind Anandh, S.; Anand, R.K.; Susan, S. 2015: PO-1073 Circadian variation in radiation induced mucositis in head and neck malignancies - retrospective analysis. RadioTherapy and Oncology 115: S579-S580
Sierko, E.; Monika Sokol, M.S.; Joanna Kruszewska, J.K.; Dominika Hempel, D.H.; Anna Lipska, A.L.; Piotr Radziwon, P.R.; Marek, M.Z.W.; Wojtukiewicz, Z. 2015: PO-1075 Endothelial microparticles: a marker of ECs activation during radiotherapy or radiochemotherapy of HNC patients?. RadioTherapy and Oncology 115: S580-S581
Ebert, M.; Dahl, B.; Prunster, J.; Zeps, N.; Reniers, B.; Verhaegen, F.; Saunders, C.; House, M.; Joseph, D. 2015: PO-1077 Comparison of in vivo and theoretical assessment of radiation-induced DNA damage. RadioTherapy and Oncology 115: S581-S582
Xiao, Q.; Bu, W; Ren, Y.; Qiu, J.; Xiangpeng, Z. 2015: PO-1079 Single W18O49 nanowire: a multifunctional nanoplatform for image-guided dose-enhancement radiation therapy. RadioTherapy and Oncology 115: S582-S583
Reynders, K.; Illidge, I.; Siva, S.; Chang, J.; De Ruysscher, D. 2015: PO-1080 The abscopal effect of local radiotherapy in the clinic: a systematic review on its occurrence. RadioTherapy and Oncology 115: S583-S584
Pulvirenti, T.; Agustin, C.; Tamas, M.; Harris, J.; Verning, M.; Cross, S.; Gebski, V.; Jayamohan, J.; Yeghiaian-Alvandi, R. 2015: PO-1083 A randomized controlled trial on the effect of thoracic immobilization in patient positioning and clinical outcomes. RadioTherapy and Oncology 115: S584-S585
Jimenez, E.; Mateos, P.; Pardo, J.; Font, J.C.; Montemuiño, S.; Ortiz, I.; Alastuey, I.; Mena, A.; Sabater, S. 2015: PO-1085 Comparison of clinical-radiological information in contouring rectal boost. RadioTherapy and Oncology 115: S585-S586
De Vet, S.; Van Oorschot, S.C.H.; Gerling, M.; Kouwenhoven, E.; Kwakkel, L.; Mast, M.; Rietveld, P.; Roos, J.; Van der Voort van Zyp, N.; Van de Vaart, P. 2015: PO-1086 Target volume comparison in lung cancer based on slow CT, 4DCT and ABC CT-scans. RadioTherapy and Oncology 115: S586-S587
Min, S.; Kwak, J.; Kim, Y.; Ahn, S.D.; Cho, B. 2015: PO-1088 Clinical feasibility of ABAS tool for radiotherapy planning in intact, post-op prostates, and endometrial cancer. RadioTherapy and Oncology 115: S587-S588
Hajduk, A.B.; Rutkowski, T.; Mazurek, A.; Skladowski, K. 2015: PO-108: The role of circulating HPV-16 DNA detection in HNSCC patients treated by definitive radiation or chemo-radiation. RadioTherapy and Oncology 114: 53-54
Li, C.H.; Wu, V.W.C.; Chiu, G. 2015: PO-1090 Dosimetric impact of brachial plexus delineation in radiotherapy planning of nasopharyngeal carcinoma. RadioTherapy and Oncology 115: S588-S589
Ehlert Tvile, S.; Nørlykke Drudegaard, J.; Edmund, J.M.; Lindberg, H.; Juhler-Nøttrup, T.; Buhl, S.K.; Holch Kristensen, B. 2015: PO-1091 Dice Comparison of OAR delineations in the pelvic region between RTT's and RadOnc's: a measure of competence. RadioTherapy and Oncology 115: S589-S590
Nijhuis, R.; Brachmann, C.; Weiler, F.; Traulsen, N.; Corr, D.; Schenk, M.; Ganswindt, U.; Thieke, C.; Wirtz, S.; Belka, C. 2015: PO-1092 A novel, efficient contour mapping method facilitates adaptive radiotherapy in head and neck patients. RadioTherapy and Oncology 115: S590-S591
Molinier, J.; Boisselier, P.; Aillères, N.; Siméon, S.; Bedos, L.; Azria, D.; Fenoglietto, P. 2015: PO-1094 Tracking, gating, free-breathing, what is the best dose distribution for lung stereotactic treatments?. RadioTherapy and Oncology 115: S591-S592
Kamphuis, M.; Van Wieringen, N.; Jin, P.; Alderliesten, T.; Van Os, R.; Bel, A.; Hulshof, M.C.C.M. 2015: PO-1096 Inter-fraction variation of gas volume in the abdominal region during radiotherapy for distal esophageal cancer. RadioTherapy and Oncology 115: S592-S593
Goddeeris, B.; Vanderstraeten, B.; Vandecasteele, K.; Van Eijkeren, M.; Derie, C.; De Wagter, C.; Lievens, Y. 2015: PO-1098 Automated planning for lung SBRT: faster optimization without compromise on plan quality. RadioTherapy and Oncology 115: S593-S594
Ryczkowski, A.; Nachyla, S.; Skorska, M.; Piotrowski, T. 2015: PO-1101: Doses in the bladder and rectum during radiotherapy for prostate cancer, depending on the technique and themargin. RadioTherapy and Oncology 115: S595-S596
Chiu, G.; Fung, W.W.K.; Wu, V.W.C. 2015: PO-1103 Geometric and actual dose delivery accuracy in supine and prone position of breast tomotherapy. RadioTherapy and Oncology 115: S596-S597
Engeseth, G.M.; Stokkevåg, C.H.; Odland, O.H. 2015: PO-1104 Effects of range uncertainties and setup errors in craniospinal proton treatment plans. RadioTherapy and Oncology 115: S597-S598
Maggio, A.; Cutaia, C.; Di Dia, A.; Bresciani, S.; Miranti, A.; Poli, M.; Garibaldi, E.; Gabriele, P.; Stasi, M. 2015: PO-1105 Tomotherapy ultra-high dose escalation for radical malignant pleural mesothelioma patients: a feasibility study. RadioTherapy and Oncology 115: S598-S599
Hori, M.; Someya, M.; Nakata, K.; Kitagawa, M.; Hasegawa, T.; Tsuchiya, T.; Gocho, T.; Fukushima, Y.; Takada, Y.; Sakata, K. 2015: PO-1107 Comparative analysis of VMAT plans for prostate cancer with different MLCs, Elekta Agility and MLCi2. RadioTherapy and Oncology 115: S599-S600
Bernard, B.; Leleu, C. 2015: PO-1109 Which optimal fiducial marker for image guidance in prostate radiotherapy treatment?. RadioTherapy and Oncology 115: S600-S601
Wipf, S.; Senning, M.; Pytko, I.; Lang, S.; Najafi, Y.; Guckenberger, M.; Winter, C. 2015: PO-1110 Clinical experience with a radiofrequency system for setup and motion monitoring of prostate radiotherapy. RadioTherapy and Oncology 115: S601-S602
Thøgersen, E.H.; Møller, D.S.; Hoffman, L. 2015: PO-1112 Quantification of interfractional movement of the oesophagus and the influence on the dose to the oesophagus. RadioTherapy and Oncology 115: S602-S603
McGarry, M.; El Kaissi, T.; Hayes, J.; Riyas, M.; Benson, K.; Paloor, S.; McLellan, J.; Sheim, S.; Perkins, G.; Hammoud, R.; Petric, P.; Al-Hammadi, N. 2015: PO-1114 A multidisciplinary developed optimized imaging strategy for frameless stereotactic radiosurgery. RadioTherapy and Oncology 115: S603-S604
Baker, A.F.; Littler, J.A.H.; Callender, J.A.; Meara, S.J.P.; Reilly, A.J.; Baker, C.R. 2015: PO-1116 Implementation of 4D-CBCT image guidance into the routine clinical workflow: an RTT led process. RadioTherapy and Oncology 115: S604-S605
Pedersen, S.K.; Pazhang, S.; Gullander, L.; Zarp, T.; Jacobsson, S.; Lynnerup, V.K.; Baker, M. 2015: PO-1117 Comparison of 2D- and 3D-ultrasound probe imaging of uterus: a volunteer study. RadioTherapy and Oncology 115: S605-S606
Bewley, M.; Marchant, T.; Stratford, J.; Chauhan, S.; Faivre-Finn, C. 2015: PO-1119 Suitability of lung margins following analysis of set up data within a multi-national lung trial. RadioTherapy and Oncology 115: S606-S607
Teske, H.; Mercea, P.; Giske, K.; Bendl, R. 2015: PO-1121 Model based 2D localization of lung tumors by incorporating the motion of diaphragm and heart. RadioTherapy and Oncology 115: S608-S609
Zucca, A.; Mancosu, P.; Comito, T.; Lobefalo, F.; Galdieri, C.; Gaudino, A.; Modugno, A.; Palumbo, V.; Reggiori, G.; Stravato, A.; Tozzi, A.; Tomatis, S.; Scorsetti, M. 2015: PO-1123 On line tracking of abdominal compression efficacy for pancreas SBRT by Calypso surface transponders. RadioTherapy and Oncology 115: S609-S610
Olling, K. 2015: PO-1125 Evaluation of the clinical practice of vaginal dilator therapy for women receiving curative pelvic radiotherapy. RadioTherapy and Oncology 115: S610-S611
Hughes, M.; Sykes, V.A.; Jessop, A.; Beavis, A.W. 2015: PO-1126 A pilot study using a computer simulation tool for patient/carer education of radiotherapy. RadioTherapy and Oncology 115: S611-S612
Beech, R.; Burgess, K.; Stratford, J. 2015: PO-1128 Process evaluation of treatment times in a busy radiotherapy department. RadioTherapy and Oncology 115: S612-S613
Møller, P.; Primdahl, H.; Kristensen, C.A.; Andersen, E.; Andersen, L.J; Overgaard, J.; Johansen, J. 2015: PO-1129 Effect of continued tobacco smoking during radiotherapy on loco-regional control for carcinoma of the larynx. RadioTherapy and Oncology 115: S613-S614
Hodgson, D.; Hodge, N. 2015: PO-1131 Learning to manage emotion in the radiotherapy setting: the role of service users in education. RadioTherapy and Oncology 115: S614-S615
Katzman, T.; Shelley, E.; Luxenburg, O.; Lawrence, Y.R.; Symon, Z. 2015: PO-1133 Outcomes of a high impact simulation rich education for RTTs bridging the gap from diagnostic radiography. RadioTherapy and Oncology 115: S615-S616
Bak, B.; Kaczmarek, A.; Kowalik, A.; Tomczak, J. 2015: PO-1135 Extended scope of practice of radiation therapist: role in clinical planning procedures and patient management. RadioTherapy and Oncology 115: S616-S617
Jager, E.A.; Schakel, T.; Caldas-Magalhaes, J.; Ligtenberg, H.; Kasperts, N.; Philippens, M.E.P.; Pameijer, F.A.; Terhaard, C.H.J.; Willems, S.M.; Raaijmakers, C.P.J. 2015: PO-117: Overestimation of tumor volume of laryngeal/hypopharyngeal cancer on MRI in clinical radiotherapy practice. RadioTherapy and Oncology 114: 57-58
Anura, A.; Conjeti, S.; Pal, M.; Paul, R.R.; Chatterjee, J. 2015: PO-121: Computer-aided quantitative interpretation to HIF-1a, c-MYC and p53 expression in oral submucous fibrosis. RadioTherapy and Oncology 114: 59-60
Mogensen, S.; Sveindottir, K.; Treldal, C.; Nygaard, A.; Mohammad, A.; Kristensen, C.A.; Petersen, J.; Andersen, O. 2015: PO-124: New local anesthetic lozenge induces no risk of aspiration in healthy subjects and head/neck cancer patients. RadioTherapy and Oncology 114: 60-61
Mota, A.; Netto, E.; Santos, A.; Ferreira, M.; Sargento, I.; Costa, D.; Gouveia, E.; Martins, L.; Esteves, S.; Roldão, M. 2015: PO-127: Prevention and treatment of oral mucositis in patients treated with chemoradiotherapy with head and neck cancer. RadioTherapy and Oncology 114: 61-62
Söderström, K.; Harnesk-Nygren, H. 2015: PO-131: Prevention of mucositis: episil in a clinical setting for oral cancer patients undergoing definitive RT. RadioTherapy and Oncology 114: 63-64
Paterson, C.; Thomson, M.; Caldwell, B.; Porteous, S.; McLean, A.; Park, G.; Messow, C.M. 2015: PO-134: Dose related efficacy of LMS-611 in Radiotherapy Induced Xerostomia an ex vivo study. RadioTherapy and Oncology 114: 64-65
Deantonio, L.; Paolini, M.; Cozzi, S.; Masini, L.; Loi, G.; Brambilla, M.; Krengli, M. 2015: PO-135: Nasopharynx IMRT: DVH parameters of constrictor muscles and parotid glands correlated to dysphagia and xerostomia. RadioTherapy and Oncology 114: 65-66
Mäkitie, A.; Loimu, V.; Aro, K.; Bäck, L.; Saarilahti, K.; Sintonen, H.; Räsänen, P.; Roine, R.P. 2015: PO-137: Health-related quality of life in head and neck cancer patients. RadioTherapy and Oncology 114: 66-67
Wang, T.C.; Liao, H.C.; Chen, C.H. 2015: PO-140: Transnasal endoscopic medial maxillectomy for maxillary and ethmoid sinus tumor- our three experience. RadioTherapy and Oncology 114: 67-68
Polyakov, A.; Kaprin, A.; Reshetov, I.; Ratushnyy, M.; Matorin, O.; Sevrukov, F.; Filushin, M.; Vasilev, V.; Rebrikova, I. 2015: PO-143: Microinvasive access to visceral autoflaps - microsurgical reconstruction laryngopharynx and upper third esophagus. RadioTherapy and Oncology 114: 68-69
Reshetov, I.; Rebrikova, I.; Polyakov, A.; Phyliushin, M.; Vasiliev, V. 2015: PO-145: Oropharyngeal region reconstruction using bioengineered flaps. RadioTherapy and Oncology 114: 69-70
Polyakov, A.; Sevrukov, F.; Ratushnyy, M.; Matorin, O.; Filushin, M.; Vasiliev, V.; Rebrikova, I.; Panaseikin, U.; Babaskina, N. 2015: PO-148: Videoassisted resections of larynx with radio frequency thermal ablation in cancer patients. RadioTherapy and Oncology 114: 70-71
Carvalho, A.L.; Scapulatempo Neto, C.; Rocha, E.T.; Capuzzo, R.C. 2015: PO-151: Initial experience on near-infrared guided surgery for sentinel lymph node biopsy for oral cavity carcinoma. RadioTherapy and Oncology 114: 71-72
Macfarlane, T.V.; Macfarlane, G.J. 2015: PO-154: Head and neck cancer case-control study: UK Biobank. RadioTherapy and Oncology 114: 72-73
Ribeiro Porfirio, L.; Silva, S.P.; Porfírio, L.K.R.; Porfírio, L.N.R.; Silva, R.R. 2015: PO-156: Pitfalls for diagnosis of pigmented skin lesions. RadioTherapy and Oncology 114: 73-74
Sun, X.S.; Khalifa, J.; Faivre, J.C.; Sio, T.; Bar-Sela, G.; Demiroz, C.; Boisselier, P.; Pan, J.J.; Miller, R.C.; Thariat, J. 2015: PO-158: The Role of concomitant radiochemotherapy in Anaplastic Thyroid Carcinomas (ATC): A study of the Rare Cancer Network. RadioTherapy and Oncology 114: 74-75
Sellami, N.; Mnejja, W.; Siala, W.; Toumi, N.; Ghorbel, M.; Frikha, M.; Daoud, J. 2015: PO-162: Multiple primary malignancies of thyroid and nasopharyngeal carcinoma. RadioTherapy and Oncology 114: 75-76
Cupissol, D.; Even, C.; Fayette, J.; Rolland, F.; Laguerre, B.; Peyrade, F.; Buffard, K.; Bidault, F.; Auperin, A.; Guigay, J. 2015: PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma. RadioTherapy and Oncology 114: 76-77
Polyakov, A.; Matorin, O.; Ratushnyy, M.; Filushin, M.; Kydrin, K. 2015: PO-166: Special aspects of surgical treatment of mucosal melanoma affecting oral and nasal cavities. RadioTherapy and Oncology 114: 77-78
Silva, S.P.; Porfírio, L.A.R.; Porfírio, L.K.R.; Porfírio, L.N.R.; Silva, D.V.S.; Azevedo, M.S.; Lourenço, A.A.; Silva, R.R. 2015: PO-169: Fine needle aspiration biopsy of thyroid at the Institute of Oncology Aldenora Bello-So Luis-Brazil. RadioTherapy and Oncology 114: 78-79
Torres, P; van Wingerden, J-Willem; Verhaegen, M 2015: PO-MOESP subspace identification of Directed Acyclic Graphs with unknown topology. Automatica 53: 60-71
Zennaki, A.; Touhami, M.; Hachelaf, W.; Boukrelda, M.; Moussaoui, K.; Belaidi, T.; Bouziane-Nedjadi, K.; Belkacem-Maatalah, R. 2015: PO04 Effet dun accompagnement infirmier codifi sur lquilibre du DT1 de ladolescent en dsquilibre mtabolique persistant. Diabetes and Metabolism 41: A23-A24
Hermans, M.P.; Ahn, S.A.; Bouenizabila, E.; Rousseau, M.F. 2015: PO08 Dans quelle mesure la prvalence du diabte prdit les vnements ischmiques: une mta-analyse de 212 850 patients de 29 grands essais cliniques. Diabetes and Metabolism 41: A24-A25
Bogenmann, L.; Vidal, P.; Pereira, B.; auveron, I. 2015: PO12 Profil des medecins prescripteurs danalogues GLP1 ou inhibiteurs de DPP4. Diabetes and Metabolism 41: A25-A26
Alzaid, F.; Dalmas, E.; Toubal, A.; Lebozec, K.; Ancel, P.; Cruciani-Guglielmacci, C.; Foufelle, F.; Poitou, C.; Torcivia, A.; Luquet, S.; Aron-Wisnewsky, J.; Clément, K.; Udalova, I.; Venteclef, N. 2015: PO16 Interferon Regulatory Factor-5 (IRF5) contrle linflammation mtabolique dans le diabte de type 2. Diabetes and Metabolism 41: A26-A27
Benomar, K.; Defrance, F.; Leroy, C.; Kerr-Conte, J.; Noel, C.; Pattou, F.; Pigny, P.; Vantyghem, M.C. 2015: PO19 volution du CA19.9 aprs greffe dlots pancratiques endocrines. Diabetes and Metabolism 41: A27-A28
Hoarau, E.; Chandra, V.; Rustin, P.; Scharfmann, R.; Duvillié, B. 2015: PO23 Contrle de la diffrenciation des cellules bta pancratiques par les espces ractives de loxygne. Diabetes and Metabolism 41: A28-A29
Croyal, M.; Nobécourt-Dupuy, E.; Ferchaud-Roucher, V.; Chétiveaux, M.; Crossouard, S.; Ouguerram, K.; Krempf, M. 2015: PO27 Les concentrations plasmatiques de PCSK9 varient en fonction de ltat nutritionnel et influencent la cintique des LDL. Diabetes and Metabolism 41: A29-A30
Pupier, E.; Tavitian, M.; Pezzino, S.; Fagour, C.; Rigalleau, V. 2015: PO31 Les patients diabtiques de type 2 sont moins actifs lhpital qu domicile. Diabetes and Metabolism 41: A30-A31
Kawakami, H; Honda, M C.; Matsumoto, K; Wakita, M; Kitamura, M; Fujiki, T; Watanabe, S 2015: POC fluxes estimated from234Th in late springearly summer in the western subarctic North Pacific. Journal of Oceanography 71(3): 311-324
Tallet, A.; Allery, C.; Allard, F. 2015: POD approach to determine in real-time the temperature distribution in a cavity. Building and Environment 93: 34-49
Ferdous, B; Habtany, Y; El Mautawakil, B; Otmani, H; Rafai, M; Slassi, I 2015: POEMS syndrome : tude de 5 cas. Revue Neurologique (Paris) 171: A153-A154
Nazir, A; Nazir, A; Abrahamson, K 2015: POISe-Care: A Team-based Bedside Model for Care in SNF Setting. Journal of the American Medical Directors Association 16(3): B20-B21
Molodenskii, D. S.; Sul'yanov, S. N. 2015: POLARCALC: A program for calculating the linear-polarization factor using an area detector. Crystallography Reports 60(3): 446-448
Lahsasni, S; Ben Hadda, T; Masand, V; Pathan, N B.; Parvez, A; Warad, I; Shaheen, U; Bader, A; Aljofan, M 2015: POM analyses of Raltegravir derivatives: a new reflection enlightening the mechanism of HIV-integrase inhibition. Research on Chemical Intermediates 41(8): 5121-5136
Youssoufi, M H.; Ben Hadda, T; Warad, I; Naseer, M Moazzam; Mabkhot, Y Nasser; Bader, A 2015: POM analyses of anti-kinase activity of thirteen peptide alkaloids extracted from Zizyphusspecies. Medicinal Chemistry Research 24(1): 267-274
Wheeler, W C.; Lucaroni, N; Hong, L; Crowley, L M.; Varón, Aés 2015: POY version 5: phylogenetic analysis using dynamic homologies under multiple optimality criteria. Cladistics 31(2): 189-196
Aksakal, A; Urumdaş, M; Yaman, M; Yücel, Oğuzhan; Ateş, A Hakan 2015: PP-001 Seldom Seen Couple: Spontaneous Coronary Artery Dissection and Musculer Bridge. American Journal of Cardiology 115: S93-S94
Ede, Hüseyin; Erkoç, M Fatih; Alüzüm, H; Özdemir, Z Tuğba; Erbay, A Rıza 2015: PP-004 Tirofiban Induced Anemia without Thyrombocytopenia. American Journal of Cardiology 115: S95-S96
Aparci, M; Ozturk, C; Tezcan, M; Isilak, Z; Yalcin, M; Uzun, M 2015: PP-012 Analysis and Management of Acute Cardiovascular Emergencies Presented to the Cardiology Polyclinic. American Journal of Cardiology 115: S99-S100
Ozkan, H; Cetinkaya, A Seckin; Ari, H; Tiryakioglu, S Kenar; Bozat, T 2015: PP-013 Endothelial Dissection due to the Usage of Synthetic Cannabinoid: Bonsai. American Journal of Cardiology 115: S100-S101
Aparci, M; Ozturk, C; Balta, S; Bozlar, U; Celik, T; Iyisoy, A 2015: PP-015 A Rare Case of Aneursym of Triple Arteries; Coronary, Aorta and Pulmonary; in a Young Subject. American Journal of Cardiology 115: S101-S102
Aparci, M; Ozturk, C; Balta, S; Isilak, Z; Celik, T; Yalcin, M; Kardesoglu, E; Uzun, M; Cebeci, B Sitki 2015: PP-017 Clinical Results of Short-Term and Long Term Follow Up Period and Antihypertensive Drug Treatment of Patients with Aortic Aneurysm. American Journal of Cardiology 115: S102-S103
Uçak, A; Temizkan, V; Şen, Hüseyin; Bulut, E Caner; Can, M Fatih; Uğur, M; Selçuk, A; Küçükodacı, Z; Özcan, Ömer 2015: PP-019 The Effect of Serum, Intestinal and Peritoneal Visfatin Levels on Early Diagnosis of Acute Mesenteric Ischemia. American Journal of Cardiology 115: S103-S104
Ugurlu, B S.; Badak, Özer; Gençpınar, Tğra; Metin, Kıvanç; Bilen, Çağatay 2015: PP-028 Coronary Bypass in Adult Progeria. American Journal of Cardiology 115: S108-S109
Aparci, M; Ozturk, C; Okutucu, S; Balta, S; Isilak, Z; Kardesoglu, E; Bozlar, U 2015: PP-031 Anteroseptal Myocardial Infarctions due to Myocardial Bridging Are Generally Misdiagnosed as Myocarditis in Young Patients. American Journal of Cardiology 115: S110-S111
Oğuz, D; Ünal, H; Eroğlu, H; Gülmez, Öykü; Çevik, H; Altun, Ağan 2015: PP-034 Is it Possible to Predict Subclinic Atherosclerosis in Non-alcoholic Fatty Liver Disease Patients by Using Non-invasive Parameters?. American Journal of Cardiology 115: S111-S112
Aparci, M; Ozturk, C; Okutucu, S; Balta, S; Isilak, Z; Yalcin, M; Kucuk, U 2015: PP-035 T Wave Surge on Precordial Leads During Treadmill Test may Indicate the Presence of Myocardial Bridging on LAD Artery in Young Subjects. American Journal of Cardiology 115: S112-S113
Aşkın, Lütfü; Karakelleoğlu, Şule; Değirmenci, Hüsnü; Demirelli, S; Şimsek, Z; Taş, M Hakan; Topçu, S; Lazoğlu, Z; Ermiş, E 2015: PP-037 Comparison of the Effects of Metoprolol or Carvedilol Upon Serum GGT and Uric Acid Levels among the Patients with Acute Coronary Syndrome without ST Segment Elevation. American Journal of Cardiology 115: S113-S114
Başyiğit, F; Elalmış, Özgül Uçar; Güray, Ümit; Gürsoy, H Tuğba; Demirtaş, B; Şahin, D; Bayır, Pınar; Ileri, M 2015: PP-041 Spontaneous Right Coronary Artery Dissection Causing Isolated Right Ventricular Myocardial Infarction Misinterpreted as Anterior Wall Myocardial Infarction. American Journal of Cardiology 115: S115-S116
Erkus, M Emre; Altiparmak, I Halil; Demirbag, R; Gunebakmaz, O; Kaya, Z; Taskin, A; Neselioglu, S; Erel, O 2015: PP-045 The Investigation of the Dynamic Thiol-disulfide Homeostasis in Acute Coronary Syndromes. American Journal of Cardiology 115: S117-S118
Hayıroğlu, M Ilker; Aydın, B Arıkan; Öz, A; Tanık, V Ozan; Keskin, M; Uzun, A Okan; Karataş, M Baran 2015: PP-050 Dignostic Enigma in a Homocystinuria Patient. American Journal of Cardiology 115: S119-S120
Ikikardeş, Müslüm Fırat; Çağlıyan, Çağlar Emre; Deveci, O Sinan; Çelik, A Inan; Demirtaş, M 2015: PP-053 Intervention to a Fistula Originating from Left Anterior Descending Artery (LAD) to Main Pulmonary Artery. American Journal of Cardiology 115: S120-S121
Alhefnawy, S Bayoumi; Albarbary, Y Hussain; Alshiekh, A Ahmed; Hegab, M Salah; Ismail, I Mahrous; Altahmoudy, K Ahmed 2015: PP-055 Association between Coronary Artery Disease and Hepatitis C Virus Seropositivity. American Journal of Cardiology 115: S121-S122
Gündeş, A; Çelik, A; Yeşil, E; Özcan, Türkay 2015: PP-057 Acute Myocardial Infarction due to Diffuse Severe LMCA Stenosis in Young Woman with Familiar Hypercholesterolemia. American Journal of Cardiology 115: S122-S123
Arziman, I; Kaldirim, U; Eyi, Y Emrah; Ardic, S 2015: PP-059 Scorpion Bite and Acute Coronary Syndrome. American Journal of Cardiology 115: S123-S124
Kardeşoğlu, E; Yalçın, M; Yiğiner, Ömer; Cebeci, B Sıtkı 2015: PP-061 Coronary Aneurysm after Bioresorbable Vascular Scaffold Implantation. American Journal of Cardiology 115: S124-S125
Demirelli, S; Ermis, E; Hatem, E; Uslu, A; Askın, Lütfü 2015: PP-066 Focal Mid-ventricular Anterior Ballooning: A Mid-Ventricular Variant of Takotsubo Cardiomyopathy. American Journal of Cardiology 115: S126-S127
Kaya, E; Karabacak, K; Kadan, M; Çelik, M; Yüksel, U Çağdaş; Gökoğlan, Yçın; Yıldırım, E; Kabul, H Kutsi; Barçın, C 2015: PP-068 Physiological Significant Constrictive Pericarditis After Blunt Trauma: A Case Report. American Journal of Cardiology 115: S127-S128
Kahramaner, M; Belen, E; Helvacı, Aşen; Çakan, C; Uzun, Y Emre 2015: PP-070 Evaluation of Cardiac Systolic and Diastolic Function with Ecocardiography in Overt Hypothyroidism. American Journal of Cardiology 115: S128-S129
Ozturk, U; Ozturk, O 2015: PP-072 Relation between Diet Quality Index and Left Ventricular Myocardial Performance Index in Patients with Acute Coronary Syndrome. American Journal of Cardiology 115: S129-S130
Asarcikli, L Dinc; Kafes, H; Guray, Y; Tufekci̇oglu, O 2015: PP-074 Plasticity of the Right Ventricle in Patient with Left Atrial Myxoma. American Journal of Cardiology 115: S130-S131
Isılak, Z; Aparcı, M; Karabacak, E; Aydın, E; Uz, Ömer; Küçük, Uğur; Uzun, M 2015: PP-080 Global Longitudinal and Circumferential Strain and also Epicardial and Endocardial Torsion Properties of Left Ventricle is Deteriorated in Patients with Behet's Disease. American Journal of Cardiology 115: S132-S133
Yilmaz, N; Dorum, B Ali; Silfeler, İbrahim; Arslan, S; Alakus, U; Akoglu, F 2015: PP-086 Middle Aortic Syndrome as a Cause of Hypertension in a Child with Hypomelanosis of Ito. American Journal of Cardiology 115: S135-S136
Yuksel, M; Yildiz, A; Tekbas, E; Gunduz, E; Ekinci, A; Yuksel, H; Bilik, M Zihni; Ozaydogdu, N; Aktan, A 2015: PP-089 Paraoxonase and Arylesterase Activities in Dipper and Non-dipper Prehypertensive Subjects. American Journal of Cardiology 115: S137-S138
Ermis, N; Otlu, Yılmaz Ömür; Afşin, A; Hidayet, Şıho; Açıkgöz, N; Cansel, M; Yağmur, J 2015: PP-091 Comparison of Left Atrial Volume and Function in Non-Dipper Versus Dipper Hypertensive Subjects: A Real-Time Three-Dimensional Echocardiography Study. American Journal of Cardiology 115: S138-S139
Aykanat, B; Set, T; Ateş, E Altunbaş 2015: PP-094 Status of Regular Drug Use and Compliance to Salt Restrictions at Hypertension Patients. American Journal of Cardiology 115: S139-S140
Ozbay, Yılmaz; Yavuzkir, Şeyda 2015: PP-102 The Effect of Pregnancy on QT Dispersion. American Journal of Cardiology 115: S142-S143
Ulucan, Şeref; Kaya, Z; Keser, A; Katlandur, Hüseyin; Karanfil, M; Ateş, I 2015: PP-105 Deterioration of Heart Rate Recovery Index in Patients with Erectile Dysfunction. American Journal of Cardiology 115: S143-S144
Özin, Bülent; Aytemir, K; Arslan, Özgür; Özcan, Türkay; Kanadaşı, M; Demir, M; Gökçe, M; Sucu, M Murat; Özdemir, M; Yiğit, Z; Yavuzkır, M Ferzeyn; Oto, A 2015: PP-112 Compliance to Anticoagulant Therapy and Time in Therapeutic Range in Patients with Non-valvular Atrial Fibrillation: Results from TREQ-AF Study. American Journal of Cardiology 115: S145-S146
Güray, Ümit; Ipek, E Gücük; Güray, Yşim Akın; Elalmış, Özgül Uçar; Gürsoy, H Tuğba 2015: PP-113 Asymptomatic Tricuspid Stenosis Following a Complex Lead Extraction Procedure. American Journal of Cardiology 115: S146-S147
Aksu, Uğur; Topcu, S; Kalkan, K; Tanboğa, I Halil 2015: PP-115 Massive Pulmonary Embolism Mimicking Electrocardiographic Pattern of Brugada Syndrome. American Journal of Cardiology 115: S147-S148
Aksu, Uğur; Topcu, S; Kalkan, K; Gulcu, O; Tanboğa, I Halil; Aksakal, E; Sevimli, S; Açıkel, M 2015: PP-118 Comparison of Standard and Lewis ECG in Detection of A-V Dissociation in Patients with Wide QRS Tachycardia. American Journal of Cardiology 115: S148-S149
Asuk, Z; Erdem, F; Kargı, A; Caglar, S Onur; Dönmez, I; Talay, F; Yazıcı, M 2015: PP-121 Atrial Conduction Times in Patients with Early Stage Chronic Obstructive Pulmonary Disease. American Journal of Cardiology 115: S149-S150
Bartoccioni, F; Monaco, C; Montecchiesi, L; Dubinski, M; Marchio, M; Vulpiani, L; Borreca, F; Morrone, A; Pacchiarini, D; Donetti, D; Amoddeo, C 2015: PP-125 The Creation and Heart Team and of a Clinical-Bureaucratic Pathways to Monitor and Induce Appropriate Use of TAVI. American Journal of Cardiology 115: S151-S152
Okutucu, S; Aksoy, H; Sabanoglu, C; Karakulak, U Nadir; Sayin, B Yetis; Tanalp, A Cevat; Oto, A 2015: PP-128 A Case of Very Prolonged Cardioinhibitory Syncope During Head-Upright Tilt Table Test. American Journal of Cardiology 115: S153-S154
Karaoğuz, M Remzi; Kocaman, S Altan; Baysan, O; Korkmaz, M Emin 2015: PP-131 Cochlear Implantation in a Patient with Cardiac Pacemaker: Electromagnetic nterference?. American Journal of Cardiology 115: S154-S155
Iyisoy, A; Ozturk, C; Balta, S; Aparci, M; Demir, M; Demirkol, S; Unlu, M; Yuksel, U Cagdas; Celik, T; Yildirim, A Osman 2015: PP-133 Aortic Arch Interruption Always Needs Surgical Approach: A Case of Angioplasty and Stenting in a 20 Years Old Man. American Journal of Cardiology 115: S155-S156
Acikel, S; Asarcikli, L Dinc; Akyel, A; Cimen, T; Efe, T; Pamukcu, H Erken; Bilgin, M; Dogan, M; Yeter, E 2015: PP-134 The Successful Percutaneous Revascularization of Subclavian Artery Stenosis Causing Coronary Subclavian and Vertebral Artery Steal Syndrome. American Journal of Cardiology 115: S156-S157
Aparci, M; Ozturk, C; Balta, S; Okutucu, S; Isilak, Z; Ozmen, Nık; Cebeci, B Sitki; Yalcin, M 2015: PP-137 Features of Aortic Diameters in Young Subjects with Bicuspid Aortic Valve and Aortic Sinus Dilatation During the Initial Diagnosis. American Journal of Cardiology 115: S157-S158
Özbudak, E; Yavuz, Şadan; Arikan, A Ahmet; Durmaz, D; Gülaştı, Ömer Faruk; Mirhanoğulları, A Fuat; Aydın, A; Kanko, M; Berki, K Turan 2015: PP-138 A Pseudoaneurysm of the Ascending Aorta. American Journal of Cardiology 115: S158-S159
Ozyildirim, S; Simsek, E Cagri; Gonencer, M; Eren, N Kahya; Tülüce, S Yakar; Kocabas, U 2015: PP-140 Acute Aortic Dissection and Death Owing to Weight Lifting in a Patient Presenting with Chest Pain. American Journal of Cardiology 115: S159-S160
Cosansu, K; Turer, Aça; Karadag, B 2015: PP-144 Is There Any Association between Left Ventricular Mass Index(LVMI) and E Point-peptal Seperation (EPSS) at Heart Failure Patients?. American Journal of Cardiology 115: S161-S162
Özkan, Gökhan; Yıldırım, V; Ince, M Emın; Dogancı, S; Kılıc, A 2015: PP-148 Pediatric Atrial Septal Defect Closure Under General Anesthesia. American Journal of Cardiology 115: S162-S163
Varol, S; Okuyan, E; Dinçkal, M Hakan; Ayça, B; Kum, Gökmen; Şahin, I; Karaayvaz, E Bilal; Kahyaoglu, S; Oto, A 2015: PP-154 Transcatheter Aortic Valve Implantation in Patient with Bicuspid Valve and Large Aortic Aneurism. American Journal of Cardiology 115: S164-S165
Asarcikli, L Dinc; Erat, M; Acikel, Sık; Dicle, C Bayindir; Yuceege, M; Efe, T Han; Bilgin, M; Akyel, A; Dogan, M; Firat, H; Yeter, E 2015: PP-156 Neutrophil to Lymphocyte Ratio is Associated with Severe Obstructive Sleep Apnea Syndrome and Increased Inflammation. American Journal of Cardiology 115: S165-S166
Sahin, I; Ozkaynak, B; Gungor, B; Uzun, F; Küçük, S Hayri; Ayca, B; Avci, I Ilker; Okuyan, E; Cetin, S Cetın; Dinckal, M Hakan 2015: PP-159 Assessment of Copeptin Levels in Hypertrophic Cardiomyopathy. American Journal of Cardiology 115: S166-S167
Celik, A Inan; Deniz, A; Deveci, O Sinan; Tangalay, M; Demirtas, M 2015: PP-163 Eosinophilic Myocarditis Associated with Eosinophilic Pneumonia and Eosinophilia Following Antibiotic and Narcotic Analgesic Treatment. American Journal of Cardiology 115: S168-S169
Zencir, C; Cetin, M; Elbi, H; Selvi, M; Onay, S; Yilmaz, M; Akgullu, C; Gungor, H; Karaman, K 2015: PP-165 Diagnostic Impact of Neutrophil / Lymphocyte and Platelet / Lymphocyte Ratio on Idiopathic Pericardial Effusion Severity. American Journal of Cardiology 115: S169-S170
Koca, S; Paç, F Ayşenur; Kavurt, V; Atik, F; Bagrul, D; Mihcioglu, A 2015: PP-169 Left Ventricular Torsion in Our First Four Heart Transplant Recipients: A Preliminary Report. American Journal of Cardiology 115: S171-S172
Ezequiel, M.; Luis, C. 2015: PP01.11 2618: Refractory epilepsy and NXF2 gene Coincidence or causality?. European Journal of Paediatric Neurology 19: S31-S32
Zelnik, N.; Shemer-Meiri, L.; Banne, E.; Meiner, V. 2015: PP01.4 2720: Novel mutation in GRIN1 gene expressed as neonatal-onset drug-resistant epilepsy associated with microcephaly and polymicrogyria. European Journal of Paediatric Neurology 19: S29-S30
Linder, I.; Nezer-Kaner, I.; Leshinsky-Silver, E.; Kivity, S.; Michelson, M.; Lev, D.; Lerman-Sagie, T. 2015: PP01.7 2726: A novel description of a homozygous partial deletion of RBFOX1 gene causing epileptic encephalopathy, severe intellectual disability and progressive post-natal microcephaly. European Journal of Paediatric Neurology 19: S30-S31
Burton, A; Silva, I dos Santos; Hipwell, J; Flugelman, A; Kwong, A; Peplonska, B; Tamimi, R; Bertrand, K; Vachon, C; Hartman, M; Lee, C; Chia, K; Nagata, C; Salem, D; Sirous, R; Maskarinec, G; Ursin, G; Dickens, C; Lee, J; Kim, J; Giles, G; Krishnan, K; Pereira, A; Garmendia, M; Perez-Gomez, B; Pollan, M; Lajous, M; Rice, M; Van Gils, C; Wanders, H; Teo, S; Mariapun, S; Vinayak, S; Ndumia, R; Ozmen, V; Stone, J; Hopper, J; Boyd, N; McCormack, V 2015: PP01International pooling project of mammographic density - insights of a marker of breast cancer risk from 22 diverse countries. Journal of Epidemiology and Community Health 69(Suppl 1): A53.2-A54
Tanriverdi, M.; Kultursay, N.; Tekgul, H.; Sozmen, E.; Koroglu, O. Altın; Serdaroğlu, G.; Yalaz, M. 2015: PP02.1 2612: The clinical value of neuromediators (brain derivated neurotrophic factor, galanin, neuropeptid Y) in neonatal encephalopathy. European Journal of Paediatric Neurology 19: S32-S33
des Portes, V.; Rolland, A.; Velazquez-Dominguez, J.; Peyric, E.; Ville, D.; Guibaud, L. 2015: PP02.4 2917: Cognitive outcome of isolated agenesis of the corpus callosum diagnosed during pregnancy: A clinical follow up of 46 patients. European Journal of Paediatric Neurology 19: S33-S34
Peeters-Scholte, C.M.P.C.D.; Aziz, N.A.; Wiggers-de Bruine, S.C.; Klumper, F.J.; Steggerda, S.J. 2015: PP02.8 2549: Foetal cerebellar haemorrhage: A case-series with neurodevelopmental follow-up. European Journal of Paediatric Neurology 19: S34-S35
Travers, J; Holloway, P 2015: PP02Testing a universal perception of disease and disability hypothesis in an irish population. Journal of Epidemiology and Community Health 69(Suppl 1): A54.1-A54
Scarpa, M.; Morin, I.; Amartino, H. 2015: PP03.12 2645: Identification of early clinical markers for the prediction of neurological involvement in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS). European Journal of Paediatric Neurology 19: S39-S40
Abela, L.; Simmons, L.; Steindl, K.; Schmitt, B.; Mastrangelo, M.; Joset, P.; Papuc, M.; Crowther, L.M.; Mathis, D.; Rauch, A.; Plecko, B. 2015: PP03.15 2755: Clinical metabolomics reveals a novel plasma biomarker for Snyder Robinson syndrome (X-linked spermine synthase deficiency). European Journal of Paediatric Neurology 19: S40-S41
Escobar, J.D. Ortigoza; Oyarzabal, A.; Montero, R.; Artuch, R.; Gort, L.; Briones, P.; González, B. Pérez; Rodriguez-Pombo, P.; Dueñas, B. Pérez 2015: PP03.2 2683: Next generation sequencing allows the identification of NDUFS4 defect in a patient with fatal early Leigh syndrome and deficiencies in pyruvate dehydrogenase and multiple respiratory chain complexes. European Journal of Paediatric Neurology 19: S36-S37
Van Coster, R.; Smet, J.; Vanlander, A.V.; Lengelé, B.; Seneca, S.; Revencu, N. 2015: PP03.5 2756: Multiple symmetrical lipomatosis: An uncommon presentation of a mitochondrial disease. European Journal of Paediatric Neurology 19: S37-S38
Nevsimalova, S.; Malinova, V. 2015: PP03.9 2553: Niemann-Pick disease type C and sleep disorders. European Journal of Paediatric Neurology 19: S38-S39
Millar, S; 'Connor, J; Buckley, C; Kearney, P; Perry, I 2015: PP03The prevalence and determinants of undiagnosed and diagnosed type 2 diabetes in middle-aged irish adults. Journal of Epidemiology and Community Health 69(Suppl 1): A54.2-A54
Cheikh, C.; Lacquement, E.; Cohen, R.; Daubit, D.; Pilain, C.; Hatem, G. 2015: PP04 Impact dun nouvel outil vido dducation thrapeutique en atelier sur les connaissances des patientes atteintes de diabte gestationnel. Diabetes and Metabolism 41: A127-A128
Po, C.; Suppiej, A.; Causin, F.; Talenti, G.; D'Avella, D.; Sartori, S.; Toldo, I. 2015: PP04.12 3020: Chromosomal rearrangements of 6p25.3 and Moyamoya syndrome: A non-incidental association. European Journal of Paediatric Neurology 19: S44-S45
Hostnik, T.; Stražišar, B. Gnidovec; Vipotnik Vesnaver, T.; Benedik, M. Perkovič 2015: PP04.2 2598: The varicella-zoster virus vasculopathy: Case report. European Journal of Paediatric Neurology 19: S41-S42
Sambo, A.A.; Harijan, P.; Hussain, N. 2015: PP04.9 2616: Stroke and progressive cerebral vasculopathy in PHACE syndrome. European Journal of Paediatric Neurology 19: S43-S44
Laugel, V.; Greff, G.; Obringer, C.; Querol, B. Gener; Mazur, A.; Sabouraud, P.; Calmels, N. 2015: PP05.10 3086: Cockayne syndrome and DNA repair disorders: Novel expanding neurological phenotype. European Journal of Paediatric Neurology 19: S48-S49
Goeral, K.; Kasprian, G.; Fuiko, R.; Schmidt, L.; Weninger, M.; Berger, A.; Olischar, M.; Klebermass-Schrehof, K. 2015: PP05.13 2693: Functional MRI score predicts neurodevelopmental outcome in infants with intraventricular hemorrhage. European Journal of Paediatric Neurology 19: S49-S50
Joseph, S.; McArthur, I.; Yeo, T.H.; Bhattacharya, J.J. 2015: PP05.3 2433: Case series of late presenting Vein of Galen Aneurysmal (VGAM) malformation: clinical features, angiographical features, interventions and outcomes. European Journal of Paediatric Neurology 19: S46-S47
Keymolen, K.; Stouffs, K.; Gheldof, A.; Seneca, S.; Vanderhasselt, T.; Jansen, A. 2015: PP05.6 2896: Genotype-phenotype correlations and counseling in carriers of Filamin A gene mutations. European Journal of Paediatric Neurology 19: S47-S48
Sartini, C; Wannamethee, S; Lennon, L; Whincup, P; Morris, R 2015: PP05Susceptibility to cardiovascular events during cold weather: prospective study of british men. Journal of Epidemiology and Community Health 69(Suppl 1): A55.1-A55
Lampe, R.; Botkin, N.; Turova, V.; Blumenstein, T.; Alves-Pinto, A. 2015: PP06.13 2344: Mathematical modeling of cerebral oxygenation in premature infants. European Journal of Paediatric Neurology 19: S54-S55
Mackie, S.; Kirkham, F.; Drew, H. 2015: PP06.3 3029: Tertiary paediatric major trauma centre cohort experience of neurocognitive symptoms post head injury. European Journal of Paediatric Neurology 19: S51-S52
Kopyta, I.; Michnik, R.; Nowakowska, K.; Jochymczyk-Woźniak, K.; Jurkojć, J. 2015: PP06.6 2552: The preliminary data on biomechanical evaluation of gait in monitoring of treatment in children with cerebral palsy. European Journal of Paediatric Neurology 19: S52-S53
Tobin, K; Gilthorpe, M; Hardiman, O 2015: PP06Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in ireland using partial least squares regression. Journal of Epidemiology and Community Health 69(Suppl 1): A55.2-A55
Zarnowska, I.; Luszczki, J.; Czuczwar, S.J.; Wlaz, P.; Gasior, M. 2015: PP07.1 2308: Attenuation of the anticonvulsant effects of classical antiepileptic drugs against electroshock-induced convulsions in mice fed the ketogenic diet. European Journal of Paediatric Neurology 19: S55-S56
Szabó, L.; Schlick-Szabó, A.; Fogarasi, A.; Herczegfalvi, Á. 2015: PP07.12 3021: Examination of speech processing in children with benign childhood epilepsy with centrotemporal spike. European Journal of Paediatric Neurology 19: S58-S59
Heil, S.; Pringsheim, M.; Betzler, C.; Hoffmann, J.; Grau, T.; Hörtnagel, K.; Staudt, M.; Kluger, G. 2015: PP07.15 2633: Familial generalized epilepsy with absences with SCN9A mutation: Therapy with carbamazepine. European Journal of Paediatric Neurology 19: S59-S60
Ferreira, J.A.; Daniels, T.; Dilley, D.; Dimova, S.; Rice, K.; Byrnes, W. 2015: PP07.5 2252: Safety and tolerability of lacosamide as adjunctive therapy in children with partial-onset seizures. European Journal of Paediatric Neurology 19: S56-S57
Duman, O.; Yavuz, H.; Gencpinar, P.; Haspolat, S.; Bozkurt, O. 2015: PP07.8 2517: Evaluation of the patients with febrile seizure after age of five years. European Journal of Paediatric Neurology 19: S57-S58
Somerville, R; Viljoen, K; McKey, S; O'Brien, J; Mehegan, J; Seguardo, R; Murrin, C; Kelleher, C 2015: PP07Predictors of mortality, including general medical services eligibility, at 10-year follow-up of grandparents in the lifeways cross-generation cohort study of a thousand families. Journal of Epidemiology and Community Health 69(Suppl 1): A56.1-A56
Cohen Solal, P.; Vincent, G.; Bonfils, Y.; Chabrière, H. 2015: PP08 Exemple de dpistage du diabte de type 2 (DT2) dans les zones urbaines sensibles: entre prvention et dpistage. Diabetes and Metabolism 41: A128-A129
Leow, J.Y.; Wassmer, E.; Smith, M. 2015: PP08.10 2608: Multiple sclerosis: Two patients with isolated and multiple cranial neuropathies. European Journal of Paediatric Neurology 19: S62-S63
Ünver, O.; Türkdoğan, D.; Kutlubay, B. 2015: PP08.7 2364: Atypical Guillain Barr syndrome with preserved deep tendon reflexes: report of three cases. European Journal of Paediatric Neurology 19: S61-S62
Jones, C.; Oskoui, M.; Zielinski, D.; Vinikoor, L.; Farwell, W. 2015: PP09.1 2352: Systematic review of incidence and prevalence of spinal muscular atrophy (SMA). European Journal of Paediatric Neurology 19: S64-S65
Sukhorukov, V.S.; Baranich, T.I.; Vinogradova, T.V.; Klejmenova, N.V.; Nevstrueva, V.V.; Brydun, A.V.; Glinkina, V.V. 2015: PP09.11 2460: Colocalization of HIF1 alpha and abnormal mitochondrial accumulations in muscle fibers in different neuromuscular diseases. European Journal of Paediatric Neurology 19: S67-S68
Vigo, G.; Toldo, I.; De Grandis, D.; Beltrame, V.; Sartori, S.; Suppiej, A. 2015: PP09.14 2843: Congenital absence of gluteal muscles without spina bifida occulta: The first case report. European Journal of Paediatric Neurology 19: S68-S69
Niks, E.H.; Doorenweerd, N.; Dumas, E.M.; Ghariq, E.; Schmid, S.; Straathof, C.S.M.; Spitali, P.; Ginjaar, H.B.; Wokke, B.H.A.; Schrans, D.G.M.; van den Bergen, J.C.; van Zwet, E.W.; Webb, A.G.; van Buchem, M.A.; Roest, A.A.W.; van Osch, M.J.P.; Verschuuren, J.J.G.M.; Hendriksen, J.G.M.; Kan, H.E. 2015: PP09.4 2839: Reduced cerebral blood flow in Duchenne muscular dystrophy and related to the Dp140 isoform. European Journal of Paediatric Neurology 19: S65-S66
Vezyroglou, K.; Vargiami, E.; Kyriazi, M.; Kirvassilis, F.; Oldridge, M.; Robb, S.; Phadke, R.; Zafeiriou, D. 2015: PP09.8 2377: Novel DOK7 mutation in a Greek patient with congenital myasthenic syndrome. European Journal of Paediatric Neurology 19: S66-S67
Cadogan, S; Browne, J; Bradley, C; Cahill, M 2015: PP09Testing times ahead: a systematic review of interventions aimed at improving laboratory testing in primary care. Journal of Epidemiology and Community Health 69(Suppl 1): A56.3-A57
Qian, W; Wang, W; Liu, H; Wang, J; Liu, F 2015: PP1 suppresses SC35 activity in the regulation of the alternative splicing of tau exon 10. Alzheimer's and Dementia 11(7): P348-P349
Fattal-Valevski, A.; Shteirman, C.; Peylan, T.; Tsarfaty, R.; Dolberg, S.; Fox, J.; Bassan, H. 2015: PP10.1 3049: The incidence of autistic spectrum disorder in a cohort of 213 prematurely born children. European Journal of Paediatric Neurology 19: S69-S70
Fernandes, A.R.; Martins, R.M.; de Carvalho, S.M.D.; Pinto, M.I.M.; Monteiro, S.; Dourado, S.; Sato, H.K.; Mohrdieck, R.; de Figueiredo, P.M.; da Costa, J.A.C. 2015: PP10.12 2525: Neurological adverse events following immunization (AEFI): Brazilian data. European Journal of Paediatric Neurology 19: S72-S73
Mundada, V.; Bem, A.; Parashar, D. 2015: PP10.15 2739: Do the paediatricians perceive the impact of disability of children same as their parents?. European Journal of Paediatric Neurology 19: S73-S74
Anwar, D.R.; Kirkham, F.; Durnford, A.J. 2015: PP10.5 2374: Mode of injury and mortality following traumatic paediatric head injury in a single centre series of 309 patients. European Journal of Paediatric Neurology 19: S70-S71
Rosdy, B.; Kollár, K.; Móser, J.; Mellár, M.; Kovács, É.; Várallyay, G. 2015: PP10.8 2503: Sinus sagittalis superior thrombosis complicating moderate traumatic head injury in a child. European Journal of Paediatric Neurology 19: S71-S72
Cadogan, S; McHugh, S; Bradley, C; Browne, J; Cahill, M 2015: PP10General practitioners attitudes towards serum immunoglobulin testing in the south of ireland: a qualitative study. Journal of Epidemiology and Community Health 69(Suppl 1): A57.1-A57
Budisteanu, M.; Tutulan-Cunita, A.; Papuc, S.M.; Focsa, I.; Vultur, S.; Arghir, A.; Grozavescu, R. 2015: PP11.11 2673: Phelan-McDermid syndrome in two siblings with complex phenotype. European Journal of Paediatric Neurology 19: S76-S77
Farmer, M.; Echenne, B. 2015: PP11.3 2494: Phenotype selection in DCD patients prior to quantitative PET imaging. European Journal of Paediatric Neurology 19: S74-S75
Carratalá-Marco, F.; Andreo-Lillo, P.; Ruiz-Miralles, R.; Pastor-Ferrándiz, L.; de Diego-Almarza, V.; Juste-Ruiz, M. 2015: PP11.7 2822: Prevalence of comparative genomic hybridization (CGH-array) abnormalities among autistic spectrum disorders (ASD) patients vs other risk populations. European Journal of Paediatric Neurology 19: S75-S76
Healy, O; Buckley, C; Droog, E; Foley, C; McHugh, S; Browne, J 2015: PP11Analysis of emergency and urgent care system policy in ireland, policy coherence and implementation. Journal of Epidemiology and Community Health 69(Suppl 1): A57.2-A58
Schinckus, L.; Van Den Broucke, S.; Housiaux, M. 2015: PP12 Fidlit de limplmentation des programmes dducation lautogestion du diabte: revue de la littrature. Diabetes and Metabolism 41: A129-A130
Brankovic, V.; Zekavica, A.; Popara, J.; Rasic, V. Milic 2015: PP12.16 2973: Congenital cerebellar ataxias Clinical, radiological and genetic considerations. European Journal of Paediatric Neurology 19: S81-S82
Eggink, H.; van Egmond, M.E.; Kuiper, A.; Verschuuren-Bemelmans, C.C.; Sival, D.A.; de Koning, T.J.; Tijssen, M.A.J. 2015: PP12.3 2284: Crossing barriers: The importance of a multidisciplinary approach to young-onset movement disorders. European Journal of Paediatric Neurology 19: S77-S78
Gimeno, H.; Selway, R.; Ashkan, K.; Lin, J.P. 2015: PP12.6 2933: Objective evaluation of functional outcomes using the assessment of motor and process skills (AMPS) following deep brain stimulation (DBS). Can we improve what really matters to children and young people?. European Journal of Paediatric Neurology 19: S78-S79
Droog, E; Foley, C; Healy, O; Buckley, C; Boyce, M; McHugh, S; Browne, J 2015: PP12Transparency in re-designing urgent and emergency care services: an examination of the consultation process, trade-offs and the role of evidence. Journal of Epidemiology and Community Health 69(Suppl 1): A58.1-A58
Ünver, O.; Thomas, G.; Hacıfazlıoğlu, N.E.; Kutlubay, B.; Direskeneli, H.; Türkdoğan, D. 2015: PP13.13 2289: Delayed diagnosis of neuro-Behet's disease: Report of 3 cases. European Journal of Paediatric Neurology 19: S85-S86
Flanagan, C.; Goodship, T.; O'Connor, M.; Peake, D. 2015: PP13.3 2868: Dramatic neurological outcome at one year in a 4 week old with atypical haemolytic syndrome (aHUS). European Journal of Paediatric Neurology 19: S82-S83
Liptai, Z.; Dobner, S.; Rosdy, B.; Rudas, G. 2015: PP13.6 3003: Choreoathetotic relapse of HSV encephalitis. European Journal of Paediatric Neurology 19: S83-S84
Flannery, C; McHugh, S; Murphy, K; Buckley, C; Thackeray, K; O'Connor, A; Moran, J; Quinlan, D; Bradley, C 2015: PP13The role of the diabetes nurse specialist (DNS) in the management of patients with diabetes: a systematic review. Journal of Epidemiology and Community Health 69(Suppl 1): A58.2-A58
Patel, A.; Janackova, S.; Munot, P.; Vincent, A.; Boyd, S. 2015: PP14.3 2698: Prolonged cortical hyperexcitability during burst-suppression associated with glycine receptor antibodies. European Journal of Paediatric Neurology 19: S86-S87
Bin, J. 2015: PP14.7 2997: Screening osteoporosis in patients with antiepileptic drug using urine N-telopeptide of collagen type I. European Journal of Paediatric Neurology 19: S87-S88
Islek, D; Kilic, B; Akdede, B 2015: PP14Out-of-pocket health expenditures for psychiatry patients in a university hospital in turkey. Journal of Epidemiology and Community Health 69(Suppl 1): A59.1-A59
De Waele, L.; Van Hoeve, K.; Janssens, P.; Claes, K.; Lagae, L.; Levtchenko, E.; Bammens, B.; Mekahli, D.; Jansen, A. 2015: PP15.1 2964: Long-term renal outcome of a large cohort of patients with tuberous sclerosis complex. European Journal of Paediatric Neurology 19: S89-S90
Ravid, S.; Shahar, E.; Schiff, A.; Gordon, S. 2015: PP15.12 2382: Chronic daily headache in children: Association with obesity, medication overuse and disability. European Journal of Paediatric Neurology 19: S92-S93
Klucken, A.; Jaskolka, H.; Wood, P.; Ali, N.; López, A.; Nagel, A.; Scalise, N.; Van Schijndel, M.; Vasseur, J.-L.; Sheppard-Whalen, M.; Gauzy-Krieger, F.; Hayflick, S.J.; Klopstock, T. 2015: PP15.15 2688: NBIA Alliance The impact of the international NBIA patient advocacy on NBIA research and vice versa. European Journal of Paediatric Neurology 19: S93-S94
Sizgoric, M. Kovac; Sabol, Z.; Sabol, F.; Delin, S.; Krakar, G.; Duranovic, V. 2015: PP15.5 2646: Value of multiple T2-hyperintensities on brain MRI as a diagnostic criterion for neurofibromatosis 1 in children: Comparison of the diagnostic accuracy of T2-hyperintensities versus the National Institutes of Health criteria. European Journal of Paediatric Neurology 19: S90-S91
Canpolat, M.; Kontaş, O.; Özçora, G.; Unal, E.; Bayram, A.K.; Küçükaydin, M.; Görkem, S.B.; Gümüş, H.; Kumandaş, S.; Per, H. 2015: PP15.8 2911: A rare cause of ptosis in four years old girl: Superior mediastinal malignant peripheral nevre sheath tumor. European Journal of Paediatric Neurology 19: S91-S92
Levin, K 2015: PP15Reshaping care for older people: trends in emergency admissions to hospital during a period of simultaneous interventions in glasgow city. Journal of Epidemiology and Community Health 69(Suppl 1): A59.2-A59
Dennehy, R; Meaney, S; O'Donoghue, K 2015: PP17Womens experience regarding the decision to deliver by caesarean section: a qualitative study. Journal of Epidemiology and Community Health 69(Suppl 1): A59.3-A60
Fahy, C; McHugh, S; Kearney, P; Kenny, L 2015: PP19Estimating the cost of pre-eclampsia in the health system: a cross sectional analysis using screening for pregnancy endpoints (scope) study. Journal of Epidemiology and Community Health 69(Suppl 1): A60.2-A61
Macfarlane, A; Dorkenoo, E 2015: PP20Estimating the numbers of women and girls with female genital mutilation in england and wales. Journal of Epidemiology and Community Health 69(Suppl 1): A61.1-A61
McHugh, S; Flannery, C; Clifford, E; Kenny, L; Kearney, P 2015: PP21Informing intervention design to improve diet and physical activity during pregnancy: a qualitative study of the attitudes and experiences of women and healthcare providers. Journal of Epidemiology and Community Health 69(Suppl 1): A61.2-A61
McCarthy, C; Meaney, S; O'Donoghue, K 2015: PP22Reduced fetal movement: an evaluation of emergency department attendance. Journal of Epidemiology and Community Health 69(Suppl 1): A61.3-A62
McCarthy, C; Meaney, S; O'Donoghue, K 2015: PP23Perinatal outcomes of reduced fetal movements: a prospective cohort study. Journal of Epidemiology and Community Health 69(Suppl 1): A62.1-A62
Layte, R; Brick, A; Cunningham, N; Sinnott, S; Turner, M 2015: PP24Decomposing public/private differences in elective and emergency caesarean delivery rates among nulliparous women. Journal of Epidemiology and Community Health 69(Suppl 1): A62.2-A63
Kuh, D; Cooper, R; Adams, J; Moore, A; MacKinnon, K; Muthuri, S; Cooper, C; Ward, K; Hardy, R 2015: PP25Timing of menopause but not hysterectomy is associated with bone health in early old age: a british birth cohort study. Journal of Epidemiology and Community Health 69(Suppl 1): A63.1-A63
Nunes, A; Lorenzoni, I; Lake, I; Few, R 2015: PP26Growing old: the impact of health inequalities on the vulnerability, resilience and adaptation of older adults to extreme temperatures. Journal of Epidemiology and Community Health 69(Suppl 1): A63.2-A63
Foley, C; MacDermott, E; Killeen, O 2015: PP28. Myeloid-related proteins 8 and 14: potential biomarkers of disease activity of arthritis in children with trisomy 21. Rheumatology 54(Suppl_2): Ii18-Ii19
Sinnott, S; Carney, P; Wren, M; Layte, R 2015: PP28Centenarians in Ireland. Journal of Epidemiology and Community Health 69(Suppl 1): A64.2-A64
Westbury, L; Syddall, H; Simmonds, S; Robinson, S; Cooper, C; Sayer, A 2015: PP29Number of lifestyle risk factors is associated with increased risk of hospital admission among community-dwelling older people: the hertfordshire cohort study. Journal of Epidemiology and Community Health 69(Suppl 1): A64.3-A65
Davies, R; Southwood, T R.; Kearsley-Fleet, L; Lunt, M; Hyrich, K L. 2015: PP3. Standardized mortality rates are increased in patients with severe JIA. Rheumatology 54(Suppl_2): Ii6-Ii6
Morgan, G; Haase, A; Campbell, R; Ben-Shlomo, Y 2015: PP31Physical activity facilitation to improve functional ability and independent living in older adults at risk of disability: a feasibility study and exploratory pilot RCT. Journal of Epidemiology and Community Health 69(Suppl 1): A65.2-A66
Morgan, G; Haase, A; Ben-Shlomo, Y; Campbell, R 2015: PP32What do older adults think about physical activity? a synthesis of the qualitative literature. Journal of Epidemiology and Community Health 69(Suppl 1): A66.1-A66
Bryden, J 2015: PP33Stability of utility values for health-related quality of life (HRQOL) when elicited from the same individual for the same health state using different standard methods and effect of beliefs about the nature of death: a pilot study. Journal of Epidemiology and Community Health 69(Suppl 1): A66.2-A67
Hartley, J 2015: PP35Situated statistics: research field notes from a revision of the family affluence scale survey of young people in deprived schools. Journal of Epidemiology and Community Health 69(Suppl 1): A67.2-A68
Sanchez-Romero, L; Scholes, S; Head, J; Mindell, J 2015: PP36Analysis of population-based health forecasting mathematical simulation models for obesity: results of a systematic literature review. Journal of Epidemiology and Community Health 69(Suppl 1): A68.1-A68
Taylor, M; Hickman, M; Lewis, G; Munafò, M 2015: PP37Use of mendelian randomisation to assess whether smoking is causally associated with alcohol consumption. Journal of Epidemiology and Community Health 69(Suppl 1): A68.2-A68
Watson, S; Chen, Y; Taylor, C; Lilford, R 2015: PP38Estimation of the burden of preventable adverse events in england: bayesian evidence synthesis. Journal of Epidemiology and Community Health 69(Suppl 1): A68.3-A69
Foley, C; Droog, E; Healy, O; Buckley, C; Boyce, M; McHugh, S; Browne, J 2015: PP39Experiments in system re-design: a typology of models for changing urgent and emergency care services in one country. Journal of Epidemiology and Community Health 69(Suppl 1): A69.1-A69
O'Connor, C; O'Hara, L; McNamara, N; McNicholas, F 2015: PP40Eating disorder literacy and stigmatisation: a survey of irish adolescents. Journal of Epidemiology and Community Health 69(Suppl 1): A69.2-A70
Drummond, A; Kelleher, C; Donnelly, N; McCausland, D; Codd, M 2015: PP41The prevalence of drug use, including intravenous drug use, among the irish prisoner population. Journal of Epidemiology and Community Health 69(Suppl 1): A70.1-A70
Egan, M; Pliakas, T 2015: PP42A mixed methods evaluation of a local-level alcohol availability intervention: reducing the strength. Journal of Epidemiology and Community Health 69(Suppl 1): A70.2-A70
McGill, E; Sumpter, C; Marks, D; Egan, M 2015: PP43Reducing problem drinking by removing a problem drink: a qualitative study of a local alcohol availability intervention. Journal of Epidemiology and Community Health 69(Suppl 1): A71.1-A71
Keenan, K; Saburova, L; Bobrova, N; Elbourne, D; Ashwin, S; Leon, D 2015: PP44Lifetime alcohol use trajectories of russian men: qualitative study exploring the role of social context and perceptions of age-appropriate behaviour. Journal of Epidemiology and Community Health 69(Suppl 1): A71.2-A71
Fat, L Ng; Scholes, S; Mindell, J; Jivraj, S 2015: PP45The relationship between social capital and drinking pattern among men and women; findings from a national survey in England. Journal of Epidemiology and Community Health 69(Suppl 1): A72.1-A72
Rudge, G; Sheldon, M; Jenkinson, D; Howie, F 2015: PP46Alcohol specific hospital admission in under-age drinkers and neighbourhood alcohol retail environment: a geospatial analysis set in a population in central England. Journal of Epidemiology and Community Health 69(Suppl 1): A72.2-A72
Vogel, C; Abbott, G; Ball, K; Ntani, G; Moon, G; Baird, J 2015: PP47Modifying health behaviours the importance of environmental and individual factors. Journal of Epidemiology and Community Health 69(Suppl 1): A73.1-A73
Melendez-Torres, G; Dickson, K; Hinds, K; Thomas, J; Bonell, C 2015: PP48Systematic review of positive youth development addressing young peoples substance use and violence. Journal of Epidemiology and Community Health 69(Suppl 1): A73.2-A73
McGeown, M; Fitzpatrick, P 2015: PP51Dental attendance and self-reported oral status among adults at high risk for oral cancer. Journal of Epidemiology and Community Health 69(Suppl 1): A75.1-A75
Balfe, M; O'Brien, K; Timmons, A; O'Sullivan, E; Butow, P; Gooberman-Hill, R; Sharp, L 2015: PP52Informal caregiving in head and neck cancer: caregiving activities and psychological wellbeing. Journal of Epidemiology and Community Health 69(Suppl 1): A75.2-A75
Rathbone, A; Husband, A; Todd, A; Jamie, K 2015: PP53Ive never been a big tablet taker: a phenomenology of the experiences of medicines adherence in men with diabetes. Journal of Epidemiology and Community Health 69(Suppl 1): A75.3-A76
Robertson, T; Estrade, M; Gracey, E; Smith, K 2015: PP54The realities of public health collaborative research with the non-profit and voluntary sector: viewpoints from policy, practice and research. Journal of Epidemiology and Community Health 69(Suppl 1): A76.1-A76
Rochford, M; O'Donoghue, K; Meaney, S 2015: PP55Do our patients know what were talking about?. Journal of Epidemiology and Community Health 69(Suppl 1): A76.2-A77
Timmons, A; Gooberman-Hill, R; Gallagher, P; Molcho, M; Thomas, A; Pearce, A; Sharp, L 2015: PP56What influences the acceptability and implementation of alternative models of cancer follow-up? health professionals views. Journal of Epidemiology and Community Health 69(Suppl 1): A77.1-A77
Hyseni, L; Atkinson, M; Bromley, H; Orton, L; Lloyd-Williams, F; McGill, R; Capewell, S 2015: PP57Effectiveness of policy actions to improve population dietary patterns and prevent diet related non-communicable diseases: scoping review. Journal of Epidemiology and Community Health 69(Suppl 1): A77.2-A78
Ordoñez-Betancourth, J; Bhopal, R; Jepson, R 2015: PP58The challenge of international studies in ethnicity and childhood obesity research: a case study using Colombia, Canada, Brazil, Mexico and the United Kingdom. Journal of Epidemiology and Community Health 69(Suppl 1): A78.1-A78
Perry, C; Keane, E; Kearney, P; Perry, I; Harrington, J 2015: PP59Applying the dietary approach to stop hypertension (DASH) score to children: is adherence to kiddash associated with childhood overweight or obesity?. Journal of Epidemiology and Community Health 69(Suppl 1): A78.2-A78
Springmann, M; Mason-D'Croz, D; Robinson, S; Ballon, P; Garnett, T; Godfray, C; Gollin, D; Rayner, M; Scarborough, P 2015: PP60The global and regional health impacts of future food production under climate change. Journal of Epidemiology and Community Health 69(Suppl 1): A78.3-A79
Visram, S; Crossley, S; Cheetham, M; Lake, A; Riby, D 2015: PP62Energy drinks: hype or hyper? a qualitative exploratory study involving children, parents and staff from schools in North East England. Journal of Epidemiology and Community Health 69(Suppl 1): A79.2-A80
Visram, S; Cheetham, M; Riby, D; Lake, A; Crossley, S 2015: PP63Consumption of commercial energy drinks by children and adolescents: a systematic review of consumer attitudes and associations with health, behavioural, educational and social outcomes. Journal of Epidemiology and Community Health 69(Suppl 1): A80.1-A80
Zhang, N; Becares, L; Callery, P 2015: PP64Intergenerational differences in beliefs about healthy eating for left-behind children in rural china: an interview and diary study. Journal of Epidemiology and Community Health 69(Suppl 1): A80.2-A80
Kaushal, A; Cadar, D; Stafford, M; Richards, M 2015: PP66Lifetime influences of religious attendance and beliefs on mental health and wellbeing in older age. Journal of Epidemiology and Community Health 69(Suppl 1): A81.1-A81
McNamara, G; Kabir, Z; O'Neill, S; Buckley, C 2015: PP67The effect of depression on amputation, in people with diabetes. a systematic review and meta-analysis. Journal of Epidemiology and Community Health 69(Suppl 1): A81.2-A82
Doyle, A; Changalucha, J; Weiss, H; Watson-Jones, D; Hayes, R; Ross, D 2015: PP68Sexual risk behaviours among young people in rural mwanza, tanzania: is marriage protective?. Journal of Epidemiology and Community Health 69(Suppl 1): A82.1-A82
Mitchell, C; Platt, S 2015: PP70Evaluation of user-perceived impact of edinburgh access practice keep well interventions on the health and wellbeing of gypsy/traveller and homeless service users: a mixed methods approach. Journal of Epidemiology and Community Health 69(Suppl 1): A82.2-A82
Nunes, A; Lorenzoni, I; Lake, I; Few, R 2015: PP71The role of assets on the vulnerability, resilience and adaptation of older adults to extreme temperatures: evidence from a mixed method study. Journal of Epidemiology and Community Health 69(Suppl 1): A83.1-A83
Fitzgerald, C; Heery, E; Conneally, N; Linnane, B; George, S; Fitzpatrick, P 2015: PP72Newborn bloodspot screening for cystic fibrosis: what do expectant women, new mothers and mothers of newly screen-detected cf know about the screened condition?. Journal of Epidemiology and Community Health 69(Suppl 1): A83.2-A83
Gibney, S; McGovern, M; Sabbath, E 2015: PP73Childhood conditions and social relationships in later life. Journal of Epidemiology and Community Health 69(Suppl 1): A84.1-A84
Dillon, C; Dahly, D; Donnelly, A; Perry, I; Rennie, K; Li, X; Phillips, C 2015: PP74Cross-sectional analysis of weekly levels and patterns of objectively measured physical behaviour with cardiometabolic health in middle-aged adults. Journal of Epidemiology and Community Health 69(Suppl 1): A84.2-A84
Dillon, C; Dahly, D; Donnelly, A; Perry, I; Rennie, K; Li, X; Phillips, C 2015: PP75Daily cumulative patterns of objectively measured physical activity and sedentary behaviour by cardiometabolic health status in middle-aged adults; a cross-sectional analysis. Journal of Epidemiology and Community Health 69(Suppl 1): A84.3-A85
Zhang, N; Becares, L; Chandola, T 2015: PP76Does the timing of parental migration matter for child growth? a life course study on left-behind children in rural china. Journal of Epidemiology and Community Health 69(Suppl 1): A85.1-A85
Grimes, R; Bennett, K; Henman, M 2015: PP78Age disparities in the use of cardiovascular medicines: a retrospective cohort analysis of newly treated type 2 diabetes patients. Journal of Epidemiology and Community Health 69(Suppl 1): A85.2-A86
Ameta, K. L. 2015: PPA-SiO2catalyzed solvent-free synthesis of some novel 4,6-diaryl-2,3a,4,5-tetrahydro-3H-indazol-3-ones from 3,5-diaryl-6-carbethoxy cyclohexenones. Research on Chemical Intermediates 41(6): 3433-3445
Akinola, O.B.; Dosumu, O.O.; Sanusi, S.A.; Ajayi, T.F.; Olajide, T.H. 2015: PPAR- agonist pioglitazone improves semen quality and testicular histomorphometrics with partial reversal of hyperglycaemia in alloxan-induced diabetic rats. Middle East Fertility Society Journal 20(4): 271-279
Xu, X; Wei, X; Yang, Y; Niu, W; Kou, Q; Wang, X; Chen, Y 2015: PPAR, FAS, HSL mRNA and protein expression during Tan sheep fat-tail development. Electronic Journal of Biotechnology 18(2): 122-127
Korhonen, H J.; Bolt, H L.; Vicente-Gines, L; Perks, D C.; Hodgson, D R. W. 2015: PPN Pyrophosphate: A New Reagent for the Preparation of Nucleoside Triphosphates. Phosphorus Sulfur and Silicon and the Related Elements 190(5-6): 758-762
Krupinska, K 2015: PPP - wissenschaftlicher Austausch mal unkompliziert. Biologie in Unserer Zeit 45(3): 131-131
Mu, B; Wen, S; Yuan, S; Li, H 2015: PPSO: PCA based particle swarm optimization for solving conditional nonlinear optimal perturbation. Computers and Geosciences 83: 65-71
Abedini-Torghabeh, J; Eshghi, H; Bakavoli, M; Rahimizadeh, M 2015: PPh3-catalyzed Mannich reaction: a facile one-pot synthesis of β-amino carbonyl compounds under solvent-free conditions at room temperature. Research on Chemical Intermediates 41(6): 3649-3658
Naudin, K.; Husson, O.; Scopel, E.; Auzoux, S.; Giner, S.; Giller, K.E. 2015: PRACT (Prototyping Rotation and Association with Cover crop and no Till) a tool for designing conservation agriculture systems. European Journal of Agronomy 69: 21-31
Pelzman, J 2015: PRC Outward Investment in the USA and Europe: A Model of R&D Acquisition. Review of Development Economics 19(1): 1-14
Kravanja, Z; Varbanov, P Sabev; Klemeš, Jří Jaromír 2015: PRES 2014: Dedicated to technologies for sustainable energy and product production. Clean Technologies and Environmental Policy 17(5): 1117-1118
Herzberg, C.; Asimow, P. D. 2015: PRIMELT3 MEGA.XLSM software for primary magma calculation: Peridotite primary magma MgO contents from the liquidus to the solidus. Geochemistry, Geophysics, Geosystems 16(2): 563-578
Doody, R S.; D'Amico, S; Cutler, A J.; Shin, P; Ledon, F; Yonan, C; Siffert, J 2015: PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort. American Journal of Geriatric Psychiatry 23(3): S163-S164
Conner, A; DiQuattro, M; Kiefel, J 2015: Professional Issues: Effort and Motivationb-96importance of Performance Validity Testing: Examined in Pediatric Concussion. Archives of Clinical Neuropsychology 30(6): 558.2-559
Fields, K; Hill, B; Slattery, T; Russ, K 2015: Professional Issues: Effort and Motivationc-34chance Performance is Higher than 50% on the Word Memory test and test of Memory Malingering. Archives of Clinical Neuropsychology 30(6): 575.2-575
Sullivan, K; Lange, R; Edmed, S 2015: Professional Issues: Effort and Motivationc-66an Analogue Investigation of the Utility of the Validity-10 Index for the Neurobehavioral Symptom Inventory. Archives of Clinical Neuropsychology 30(6): 587.3-588
Lippa, S; Lange, R; Axelrod, B 2015: Professional Issues: Effort and Motivationc-74utility of the Mild Brain Injury Atypical Symptoms (Mbias) Scale in a Mixed Clinical Sample. Archives of Clinical Neuropsychology 30(6): 590.2-590
Santos, O; Block, C; Rivera, D; Arango-Lasprilla, J 2015: PROFESSIONAL ISSUES: ETHICSC-86Neuropsychology Research-Related Activities in the U.S. and Canada: Results from a Professional Survey. Archives of Clinical Neuropsychology 30(6): 594.2-594
Fabian, J 2015: PROFESSIONAL ISSUES: FORENSIC PRACTICEB-101Evaluating a Sexually Dangerous Person Rape Case in Light of Antisocial Personality Burnout and Onset of Mild Neurocognitive Disorder. Archives of Clinical Neuropsychology 30(6): 560.2-561
Harrison, A; Armstrong, I 2015: Professional Issues: Test Development and Methodsb-102comparing Canadian and American Normative Scores on the Wechsler Intelligence Scale for Children-Fourth Edition. Archives of Clinical Neuropsychology 30(6): 561.1-561
Parsey, C; Schmitter-Edgecombe, M 2015: Professional Issues: Test Development and Methodsb-22validation of a Modified Scoring System for the Clock Drawing Test: Psychometrics for Healthy Aging, Mild Cognitive Impairment and Dementia. Archives of Clinical Neuropsychology 30(6): 530.1-530
Parks, A; Logue, E; Carter, K; Scarisbrick, D; Linck, J 2015: Professional Issues: Test Development and Methodsc-60introducing a Novel Computerized Scoring Method for the Clock Drawing test. Archives of Clinical Neuropsychology 30(6): 584.3-585
Heinly, M; Vitelli, K; Murah, J; Mangini, D; Stryjewski, A; Brown, C; Brown, F 2015: Professional Issues: Test Development and Methodsc-62an Alternate Forms Reliability Study of the Brown Location test Paper Vs. Computer-Based Versions within a Single Testing Session. Archives of Clinical Neuropsychology 30(6): 586.1-586
Lippa, S; Axelrod, B; Lange, R 2015: Professional Issues: Test Development and Methodsc-73psychometric Properties of the Mild Brain Injury Atypical Symptoms (Mbias) Scale in a Mixed Clinical Sample. Archives of Clinical Neuropsychology 30(6): 590.1-590
Gavett, B; John, S 2015: Professional Issues: Test Development and Methodsc-87rethinking Abnormal test Scores in Normal People: Application of Base Rate Data to the Individual Patient. Archives of Clinical Neuropsychology 30(6): 594.3-595
Moth-Poulsen, K 2015: PROFILE: Early Excellence in Physical Organic Chemistry. Journal of Physical Organic Chemistry 28(3): 171-171
Wiestner, A 2015: PROLONGing remissions in patients with CLL. Lancet Oncology 16(13): 1282-1284
Buddenbaum, H; Hill, J 2015: PROSPECT Inversions of Leaf Laboratory Imaging Spectroscopy a Comparison of Spectral Range and Inversion Technique Influences. Photogrammetrie - Fernerkundung - Geoinformation 2015(3): 231-240
Landrum, L R.; Lafferty, D 2015: PROXIMITY and CORRELATION: Two new computer programs for mining phytosociological information held in herbarium databases using central Arizona as a test case. Taxon 64(5): 998-1016
Schippinger, G; Studencnik, G; Fankhauser, F 2015: PRP bei sportmedizinischen Indikationen – eine Literaturübersicht. Sport-Orthopädie - Sport-Traumatologie - Sports Orthopaedics and Traumatology 31(1): 45-53
Dee, S.; Emile-Geay, J.; Evans, M. N.; Allam, A.; Steig, E. J.; Thompson, D.M. 2015: PRYSM: An open-source framework for PRoxY System Modeling, with applications to oxygen-isotope systems. Journal of Advances in Modeling Earth Systems 7(3): 1220-1247
Casasanta, L; Gray, S H. 2015: PS imaging of ocean-bottom data. Leading Edge 34(4): 414-420
Yang, T; Yang, C; Sun, Z; Feng, H 2015: PSC Ship-Selecting Model Based on Improved Particle Swarm Optimization and Support Vector Machine Algorithm. Journal of Coastal Research 73: 692-697
Zhao, L-Bao; Liu, M; Xu, Z-Liang; Wei, Y-Ming; Xu, M-Xian 2015: PSF hollow fiber membrane fabricated from PSFHBPEPEG400DMAc dope solutions via reverse thermally induced phase separation (RTIPS) process. Chemical Engineering Science 137: 131-139
Papoulia, J.; Fahjan, Y. M.; Hutchings, L.; Novikova, T. 2015: PSHA for Broad-Band Strong Ground-Motion Hazards in the Saronikos Gulf, Greece, from Potential Earthquake with Synthetic Ground Motions. Journal of Earthquake Engineering 19(4): 624-648
Câmara Augusto, Jão Pedro da Silveira; Santos Nicolau, A dos; Schirru, R 2015: PSO with Dynamic Topology and Random Keys method applied to Nuclear Reactor Reload. Progress in Nuclear Energy 83: 191-196
Ellis, M J. 2015: PSY1-1Genome directed therapy for estrogen receptor positive breast cancer. Annals of Oncology 26(Suppl 7): Vii 3.1-Vii 3
Diehn, M 2015: PSY1-4Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring. Annals of Oncology 26(Suppl 7): Vii 3.2-Vii 3
Ueno, N T. 2015: PSY3-1Importance of fellowship training and career development planning to advance the field of medical oncology. Annals of Oncology 26(Suppl 7): Vii 4.1-Vii 4
Shirai, K 2015: PSY3-2How to become a clinical trialist. Annals of Oncology 26(Suppl 7): Vii 4.2-Vii 4
Kobayashi, K 2015: PSY3-4Career development in the US pharmaceutical industry. Annals of Oncology 26(Suppl 7): Vii 4.3-Vii 4
Ferrini, A Maria; Agrimi, U; Appicciafuoco, B; Borroni, R; Ciccaglioni, G; Galati, F; Massaro, M Rosa; Patriarca, M 2015: PT as a tool to point out criticalities in the strategy for control of antibiotic residues in milk: the Italian experience. Accreditation and Quality Assurance 20(4): 267-272
Wu, L; Du, H; Wu, W; Zhu, Y; Wang, A; Lee, W 2015: PTAS for routing-cost constrained minimum connected dominating set in growth bounded graphs. Journal of Combinatorial Optimization 30(1): 18-26
Ward, S; Hancox, A; Ismail, T; Valori, R; Dunckley, P 2015: PTH-001 The learning curve to achieve competency in upper gastrointestinal endoscopy: analysis of completion rates using the jets database. Gut 64(Suppl 1): A405.1-A405
Orchard, P; Rashid, M; Thorn, C; Alexander, R 2015: PTH-002 The yield of pathology from diagnostic flexible sigmoidoscopy in patients under 40yrs. Gut 64(Suppl 1): A405.2-A405
Nesargikar, P; Amadio, L; Noble, C; Wilson, G; Potter, M 2015: PTH-003 Outcomes following endoscopic mucosal resection (emr) of colonic polyps in a tertiary centre: a three year experience. Gut 64(Suppl 1): A405.3-A406
Axe, K; Etezadi, A; Mapstone, M; Jones, F; Galliford, S; Pinch, N; Hawthorne, A 2015: PTH-005 Peg insertion: endoscopists recognition of patient comfort and recall. Gut 64(Suppl 1): A406.2-A407
Ososanya, A; Pick, H; Kayani, J; Austin, A; Salmon, C; Taylor, N; Lawson, A 2015: PTH-006 Experience in the use of self-expandable metal stents for the management of variceal haemorrhage. Gut 64(Suppl 1): A407.1-A407
Hussain, H.; McGeer, A.; McNeil, S.; Katz, K.; Loeb, M.; Simor, A.; Powis, J.; Langley, J.; Muller, M.; Coleman, B.L. 2018: Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada. Influenza and other Respiratory Viruses 12(3): 319-325
Subramaniam, S; Dadds, H; Besherdas, K 2015: PTH-008 Portal hypertensive gastropathy in the non cirrhotic patient: are we investigating this endoscopic finding adequately?. Gut 64(Suppl 1): A408.1-A408
Marlet, J.; Gaudy-Graffin, C.; Marc, D.; Boennec, R.; Goudeau, A. 2018: Factors associated with influenza vaccination failure and severe disease in a French region in 2015. Plos one 13(4): E0195611
Basford, P; Samji, S 2015: PTH-010 Uk training in therapeutic endoscopy are we achieving the basics? results of the bsg national training survey. Gut 64(Suppl 1): A409.1-A409
Morrell, L.; Camic, P.M.; Genis, M. 2019: Factors associated with informant-reported cognitive decline in older adults: A systemised literature review. Dementia 18(7-8): 2760-2784
Sethi, R; Singh, K; Warner, B; Wilkinson, M 2015: PTH-012 The sensitivity and specificity of brush cytology at ERCP and the impact on the number of further investigations for patients. Gut 64(Suppl 1): A410.1-A410
Benn, P.; Valenti, E.; Shah, S.; Martin, K.; Demko, Z. 2018: Factors Associated with Informative Redraw After an Initial no Result in Noninvasive Prenatal Testing. Obstetrics and Gynecology 132(2): 428-435
Jarrell, A.S.; Kruer, R.M.; Berescu, L.D.; Pronovost, P.J.; Trivedi, J.B. 2018: Factors associated with in-hospital mortality among critically ill surgical patients with multidrug-resistant Gram-negative infections. Journal of Critical Care 43: 321-326
Saleem, R; Raja, O; Latif, L; Ollerton, A; Harrison, P; Devlin, J 2015: PTH-015 Safety and utility of endoscopic retrograde cholangio-pancreatography (ercp) in children and adolescents performed by adult gastroenterologists a tertiary care hospital experience. Gut 64(Suppl 1): A411.2-A412
Saleem, R; Iqbal, J; Vithayathil, M; Sher, Z; Mairs, P 2015: PTH-016 Post colonoscopy colorectal cancer (pccrc) rates a district general hospital experience. Gut 64(Suppl 1): A412.1-A412
Saleem, R; Vithayathil, M; Iqbal, J; Sher, Z; Melia, W; Ede, R 2015: PTH-017 Safety of self-expandable metal stents for malignant biliary strictures in a district general hospital setting. Gut 64(Suppl 1): A412.2-A413
Driver, R; Handforth, C; Kite, S; Radhakrishna, G; Hull, M; Everett, S 2015: PTH-018 Predicting survival in palliative oesophageal stent insertion. Gut 64(Suppl 1): A413.1-A413
Driver, R; Kite, S; Radhakrishna, G; Wright, P; Hull, M; Everett, S 2015: PTH-019 Palliative stenting for inoperable oesophageal cancer: results of a national survey of health professionals. Gut 64(Suppl 1): A413.2-A413
Safiri, S.; Ashrafi-Asgarabad, A. 2018: Factors associated with in-hospital mortality among critically ill surgical patients with multidrug-resistant Gram-negative infections: Methodological issues. Journal of Critical Care 44: 473
Jafri, S; Ishtiaq, M 2015: PTH-021 A single centre audit of compliance with guidelines for management of anticoagulation and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 64(Suppl 1): A414.2-A415
Murray, S; Mahmoud, A; Mannur, K; Shidrawi, R 2015: PTH-022 The endoscopic management of post-operative bariatric complications: single-centre, single-operator experience in a bariatric unit in the united kingdom. Gut 64(Suppl 1): A415.1-A415
Fang, N.Z.; Sheeder, J.; Teal, S.B. 2018: Factors associated with initiating long-acting reversible contraception immediately after first-trimester abortion. Contraception 98(4): 292-295
Ansari, S; Sood, R; Smith, L-A; Hegade, V 2015: PTH-024 High correlation between kudo score and histology using chromoendoscopy. Gut 64(Suppl 1): A416.1-A416
Ansari, S; Smith, L-A; Mayers, R; Yu, C 2015: PTH-025 Which patients tolerate unsedated colonoscopy? a uk bowel cancer screening centre experience. Gut 64(Suppl 1): A416.2-A416
Png, W.Y.; Kwan, Y.H.; Lee, Y.X.; Lim, K.K.; Chew, E.H.; Lui, N.L.; Tan, C.S.; Thumboo, J.; Østbye, T.; Fong, W. 2019: Factors Associated with Initiation of Biologics in Patients with Axial Spondyloarthritis in an Urban Asian City: a PRESPOND Study. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 25(2): 59-64
Schuh-Renner, A.; Canham-Chervak, M.; Hearn, D.W.; Loveless, P.Ann.; Jones, B.H. 2018: Factors Associated With Injury Among Employees at a U.S. Army Hospital. Workplace Health and Safety 66(7): 322-330
Cohen, E.M.; Dossett, M.L.; Mehta, D.H.; Davis, R.B.; Lee, Y.C. 2018: Factors associated with insomnia and complementary medicine use in children: results of a national survey. Sleep Medicine 44: 82-88
Román-Gálvez, R.M.; Amezcua-Prieto, C.; Salcedo-Bellido, I.; Martínez-Galiano, J.M.; Khan, K.S.; Bueno-Cavanillas, A. 2018: Factors associated with insomnia in pregnancy: a prospective Cohort Study. European Journal of Obstetrics Gynecology and Reproductive Biology 221: 70-75
Dunn, S; Neilson, L; Hassan, C; Sharma, P; Guy, C; Rees, C 2015: PTH-030 Esge survey: practice patterns amongst european gastroenterologists regarding the endoscopic management of barretts oesophagus. Gut 64(Suppl 1): A419.1-A419
Liu, L.-Y.; Wang, Y.-J.; Wang, F.; Yu, L.-X.; Xiang, Y.-J.; Zhou, F.; Li, L.; Zhang, Q.; Fu, Q.-Y.; Ma, Z.-B.; Gao, D.-Z.; Li, Y.-Y.; Yu, Z.-G. 2018: Factors associated with insufficient awareness of breast cancer among women in Northern and Eastern China: a case-control study. Bmj Open 8(2): E018523
Kotha, S; Holohan, C; Gera, A; Loganayagam, A 2015: PTH-032 D2 biopsies in weight loss referrals is it necessary and cost effective?. Gut 64(Suppl 1): A420.1-A420
Kotha, S; McLaren, K; Gera, A; Loganayagam, A 2015: PTH-033 An ogd too many: investigation of iron deficiency anaemia. Gut 64(Suppl 1): A420.2-A420
Dixon, S; Tate, D; Przemioslo, R; Lockett, M 2015: PTH-034 Hemospray may not reliably achieve hemostasis beyond 48 hours in acute upper gastrointestinal bleeding. Gut 64(Suppl 1): A420.3-A421
Aujla, U; Lee, H; Robinson, E; Noorullah, O; Dwyer, L; Stern, N; Hood, S; Sturgess, R 2015: PTH-035 Dilated common bile duct, stone size and multiple stones are predictors of endoscopic papillary large volume balloon dilatation in the management of complex common bile duct stones. Gut 64(Suppl 1): A421.1-A421
Aujla, U; Ladep, N; Lee, H; Noorullah, O; Dwyer, L; Stern, N; Hood, S; Sturgess, R 2015: PTH-036 Effectiveness of endoscopic retrograde cholangiopancreatography for palliative biliary drainage in patients with inoperable hilar cholangiocarcinoma and its impact on survival. Gut 64(Suppl 1): A421.2-A422
Tate, D; Pattni, V; Hughes, S; Terlevich, A; Marden, P 2015: PTH-037 Double balloon enteroscopy under conscious sedation is safe and well tolerated. Gut 64(Suppl 1): A422.1-A422
Cebeci, N.Öz.şc. 2018: Factors associated with insufficient removable partial denture design instructions. Dental and Medical Problems 55(2): 173-177
Garg, M; Tsiamoulos, Z; Rameshshanker, R; Beintaris, I; Spranger, H; Rajendran, A; Faiz, O; Antoniou, A; Warusavitarne, J; Saunders, B 2015: PTH-040 Laparoscopic-assisted colonoscopic polypectomy is a safe and effective option for difficult polyps: a single tertiary referral centre experience. Gut 64(Suppl 1): A423.2-A424
Tsiamoulos, Z; Elliott, T; Rameshshanker, R; Suzuki, N; Peake, S; Bourikas, L; Saunders, B 2015: PTH-041 Large (<4 cm) and giant (4 cm) colorectal polyps: comparison of piecemeal resection outcomes. Gut 64(Suppl 1): A424.1-A424
Tsiamoulos, Z; Rameshshanker, R; Suzuki, N; Bourikas, L; Saunders, B 2015: PTH-042 Spiral snare resection and hybrid endoscopic mucosal ablation: a comparison of outcomes after piecemeal resection/ablation. Gut 64(Suppl 1): A424.2-A424
Zabkiewicz, C; Chatha, R; Sabah, T; Oliver, A; Kelly, T; Whiteley, G 2015: PTH-043 Anastomotic leak rate after intestinal resection for crohns: does pathological subtype make a difference?. Gut 64(Suppl 1): A424.3-A425
Singh, D; Ainley, P; Garg, D; Gill, T 2015: PTH-044 Single port laparoscopic ileoanal pouch surgery: is this the end of the era of open surgery for ulcerative colitis?. Gut 64(Suppl 1): A425.1-A425
Ahmed, J; Stefan, S; Goh, N; Flashman, K; Khan, J; Parvaiz, A 2015: PTH-045 Minimally invasive proctocolectomy and ileal pouch-anal anastomosis: an attractive management option for patients with ulcerative colitis. Gut 64(Suppl 1): A425.2-A426
Patel, M; Verma, A; Aslam, I; West, K; Jameson, J; Pringle, H; Singh, B 2015: PTH-046 Microrna expression profiling in the plasma of patients with ulcerative colitis and colitis associated cancer. Gut 64(Suppl 1): A426.1-A426
Khan, M; Newman, W; Hill, W 2015: PTH-047 Differences in luminal distribution and clinical characteristics of crohns disease in south asians and white british in the north of england. Gut 64(Suppl 1): A426.2-A427
Ainley, P; Shaban, F; Borowski, D; Garg, D; Gill, T 2015: PTH-049 Single port laparoscopic colectomies for ibd in an elective and emergency setting; the new gold standard?. Gut 64(Suppl 1): A427.2-A427
Mclean, R; Jones, M; Fung, D; Dixon, S; McCallum, P.; O'Loughlin, I 2015: PTH-050 Outcomes for emergency colectomy for inflammatory bowel disease over 14 years. Gut 64(Suppl 1): A427.3-A428
Adamova, Z; Vlcek, P; Sankot, J; Slovacek, R; Sindler, P 2015: PTH-051 Quality of life after surgery for colonic diverticular disease another reason for surgery?. Gut 64(Suppl 1): A428.1-A428
Iaculli, E; Sica, G; Biancone, L; Tema, G; Maggi, G; Di Carlo, S 2015: PTH-052 C-reactive protein levels in the perioperative period as a predictive marker of endoscopical recurrence. Gut 64(Suppl 1): A428.2-A428
Bouri, S; Wallis, K; Shariff, M 2015: PTH-053 Inflammatory bowel disease and liver function disturbance: literature review and retrospective study of 574 patients. Gut 64(Suppl 1): A428.3-A429
Henderson, P; Cameron, F; Jagger, F; Hansen, R; Drummond, H; Reynish, E; Loganathan, S; Russell, R; Satsangi, J; Wilson, D 2015: PTH-054 The rising incidence of early-onset paediatric inflammatory bowel disease (PARIS A1A) in scotland since 1981: a national, population-based, cohort study. Gut 64(Suppl 1): A429.1-A429
Hendy, P; Bernardo, D; Al-Hassi, H; Ding, N; Reddi, D; Siaw, Y; Knight, S; Hart, A 2015: PTH-057 Dendritic cell phenotype in crohns disease may correlate with disease severity and explain the high prevalence of cutaneous manifestations. Gut 64(Suppl 1): A430.2-A431
Pavlidis, P; Pal, S; Chung-Faye, G; Hayee, B 2015: PTH-058 Long-term prognosis of patients presenting with gastrointestinal symptoms and abnormal calprotectin diagnosed with non-organic disease. Gut 64(Suppl 1): A431.1-A431
Pavlidis, P; Cavazza, A; Siddique, N; Stamoulos, P; Tumova, J; Medcalf, L; Chung-Faye, G; Dubois, P; Bjarnason, I; Hayee, B 2015: PTH-059 Faecal calprotectin identifies non responders to anti-tnf therapy when measured after induction in inflammatory crohns disease. Gut 64(Suppl 1): A431.2-A432
Hulgan, T. 2018: Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update. Current Hiv/Aids Reports 15(3): 223-232
Muhammed, R; Wong, T; Haller, W; Bremner, R; Protheroe, S 2015: PTH-061 Anti-tumour necrosis factor-alfa drug monitoring in paediatric inflammatory bowel disease. Gut 64(Suppl 1): A432.2-A433
Kalla, R; Kennedy, N; Ventham, N; Visconti, M; Adams, A; Jarvie, A; Pattenden, R; Satsangi, J 2015: PTH-062 The utility of serum calprotectin as a biomarker in predicting inflammatory bowel disease. Gut 64(Suppl 1): A433.1-A433
Vermeiden, T.; Braat, F.; Medhin, G.; Gaym, A.; van den Akker, T.; Stekelenburg, J. 2018: Factors associated with intended use of a maternity waiting home in Southern Ethiopia: a community-based cross-sectional study. Bmc Pregnancy and Childbirth 18(1): 38
Rosenberger, J.; McCrudden, S.; McCullough, C.; Wang, L.; Kime, J.; Albert, N.M. 2018: Factors associated with inter-arm blood pressure differences in patients admitted to critical care units. Heart and Lung: the Journal of Critical Care 47(2): 100-106
Mohr, D.C.; Eaton, J.L.; Meterko, M.; Stolzmann, K.L.; Restuccia, J.D. 2018: Factors associated with internal medicine physician job attitudes in the Veterans Health Administration. Bmc Health Services Research 18(1): 244
Speight, R; Davey, T; White, K; Kirby, J; Mansfield, J 2015: PTH-066 Activation of the bile acid receptor, farnesoid-x receptor, maintains gut epithelial cell morphology, possibly via inhibition of myosin light chain kinase expression. Gut 64(Suppl 1): A435.1-A435
Goel, R; Ormond, M; Hullah, E; Nayee, S; Escudier, M; Sanderson, J 2015: PTH-067 An evaluation study of lactobacillus brevis cd2 in orofacial granuolomatosis. Gut 64(Suppl 1): A435.2-A436
Goel, R; Ormond, M; Hullah, E; Nayee, S; Escudier, M; Sanderson, J 2015: PTH-068 The presence of perianal disease in patients with orofacial granulomatosis increases the risk of developing intestinal crohns disease. Gut 64(Suppl 1): A436.1-A436
Powles, S; Hicks, L; Jiménez, B; Merrifield, C; Holmes, E; Williams, H; Orchard, T 2015: PTH-069 Effect of co-morbidities on urinary metabolic profiling in the characterisation of patients with inflammatory bowel disease. Gut 64(Suppl 1): A436.2-A437
Meredith, S; Dibb, M; Ellis, T; Gordon, M; Probert, C; Subramanian, S; Collins, P 2015: PTH-070 Patients receiving anti-tnf agents for inflammatory bowel disease: exposure to diagnostic ionising radiation and trends in imaging modalities. Gut 64(Suppl 1): A437.1-A437
Squires, S; Boal, A; Hamid, R; Heydtmann, M; Naismith, G 2015: PTH-071 Prospective anti-tnf withdrawal in quiescent crohns disease 12 month clinical outcomes. Gut 64(Suppl 1): A437.2-A437
Subramaniam, S; Makanyanga, J; Whitley, L; Murray, C; Shah, N; Watson, T; McCartney, S; Kiparassi, F 2015: PTH-072 Diagnostic yield of mr enterography versus wireless video capsule endoscopy in suspected small bowel paediatric crohns disease. Gut 64(Suppl 1): A438.1-A438
Whitehead, S; Brookes, M; French, J; Ford, C; Gama, R 2015: PTH-075 The effect of storage conditions on the stability of faecal calprotectin. Gut 64(Suppl 1): A439.1-A439
Both, C.P.; Thomas, Jörg.; Bühler, P.K.; Schmitz, A.; Weiss, M.; Piegeler, T. 2018: Factors associated with intravenous lidocaine in pediatric patients undergoing laparoscopic appendectomy - a retrospective, single-centre experience. Bmc Anesthesiology 18(1): 88
Zammit, S Chetcuti; Caruana, M; Katsanos, K; Mantzaris, G; Cesarini, M; Kopylov, U; Zammit, L; Brookes, M; Ellul, P 2015: PTH-077 Fertility and pregnancy related misconceptions in female patients with inflammatory bowel disease. Gut 64(Suppl 1): A440.1-A440
Zammit, S Chetcuti; Caruana, M; Katsanos, K; Mantzaris, G; Cesarini, M; Kopylov, U; Zammit, L; Brookes, M; Ellul, P 2015: PTH-078 Pregnancy outcomes in female patients with inflammatory bowel disease. Gut 64(Suppl 1): A440.2-A441
Grainger, S; Jones, S 2015: PTH-079 Vitamin d deficiency in active crohns disease: cause or consequence?. Gut 64(Suppl 1): A441.1-A441
Zhou, X.; Fang, J.; Luo, J.; Wang, H.; Du, Q.; Huang, G.; Feng, B. 2018: Factors associated with introduction of solid, semi-solid or soft foods among infants aged 6-8 months in poor rural areas in Hunan Province in 2015. Wei Sheng Yan Jiu 47(1): 46-50
Akbar, T; Rahmany, S; Harris, R; Cotton, S; McCabe, L-A; Lloyd, D; Gordon, J 2015: PTH-081 Colorectal cancer in inflammatory bowel disease is surveillance working?. Gut 64(Suppl 1): A442.1-A442
Gledhill, T; Bodger, K 2015: PTH-082 Factors associated with rating of care and the family and friends test: secondary analysis of the uk ibd audit inpatient experience survey. Gut 64(Suppl 1): A442.2-A443
Dolo, H.; Coulibaly, Y.I.; Kelly-Hope, L.; Konate, S.; Dembele, B.; Coulibaly, S.Y.; Sanogo, D.; Soumaoro, L.; Coulibaly, M.E.; Doumbia, S.S.; Diallo, A.A.; Traore, S.F.; Colebunders, R.; Nutman, T.B.; Klion, A.D. 2018: Factors Associated with Wuchereria bancrofti Microfilaremia in an Endemic Area of Mali. American Journal of Tropical Medicine and Hygiene 98(6): 1782-1787
Shivaji, U; Awasthi, A; Kasturi, R; Desai, K 2015: PTH-084 Bullous cutaneous vasculitis-a rare side effect to adalimumab therapy. Gut 64(Suppl 1): A443.2-A444
Chhaya, V; Saxena, S; Cecil, E; Subramanian, V; Curcin, V; Majeed, A; Pollok, R 2015: PTH-085 The use of 5-asa in inflammatory bowel disease: national population based study. Gut 64(Suppl 1): A444.1-A444
Chhaya, V; Saxena, S; Cecil, E; Curcin, V; Subramanian, V; Majeed, A; Pollok, R 2015: PTH-086 Surgery for perianal crohns disease: uk national population based cohort study. Gut 64(Suppl 1): A444.2-A445
Taj-Aldeen, W; Shaul, T; cairnns, T; Sherwood, P 2015: PTH-087 Pre-screening tests for biological therapy: is clinical acumen enough?. Gut 64(Suppl 1): A445.1-A445
Czuber-Dochan, W; Armes, J; Ream, E; Norton, C 2015: PTH-089 Experience of living with fatigue as reported by people diagnosed with inflammatory bowel disease a phenomenological study. Gut 64(Suppl 1): A446.1-A446
De Arruda Amaral, I.C.G.; Baccaro, L.F.; Lui-Filho, J.F.; Osis, M.J.D.; Pedro, A.O.; Costa-Paiva, L.úc. 2018: Factors associated with knowledge about menopause and hormone therapy in middle-aged Brazilian women: a population-based household survey. Menopause 25(7): 803-810
Eknithiset, R.; Samrongthong, R.; Kumar, R. 2018: Factors Associated with Knowledge, Perception, and Practice Toward Self-Care Among Elderly Patients Suffering from Type 2 Diabetes Mellitus in Rural Thailand. Journal of Ayub Medical College Abbottabad: Jamc 30(1): 107-110
Gangadharan, B; Kumar, A; Barnes, E; Klenerman, P; Zitzmann, N 2015: PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics. Gut 64(Suppl 1): A448.1-A448
Handa, S.; Saffari, S.E.; Borchert, M. 2018: Factors Associated With Lack of Vision Improvement in Children With Cortical Visual Impairment. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 38(4): 429-433
Palma, E; Riva, A; Williams, R; Chokshi, S 2015: PTH-094 Are megamitochondria a cellular survival strategy for ethanol-induced liver toxicity?. Gut 64(Suppl 1): A449.1-A449
Macnaughtan, J; Ranchal, I; Soeda, J; Sawhney, R; Oben, J; Davies, N; Mookerjee, R; Marchesi, J; Cox, J; Jalan, R 2015: PTH-095 Oral carbon therapy is associated with a selective modulation of the microbiome in cirrhotic rats which is associated with a significant reduction in inflammatory activation. Gut 64(Suppl 1): A449.2-A450
Beale, K; Vergis, N; Sadiq, F; Petts, G; Khamri, W; Antoniades, H; Thursz, M 2015: PTH-096 Monocyte oxidative burst defect in alcoholic hepatitis is resistant to interferon gamma. Gut 64(Suppl 1): A450.1-A450
Hoare, M; Ito, Y; Kang, T-W; Menon, S; Salama, R; Zender, L; Narita, M 2015: PTH-097 Notch1 is a master regulator of the senescence secretome through repression of c/ebp. Gut 64(Suppl 1): A450.2-A450
Trivedi, P; Bruns, T; Ward, S; Mai, M; Schmidt, C; Hirschfield, G; Weston, C; Adams, D 2015: PTH-098 Connecting liver and gut in psc: ccl25 expression is upregulated in colitis, correlates with inflammatory activity and facilitates effector ccr9+ lymphocyte recruitment. Gut 64(Suppl 1): A451.1-A451
Trivedi, P; Tickle, J; Smith, D; Vainio, J; Hirschfield, G; Weston, C; Adams, D 2015: PTH-099 Vap-1 is elevated in psc, correlates with clinical outcome and exhibits amine oxidase activity in a substrate-dependent manner. Gut 64(Suppl 1): A451.2-A452
Mandalou, P; Robinson, M; Felmlee, D; Sieberhagen, C; Mindos, T; Hegazy, D; MacLaughlan, J; Cramp, M 2015: PTH-100 A comparative gene expression study between individuals with apparent resistance, spontaneous clearance, or chronic infection from hcv. Gut 64(Suppl 1): A452.1-A452
Petts, G; Kudo, H; Dorling, A; Thursz, M; Goldin, R 2015: PTH-101 The role of tissue factor pathway inhibitor (tfpi) in liver injury. Gut 64(Suppl 1): A452.2-A452
Alazawi, W; Heath, H; Petts, G; Kudu, H; Feakins, R; O'Brien, A; Goldin, R; Foster, G 2015: PTH-102 Stat2 is a key inflammatory molecule in human non-alcoholic fatty liver disease and murine liver injury. Gut 64(Suppl 1): A452.3-A453
Schneider, C; Thompson, S; Totz, J; Song, Y; Johnsen, S; Stoyanov, D; Ourselin, S; Gurusamy, K; Hawkes, D; Clarkson, M; Davidson, B 2015: PTH-103 Evaluation of a novel system for image guided laparoscopic liver surgery in an animal model and first clinical experience. Gut 64(Suppl 1): A453-A454
Wiggans, M; Shahtahmassebi, G; Aroori, S; Bowles, M; Briggs, C; Stell, D 2015: PTH-104 Tumour doubling time of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival. Gut 64(Suppl 1): A454.1-A454
Iype, S; Harper, S; Huguet, E; Jah, A 2015: PTH-105 Salvage hepatectomy in failed portal vein embolisation. Gut 64(Suppl 1): A454.2-A454
Sifaki-Pistola, D; Mantaka, A; Koulentaki, M; Samonakis, D; Karageorgos, S; Stratakou, S; Digenakis, E; Kouroumalis, E 2015: PTH-107 Geoepidemiology of hepatocellular carcinoma (hcc) in the island of crete. a possible role of pesticides. Gut 64(Suppl 1): A455.1-A455
Ellis, J 2015: PTH-108 Predictors of complications after hpb resections. Gut 64(Suppl 1): A455.2-A456
Corless, L; Majeed, F; West, A; Abouda, G 2015: PTH-109 Hepatocellular carcinoma: opportunities in primary and secondary care to improve patient outcomes. Gut 64(Suppl 1): A456.1-A456
Mcphail, M; Abbott, L; Al-Kadhimi, G; Kane, P; Karani, J; Heaton, N; O'Grady, J; Bomford, A; Suddle, A 2015: PTH-110 Long term survival following treatment for hepatocellular carcinoma in patients with hereditary haemochromatosis. Gut 64(Suppl 1): A456.2-A456
Ladep, N; Noorullah, O; Sieberhagen, C; Boland, E; Ding, W; Cross, T; Sturgess, R; Stern, N 2015: PTH-111 Alpha-fetoprotein (afp) in hepatocellular carcinoma (hcc): determination of optimum cut-off value for prognosis. Gut 64(Suppl 1): A457.1-A457
Ladep, N; Noorullah, O; Sieberhagen, C; Boland, E; Ding, W; Cross, T; Sturgess, R; Stern, N 2015: PTH-112 Changing trends in hepatocellular carcinoma presentation: a 5-year regional hepatobiliary centre experience in liverpool, uk. Gut 64(Suppl 1): A457.2-A457
Ladep, N; Aujla, U; Dwyer, L; Noorullah, O; Hood, S; Stern, N; Sturgess, R 2015: PTH-113 Factors affecting survival outcomes in patients with cholangiocarcinoma a uk regional hepato-biliary centre experience. Gut 64(Suppl 1): A457.3-A458
Ladep, N; Aujla, U; Dwyer, L; Noorullah, O; Hood, S; Stern, N; Sturgess, R 2015: PTH-114 Usefulness of pre-treatment serum CA19-9 concentration in prediction of prognosis for patients with intrahepatic bile duct tumours. Gut 64(Suppl 1): A458.1-A458
Choy, P; Sufi, J; Glaser, S; Alpini, G; Heaton, N; Williams, R; Quaglia, A; Syn, W-K; Bubici, C; Papa, S 2015: PTH-115 Inhibition of mapk signalling promotes cell cycle arrest and sensitises intrahepatic cholangiocarcinoma cells to chemotherapy. Gut 64(Suppl 1): A458.2-A459
Kia, R; Buck, I; Clark, K; Halpen, A; Farrell, C; Palmer, D; Cross, T 2015: PTH-116 Evaluation of the damico clinical staging system and the albi grade for prognostication in cirrhosis and hepatocellular carcinoma. Gut 64(Suppl 1): A459.1-A459
AlDuwaisan, A; Pathak, S; Khoyratty, F; Miskovic, D; Prasad, R 2015: PTH-117 What are the long- and short-term effects of polymorbidity following resection for colorectal liver metastases?. Gut 64(Suppl 1): A459.2-A459
Onali, S; Marshall, A; Sharma, D; O'Donoghue, P; Dannhorn, E; Johnson, P; O'Beirne, J 2015: PTH-118 Albi score predicts survival in patients with bclc 0/a stage hepatocellular carcinoma (HCC) independently of child pugh (CP) score and treatment allocation. Gut 64(Suppl 1): A459.3-A460
Onali, S; Al-Nujaidi, D; Al-Rubaish, F; Tsochatzis, E; O'Beirne, J; Marshall, A; Yu, D; Meyer, T; Luong, T; Pinzani, M; Manousou, P 2015: PTH-119 Differences between radiology and histopathology: are we judging wrong? should we lower alpha-fetoprotein cut-off in the selection criteria?. Gut 64(Suppl 1): A460.1-A460
Onali, S; Marshall, A; Sharma, D; O'Donoghue, P; Dannhorn, E; Johnson, P; O'Beirne, J 2015: PTH-120 Albi score predicts survival independently of hepatic venous pressure gradient (HVPG) and indocyanine green (ICG) clearance in HCC patients undergoing resection. Gut 64(Suppl 1): A460.2-A461
Pennycuick, A; McPhail, M; Considine, A; O'Grady, N. Heaton, J; Suddle, A 2015: PTH-121 Transarterial chemoembolisation at kings a comparison of conventional tace vs tace with beads in clinical practice. Gut 64(Suppl 1): A461.1-A461
Al Khathaami, A.M.; Mohammad, Y.O.; Alibrahim, F.S.; Jradi, H.A. 2018: Factors associated with late arrival of acute stroke patients to emergency department in Saudi Arabia. Sage Open Medicine 6: 2050312118776719
Bond, A; Aggio, R; Johnson, P; Berhane, S; Probert, C 2015: PTH-123 Urinary volatile organic compounds as a biomarker for hepatocellular carcinoma (HCC). Gut 64(Suppl 1): A462.1-A462
Norton, B; Adebayo, D; Ramos, K; Smith, A; Cramp, M 2015: PTH-124 Liver transplant outcomes in patients with care devolved to a non-transplanting centre: south west liver unit experience. Gut 64(Suppl 1): A462.2-A463
Vickerstaff, V; Low, J; Davis, S; Bichard, J; Greenslade, L; Hopkins, K; Marshall, A; Thorburn, D; Langford, A; Jones, L 2015: PTH-125 A national survey of palliative care in end stage liver disease in the UK. Gut 64(Suppl 1): A463.1-A463
Saffioti, F; Manousou, P; Aspite, S; Chatzidis, D; Marshall, A; Pinzani, M; Thorburn, D 2015: PTH-126 Azathioprine, steroids and the presence of inflammatory bowel disease before liver transplantation influence transplant free survival in primary sclerosing cholangitis. Gut 64(Suppl 1): A463.2-A464
Kasi, M; Griffiths, B; Butler, A; Mowlem, E; Smith, S; Mierkalns, A; Aithal, G; Wilkes, E; James, M 2015: PTH-127 Nottingham-cambridge liver transplant (OLT) combined service evaluation. Gut 64(Suppl 1): A464.1-A464
Halliday, N; Martin, K; Allen, E; Thorburn, D 2015: PTH-128 The weekend effect: the impact of out-of-hours liver transplantation upon transplant survival. Gut 64(Suppl 1): A464.2-A465
Sagar, N; Tripathi, D 2015: PTH-130 An audit of primary prophylaxis against variceal bleeding in the liver transplant population. Gut 64(Suppl 1): A465.2-A466
John, S; Burnell, P; Robinson, S; Masson, S; Sen, G; Hudson, M; Manas, D 2015: PTH-131 Umbilical hernia repair in cirrhosis: outcomes and prognostic factors in a liver transplant unit. Gut 64(Suppl 1): A466.1-A466
Townsend, S; Dhaliwal, H; Gunson, B; Mutimer, D 2015: PTH-132 Outcomes following transplant for hepatitis c: a single centre study. Gut 64(Suppl 1): A466.2-A467
Davis, S; Low, J; Vickerstaff, V; Greenslade, L; Hopkins, K; Marshall, A; Thorburn, D; Jones, L 2015: PTH-133 Understanding the care pathway of patients with cirrhosis in the last year of life. Gut 64(Suppl 1): A467.1-A467
Onali, S; Mansell, A; Aspite, S; De Luca, L; Tsochatzis, E; O'Beirne, D. Patch, J; Thorburn, D; Pinzani, M; Manousou, P 2015: PTH-134 Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy. Gut 64(Suppl 1): A467.2-A467
Dsouza, S; Garner, M; Westbrook, R 2015: PTH-135 Prevalence and treatment of reduced BMD and vitamin D levels in patients assessed for liver transplantation. Gut 64(Suppl 1): A467.3-A468
Amer, A; Vallance, A; Wright, M; White, S 2015: PTH-136 Activation of the pregnane X receptor (PXR) reduces the risk of early allograft dysfunction following liver transplantation. Gut 64(Suppl 1): A468.1-A468
Foster, G; Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Craxi, A; Buggisch, P; Ryan, R; Lenz, O; Van Dooren, G; Lonjon-Domanec, I; Schlag, M; Buti, M 2015: PTH-137 Safety and efficacy of simeprevir (SMV) plus PEG-IFN/RBV in treatment-nave chronic hepatitis c genotype 1 patients eligible for 12 weeks of treatment. Gut 64(Suppl 1): A468.2-A469
Hidalgo-Lopezosa, P.; Cobo-Cuenca, A.I.; Carmona-Torres, J.M.; Luque-Carrillo, P.; Rodríguez-Muñoz, P.M.; Rodríguez-Borrego, M.ía.A. 2018: Factors associated with late fetal mortality. Archives of Gynecology and Obstetrics 297(6): 1415-1420
Dorrington, M; Saunders, J; Ragunath, K; Parsons, S 2015: PTH-139 The effect of neo-adjuvant chemotherapy on the discrepancy between the eus and pathological staging of oesophageal cancer. Gut 64(Suppl 1): A469.2-A469
Almond, M; Florance, C; Old, O; Oliphant, Z; Barr, H 2015: PTH-140 Dual modality endoscopic therapy for barretts-associated oesophageal dysplasia in a tertiary referral centre: completing the audit cycle. Gut 64(Suppl 1): A469.3-A470
Gebremedhin, G.; Tetemke, D.; Gebremedhin, M.; Kahsay, G.; Zelalem, H.; Syum, H.; Gerensea, H. 2018: Factors associated with latrine utilization among model and non-model families in Laelai Maichew Woreda, Aksum, Tigray, Ethiopia: comparative community based study. Bmc Research Notes 11(1): 586
Hernandez, M; Franklin, M; Glass, J 2015: PTH-142 Laparoscopic assisted surgery (Intraluminal Surgery): gastroduodenal lesions resecction and laparoscopic monitored colonoscopic polypectomy (LMCP). texas endosurgery institute experience. Gut 64(Suppl 1): A470.2-A471
Groene, O; Cromwell, D; Hardwick, R; Fischer, C 2015: PTH-144 Risk adjustment for surgical short-term outcomes for oesophago-gastric cancer patients. Gut 64(Suppl 1): A471.2-A472
Ng, O; Oakley, B; Holmes, S; Saunders, J; Bowman, C; Ayantunde, A; Brookes, M; Acheson, A 2015: PTH-145 The effects of magic and laparoscopic surgery on anaemia and blood transfusions in oesophagectomy. Gut 64(Suppl 1): A472.1-A472
Ng, O; Oakley, B; Holmes, S; Parsons, S; Catton, J; Madhusudan, S; James, E; Brookes, M; Acheson, A 2015: PTH-146 Impact of haemoglobin on survival in oesophagogastric cancer: haemoglobin at diagnosis and prior to surgery predicts survival. Gut 64(Suppl 1): A472.2-A473
Hynes, O; Champion, A; Gardiner, A; Davies, A; Gossage, J 2015: PTH-147 Weight loss in patients undergoing oesophagectomy/total gastrectomy (TG) for oesophagogastric (OG) cancer. Gut 64(Suppl 1): A473.1-A473
Gay, A.C.; Barreto, N.B.; Schrager, S.M.; Russell, C.J. 2018: Factors Associated with Length of Stay and 30-Day Revisits in Pediatric Acute Pancreatitis. Journal of Pediatric Gastroenterology and Nutrition 67(2): E30-E35
Serrani, D.; Galfetti, G.; Rodríguez, C. 2017: Factors associated with length of stay and the risk of readmission in an acute psychiatric inpatient facility: A retrospective study. Vertex 28(134): 260-270
Camprodon, R; Dighe, S; Wan, A; Reddy, M; Vasilikostas, G 2015: PTH-150 Giant hiatus hernias in the laparoscopic era. Gut 64(Suppl 1): A474.2-A474
Evans, R; Evans, J; Kirby, G; Curran, F; Cheruvu, C 2015: PTH-151 Are the current management strategies for T1/T2 n0 oesophageal cancer optimal?. Gut 64(Suppl 1): A475.1-A475
Gray, R; Coleman, H; Lau, K; McCaughey, C; Coyle, P; Murray, L; Johnston, B 2015: PTH-152 Hellers myotomy and pneumatic dilatation in the treatment of achalasia: a population-based case-control study assessing long-term quality of life. Gut 64(Suppl 1): A475.2-A475
Mclean, R; Sturrock, J; Jaretzke, H; Jones, L; Griffin, S 2015: PTH-153 Nutritional enhanced recovery after oesophagectomy: post-pyloric feeding following discharge. Gut 64(Suppl 1): A476.1-A476
Mclean, R; Jones, M; Fung, D; Dixon, S; McCallum, I 2015: PTH-154 Changes in incidence and management of upper gi perforation over 14 years. Gut 64(Suppl 1): A476.2-A476
Markar, S; Mariette, C 2015: PTH-155 Significance of microscopically incomplete resection margin following oesophagectomy for oesophageal cancer. Gut 64(Suppl 1): A476.3-A477
Hey, S; Chalmers, G; Craig, C; MacKay, C; Fullarton, G; Forshaw, M 2015: PTH-156 The role of bronchoscopy and ebus in the modern multidisciplinary management of oesophageal and gastric cancer. Gut 64(Suppl 1): A477.1-A477
Lagarde, S; Navidi, M; Sultan, J; Gisbertz, S; van Laarhoven, H; Meijer, S; Immanuel, A; van Berge Henegouwen, M; Griffin, M 2015: PTH-157 The prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy. Gut 64(Suppl 1): A477.2-A477
Lagarde, S; Navidi, M; Phillips, A; Disep, B; Immanuel, A; Griffin, M 2015: PTH-158 The presence of perineural, blood and lymphvessel invasion after neoadjuvant therapy and oesophagectomy identifies high risk patients for recurrence. Gut 64(Suppl 1): A477.3-A478
Lagarde, S; Jagadesham, V; Gisbertz, S; Immanuel, A; van Berge Henegouwen, M; Griffin, M 2015: PTH-159 The relevance of lymph node metastases in the proximal field of the chest in patients with adenocarcinoma of the gastro-oesophageal junction treated with neoadjuvant therapy followed by transthoracic oesophagectomy. Gut 64(Suppl 1): A478.1-A478
Goh, Y; Goh, Y; Krishnamohan, N; Shetty, V; Turner, P; Ward, J; Pursnani, K; Date, R 2015: PTH-160 Laparoscopic repair of giant hiatus hernia significantly improves quality of life a single centre experience. Gut 64(Suppl 1): A478.2-A479
Wong, C; Aly, E 2015: PTH-161 The effects of immunonutrition in upper gastrointestinal surgery: a systematic review and meta-analysis. Gut 64(Suppl 1): A479.1-A479
Bidgood, E 2015: PTH-162 An audit of nutritional practices in patients with oesophago-gastric malignancies undergoing surgical resection: a single centre cohort study. Gut 64(Suppl 1): A479.2-A479
Grace, E; Mohammed, K; Shaw, C; Andreyev, J; Whelan, K 2015: PTH-163 Malnutrition persists or develops in the majority of patients with upper-gastrointestinal cancer: a longitudinal cohort study. Gut 64(Suppl 1): A480.1-A480
Habermeyer, B.; De Gennaro, H.; Frizi, R.C.; Roser, P.; Stulz, N. 2018: Factors Associated with Length of Stay in a Swiss Mental Hospital. Psychiatric Quarterly 89(3): 667-674
Lemos, L; Miyajima, F; Martins, D Tabajara de Oliveira; Pritchard, D; Burkitt, M 2015: PTH-165 Hexane extracts of calophyllum brasiliense inhibit the development of gastric preneoplasia in helicobacter felis infected ins-gas mice. Gut 64(Suppl 1): A481.1-A481
Griffiths, L; Farrant, J; Colleypriest, B; Tosh, D 2015: PTH-166 Generation of a human oesophageal tissue culture model from forceps biopsies. Gut 64(Suppl 1): A481.2-A481
Farrell, M; Bornschein, J; Zeki, S; DiPietro, M; Fitzgerald, R 2015: PTH-167 Clinico-pathological characteristics of patients under barretts surveillance at a tertiary referral centre. Gut 64(Suppl 1): A482.1-A482
Williams, J; Norman, R; Tang, J; Duckworth, C; Caamano, J; Pritchard, D; Burkitt, M 2015: PTH-168 Tamoxifen induced gastric atrophy is regulated by the nf-b subunit nfkb1. Gut 64(Suppl 1): A482.2-A482
Derakhshan, M; Arnold, M; Brewster, D; Going, J; Mitchell, D; Forman, D; McColl, K 2015: PTH-169 Global inverse associations between gastric and oesophageal adenocarcinoma supports h. pylori infection protecting from latter. Gut 64(Suppl 1): A482.3-A483
Butt, M; Haidry, R; Sehgal, V; Graham, D; Gandy, M; Arez, M; Bloom, E; Khan, S; Puccio, I; Oukrif, D; Banks, M; Hamoudi, R; Rodriguez-Justo, M; Lovat, L; Novelli, M 2015: PTH-170 Evaluating the relationship between clinicopathological variables and mortality in patients with esophagogastric adenocarcinomas. Gut 64(Suppl 1): A483.1-A483
Arez, M; Butt, M; Gandy, M; Sehgal, V; Puccio, I; Hamoudi, R; Haidry, R; Novelli, M; Banks, M; Lovat, L; Rodriguez-Justo, M 2015: PTH-172 Expression patterns of human epidermal growth factor receptor proteins in early gastric cancer. Gut 64(Suppl 1): A484.1-A484
Lewis, N; Vinogradova, Y; Hawkey, C 2015: PTH-173 Trends in the use of nsaids and aspirin and the use of proton pump inhibitors for gastro-duodenal protection in the uk: a cross-sectional study using the cprd database. Gut 64(Suppl 1): A484.2-A485
Old, O; Lloyd, G; Almond, M; Kendall, C; Barr, H; Shore, A; Stone, N 2015: PTH-174 Non-endoscopic screening for barretts oesophagus: identifying neoplasia with infrared spectroscopy. Gut 64(Suppl 1): A485.1-A485
Kelso, M.; Weideman, R.A.; Cipher, D.J.; Feagins, L.A. 2017: Factors Associated with Length of Stay in Veterans with Inflammatory Bowel Disease Hospitalized for an Acute Flare. Inflammatory Bowel Diseases 24(1): 5-11
Hall, P; Reed, O; Mainie, I 2015: PTH-177 Radiofrequency ablation for complicated barretts oesophagus: experience of a tertiary centre in northern ireland at 5 years. Gut 64(Suppl 1): A486.2-A487
Rusu, R-I; Jafari, J; Miah, I; Wong, T 2015: PTH-179 Prolonged reflux monitoring may change the diagnosis of oesophageal hypersensitivity to pathological gastroesophageal reflux. Gut 64(Suppl 1): A487.2-A488
Haidry, R; Lipman, G; Gupta, A; Dunn, J; Smart, H; Bhandari, P; Willert, R; Fullarton, G; di Pietro, M; Gordon, C; Penman, I; Boger, P; Ravi, N; Ang, Y; Novelli, M; Lovat, L 2015: PTH-180 Outcomes of patients who fail initial endoscopic therapy for barretts related neoplasia. Gut 64(Suppl 1): A488.1-A488
Hewett, R; Alexakis, C; Farmer, A; Ainley, J; Chhaya, V; Poullis, A; Kang, J-Y 2015: PTH-181 Eosinophilic oesophagitis in the uk is not associated with a diminution in quality of life. Gut 64(Suppl 1): A488.2-A488
Sultan, S; Shandro, B; Friday, S; Wang, B; Suleman, M; Cooney, J; Paskaran, P; Gupta, S; Mendall, M 2015: PTH-183 Upper gastrointestinal cancer red flag symptoms alone except dysphagia do not predict the presence of upper gastrointestinal tract cancer: implications for practice. Gut 64(Suppl 1): A489.1-A489
Sami, S; di Pietro, M; Ortiz-Fernández-Sordo', J; White, J; Guha, I; Fitzgerald, R; Ragunath, K 2015: PTH-184 Superior patient preference and high diagnostic accuracy for the detection of barretts oesophagus using a novel, portable, probe-based transnasal endoscope. Gut 64(Suppl 1): A489.2-A490
Holmes, G; Hale, M; McAlindon, M; Anderson, S 2015: PTH-185 Mapping the gastric mucosal surface: image mosaicking for capsule endoscopy. Gut 64(Suppl 1): A490.1-A490
Arutyunov, G.P.; Dragunov, D.O.; Sokolova, A.V.; Mitrokhin, V.M.; Kamkin, A.G.; Latyshev, T.V. 2017: Factors associated with levels of interleukins -18, -8, and -6 in hypertensive patients at high and very high cardiovascular risk. Kardiologiia 57(S3): 69-75
De Caestecker, J; Stokes, C; Barr, H; Smart, H; Lovat, L; Ragunath, K; Bhandari, P; Budihal, S 2015: PTH-187 Treatment of barretts early neoplasia (EN) in the UK: results of a survey of gastroenterologists and upper GI surgeons. Gut 64(Suppl 1): A491.1-A491
Spitzer, N.; Phillips, M.T.; Chow, W.; Mangione, T.W. 2018: Factors associated with life jacket use among cabin sailboat and day sailor boaters in the United States. Journal of Safety Research 65: 101-114
Mcclements, S; Roberts, M; Ashcroft, H; Robinson, A 2015: PTH-189 Retrospective analysis of the cancer detection rates in patients referred via the two-week-wait (TWW) upper-gi endoscopy pathway in a single centre prior to the introduction of the national be clear on cancer heartburn awareness campaign. Gut 64(Suppl 1): A492.1-A492
Alaei, A.; Nautiyal, N.; Mishkin, K.; Saifuddin Karimov, D.; Saidi, D.; Alaei, K. 2018: Factors associated with linkage to care for HIV patients in Tajikistan. International Journal of Std and Aids 29(12): 1183-1189
Zhang, X; Ferrier, R; Orange, C; Going, J; Iwata, T; Derakhshan, M 2015: PTH-192 Gastric adenocarcinoma of diffuse type develops on a healthy-looking mucosal background, unlike intestinal type gastric adenocarcinoma. Gut 64(Suppl 1): A493.2-A494
Culkin, A 2015: PTH-193 Time to prescribe? an audit of the management of patients on parenteral nutrition. Gut 64(Suppl 1): A494.1-A494
Charlesworth, A; LeCouteur, J; Newall, S; White, R; O'Sullivan, S; Tocher, K; Ferreira, C; McCarthy, M; Dunn, J 2015: PTH-194 Palliative home parenteral nutrition (HPN) tertiary gi oncology centre audit of practice. Gut 64(Suppl 1): A494.2-A495
Meehan, S.-A.; Sloot, R.; Draper, H.R.; Naidoo, P.; Burger, R.; Beyers, N. 2018: Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa. Plos one 13(4): E0195208
Adaba, F; Iqbal, F; Vaizey, C; Gabe, S; Warusavitarne, J; Nightingale, J 2015: PTH-196 Chronic cholestasis and parenteral nutrition: prevalence and effect of bowel restoration surgery. Gut 64(Suppl 1): A495.2-A495
Abreu, D.; Salomé Cabral, M.; Ribeiro, F. 2014: Factors associated with longer delays in reperfusion in ST-segment elevation myocardial infarction. International Journal of Cardiology. Heart and Vessels 4: 97-101
Le Couteur, J; Patel, K; O'Sullivan, S; Ferreira, C; Williams, A; Darakhshan, A; Irving, P; Sanderson, J; McCarthy, M; Dunn, J 2015: PTH-198 Preoperative parenteral nutrition in crohns disease patients requiring abdominal surgery. Gut 64(Suppl 1): A496.2-A496
Beeby, I; Elston, J 2015: PTH-199 Home parenteral nutrition: safe and effective documentation. Gut 64(Suppl 1): A497.1-A497
Fragkos, K; Samaan, M; Morgan, S; Barnova, I; Smith, L; Babington, M; Patel, P; Keane, N; Rahman, F; Di Caro, S 2015: PTH-200 Amino acid profiles in patient with intestinal failure: preliminary data on biochemical insights. Gut 64(Suppl 1): A497.2-A498
Oudenhoven, L.M.; van der Krogt, M.M.; Romei, M.; van Schie, P.E.M.; van de Pol, L.A.; van Ouwerkerk, W.J.R.; Harlaar, J.; Buizer, A.I. 2019: Factors Associated with Long-Term Improvement of Gait After Selective Dorsal Rhizotomy. Archives of Physical Medicine and Rehabilitation 100(3): 474-480